Drug Test False PositivesWhich Medicines Can Make a Urine Drug Screen Read Positive

Look up your test or a drug you take

Some medicines can make a urine drug screen read positive for a drug you never took. Look up your test or a drug you take below.

Dr. Brian Staiger, PharmD, BCPS

Researched, compiled and medically reviewed by ⁠

Clinical pharmacistUpdated Sources ↓

A pharmacist’s research of 488 published studies, case reports and test makers’ instructions, compiled into 1,236 entries for 43 urine tests. Every entry cites its sources.

Look Up Your Test or a Drug You Take

Or ask a question in your own words

Matching tests appear below as you type. You can also type the short code on your report, like BZO or THC.

Or tap the test

Other tests on a report

Tap a test to see what can make it read positive.

What Can Cause a False Positive Fentanyl Test?

Use this section when the report specifically says fentanyl. Laboratories use different fentanyl assays, and their responses to other medicines can differ.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 6 kinds of results in this list

Has Caused a False Positive23

Studies or case reports found it can make the screen read positive for a drug that was not there. How often that happens at a usual dose is not known.

  • CiprofloxacinCiproSeen in people taking it, and again in lab experiments.
    1 source, 2023
    • Clinical samples with unconfirmed fentanyl screens contained ciprofloxacin.
    • Spiked urine turned positive above 40 micrograms/mL, a level observed in five of six false-positive specimens evaluated for ciprofloxacin.

    What each source found

  • DextromethorphanDelsym, DXMSeen in people taking it, and again in lab experiments.
    2 sources, 2018 to 2024
    • The earlier reagent produced a positive with 40,000 ng/mL dextromethorphan in drug-free urine.
    • In a later Lin-Zhi II study, two people with known dextromethorphan exposure had unconfirmed low-positive screens.

    What each source found

  • HaloperidolHaldolSeen in people taking it, and again in lab experiments.
    2 sources, 2017 to 2024
    • Haloperidol was among three drugs implicated in clinical samples and verified by spiking urine.
    • The FDA decision summary also documents a positive result with added haloperidol.

    What each source found

  • MethamphetamineD-methamphetamine, DesoxynSeen in people taking it, and again in lab experiments.
    2 sources, 2017 to 2022
    • A forensic laboratory traced a series of unexpected screens to urine methamphetamine above 40 micrograms/mL on the Neogen assay.
    • The SEFRIA submission also reports reactivity at 70 micrograms/mL.

    What each source found

  • OfloxacinFloxinSeen in people taking it, and again in lab experiments.
    1 source, 2023
    • Desmethyl-ofloxacin produced a positive signal at a concentration found in clinical specimens.
    • Ofloxacin itself produced a partial response and the N-oxide metabolite did not react.

    What each source found

  • PaliperidoneInvega, 9-hydroxyrisperidoneSeen in people taking it, and again in lab experiments.
    3 sources, 2014 to 2026
    • Paliperidone is 9-hydroxyrisperidone and reacted in laboratory testing.
    • A patient receiving paliperidone screened positive, with neither fentanyl nor its metabolites detected on follow-up LC-MS/MS.

    What each source found

  • RisperidoneRisperdal, Risperdal ConstaSeen in people taking it, and again in lab experiments.
    5 sources, 2014 to 2026
    • Five of seven DRI false positives contained risperidone and its active metabolite.
    • Reagent testing confirmed reactivity.
    • Additional reports include three patients taking long-acting injectable risperidone.

    What each source found

  • TrazodoneDesyrel, OleptroSeen in people taking it, and again in lab experiments.
    2 sources, 2017 to 2024
    • Trazodone was identified in the hospital's investigation of unconfirmed fentanyl screens.
    • Spiking experiments reproduced interference.
    • The original submission also found reactivity with high concentrations of the metabolite mCPP.

    What each source found

  • AmitriptylineElavilOnly in lab experiments so far, not in people taking it.
    1 source, 2017

    Urine spiked with amitriptyline at 75 micrograms/mL met the fentanyl screen cutoff.

    What each source found

  • BenzylpiperazineOnly in lab experiments so far, not in people taking it.
    1 source, 2017

    Urine spiked with benzylpiperazine at 50 micrograms/mL met the fentanyl screen cutoff.

    What each source found

  • ChlorpromazineThorazineOnly in lab experiments so far, not in people taking it.
    1 source, 2017

    Urine spiked with chlorpromazine at 75 micrograms/mL met the fentanyl screen cutoff.

    What each source found

  • ClomipramineAnafranilOnly in lab experiments so far, not in people taking it.
    1 source, 2017

    Urine spiked with clomipramine at 45 micrograms/mL met the fentanyl screen cutoff.

    What each source found

  • CyclobenzaprineAmrix, FlexerilOnly in lab experiments so far, not in people taking it.
    1 source, 2017

    Urine spiked with cyclobenzaprine at 100 micrograms/mL met the fentanyl screen cutoff.

    What each source found

  • DesipramineNorpraminOnly in lab experiments so far, not in people taking it.
    1 source, 2017

    Urine spiked with desipramine at 100 micrograms/mL met the fentanyl screen cutoff.

    What each source found

  • DiphenhydramineBenadryl, Unisom SleepGelsOnly in lab experiments so far, not in people taking it.
    1 source, 2017

    Urine spiked with diphenhydramine at 100 micrograms/mL met the fentanyl screen cutoff.

    What each source found

  • DoxepinSilenor, SinequanOnly in lab experiments so far, not in people taking it.
    1 source, 2017

    Urine spiked with doxepin at 100 micrograms/mL met the fentanyl screen cutoff.

    What each source found

  • FenfluramineFinteplaOnly in lab experiments so far, not in people taking it.
    1 source, 2017

    Urine spiked with fenfluramine at 60 micrograms/mL met the fentanyl screen cutoff.

    What each source found

  • FluoxetineProzacOnly in lab experiments so far, not in people taking it.
    1 source, 2017

    Urine spiked with fluoxetine at 60 micrograms/mL met the fentanyl screen cutoff.

    What each source found

  • ImipramineTofranilOnly in lab experiments so far, not in people taking it.
    1 source, 2017

    Urine spiked with imipramine at 100 micrograms/mL met the fentanyl screen cutoff.

    What each source found

  • NortriptylinePamelorOnly in lab experiments so far, not in people taking it.
    1 source, 2017

    Urine spiked with nortriptyline at 100 micrograms/mL met the fentanyl screen cutoff.

    What each source found

  • PentazocineTalwinOnly in lab experiments so far, not in people taking it.
    1 source, 2017

    Urine spiked with pentazocine at 75 micrograms/mL met the fentanyl screen cutoff.

    What each source found

  • PhencyclidinePCPOnly in lab experiments so far, not in people taking it.
    1 source, 2017

    Urine spiked with phencyclidine at 100 micrograms/mL met the fentanyl screen cutoff.

    What each source found

  • PipamperoneDipiperonOnly in lab experiments so far, not in people taking it.
    1 source, 2017

    Urine spiked with pipamperone at 1.5 micrograms/mL met the fentanyl screen cutoff.

    What each source found

Depends on the Brand of Test4

Some brands of the screen reacted to it and others did not, or the studies disagree. The lab can tell you which brand it used.

  • LabetalolNormodyne, TrandateIn people and in lab experiments, some brands reacted and others did not.
    4 sources, 2017 to 2024
    • A hospital investigation found labetalol among the major interferents and reproduced interference by spiking.
    • Three pregnant or recently pregnant patients also had presumptive fentanyl positives while taking it.

    What each source found

  • LoperamideImodiumIn people and in lab experiments, some brands reacted and others did not.
    2 sources, 2022 to 2025
    • At high concentrations, loperamide and its N-desmethyl metabolite triggered the first three assays.
    • The other three were negative under the follow-up study conditions.
    • One patient specimen had enough loperamide-related material to explain the initial result.

    What each source found

  • AlfentanilAlfentaIn lab experiments, some brands reacted and others did not.
    3 sources, 2006 to 2025
    • The related anesthetic alfentanil produced a positive at 10,000 ng/mL in the device's spiking study.
    • None of the four reagents detected added Alfentanil in the study’s series tested at 1, 10 and 100 ng/mL.
    • The experimental antibody showed less than 1% relative response to Alfentanil.

    What each source found

  • SufentanilDsuvia, SufentaIn lab experiments, some brands reacted and others did not.
    4 sources, 2006 to 2025
    • Sufentanil, an opioid anesthetic related to fentanyl, produced a positive at 1,000 ng/mL in the device's spiking study.
    • Neither reagent detected norsufentanil, a metabolite of sufentanil, in the studied series up to 100 ng/mL.
    • The four reagents did not detect the metabolite norsufentanil in the 1–100 ng/mL challenge series.
    • The experimental antibody showed less than 1% relative response to Sufentanil.

    What each source found

The Test Is Made to Find It1

It is the drug the test looks for, contains it, or the body turns it into it. A positive here can be real.

  • FentanylDuragesic, SublimazeA positive here is expected, not a false positive.
    11 sources, 1995 to 2025
    • Medically administered fentanyl can give a genuine fentanyl result.
    • The laboratory can compare the detected analytes with the medication and anesthesia record.
    • Fentanyl in a labor epidural has produced true positives in maternal and neonatal urine.
    • The assay detected fentanyl in urine from surgical patients receiving the drug.
    • Its antibody responded less to norfentanyl than to fentanyl.
    • Norfentanyl showed approximately 7% relative reactivity with ARK II and 0.005% with the SEFRIA method studied.
    • Two specimens from patients prescribed fentanyl were ARK-positive and FEN2-negative.
    • The authors found that different parent-drug and norfentanyl cutoffs affected detection.
    • A historical 2 ng/mL urine HEIA was evaluated against LC-MS/MS.
    • In a separate chronic opioid therapy cohort, Immunalysis HEIA detected 37 of 38 LC-MS/MS-positive urine specimens in the initial evaluation.
    • The authors classified positive fentanyl screens after labor epidural fentanyl as expected in their obstetric cohort.
    • The same investigators' preliminary report found only 0.05–0.20% relative response to norfentanyl in fortified urine.

    What each source found

Tested With No False Positive, or Not Proven (6)

Suspected, but Not Proven2

A report, a list or a study names it, but no study we found showed it makes the screen read positive.

  • ZiprasidoneGeodonSuspected in a case report, but not shown to cause it.
    1 source, 2022
    • A patient taking ziprasidone had an unexpected fentanyl screen.
    • The authors suspected ziprasidone because of the history and its structural relationship to risperidone.

    What each source found

  • IloperidoneFanaptNamed in a list, but no study we found shows it.
    2 sources, 2014 to 2022
    • Our earlier answer on fentanyl false positives lists iloperidone.
    • The study usually cited for it tested risperidone and its active metabolite, 9-hydroxyrisperidone, on the DRI fentanyl screen, and reported no result for iloperidone.

    What each source found

Tested: No False Positive Found4

It was tested and did not make the screen read positive. Other brands of the test can differ.

  • Alpha methylfentanylIn lab experiments, this test stayed negative.
    1 source, 2006

    The experimental antibody showed 5% relative response to Alpha methylfentanyl.

    What each source found

  • LidocaineLignocaine, XylocaineIn lab experiments, this test stayed negative.
    1 source, 2017

    At 100,000 ng/mL, lidocaine did not change the near-cutoff classifications in the SEFRIA urine interference experiment.

    What each source found

  • LofentanilIn lab experiments, this test stayed negative.
    1 source, 2006

    The experimental antibody showed less than 1% relative response to Lofentanil.

    What each source found

  • RemifentanilUltivaIn lab experiments, this test stayed negative.
    2 sources, 2024 to 2025
    • Remifentanil did not produce a positive at the tested concentration of 20,000 ng/mL on this fentanyl line.
    • None of the four reagents detected added Remifentanil in the study’s series tested at 1, 10 and 100 ng/mL.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Amphetamines Test?

Check whether the report names an amphetamine class screen, methamphetamine, or MDMA. The targets and cross-reactions differ.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 6 kinds of results in this list

Has Caused a False Positive46

Studies or case reports found it can make the screen read positive for a drug that was not there. How often that happens at a usual dose is not known.

  • BisoprololZebetaSeen in people taking it, and again in lab experiments.
    2 sources, 2023 to 2026
    • Bisoprolol reacted with CEDIA at 400 micrograms/mL in spiked urine.
    • In a small emergency-department comparison, investigators also associated one unconfirmed lateral-flow result with bisoprolol.

    What each source found

  • BuflomedilLoftylSeen in people taking it, and again in lab experiments.
    1 source, 1997
    • Patient urine and drug-free urine spiked with buflomedil yielded false positives on the monoclonal reagent.
    • The polyclonal test was negative in that study.

    What each source found

  • BupropionAplenzin, WellbutrinSeen in people taking it, and again in lab experiments.
    5 sources, 2009 to 2016
    • In a hospital chart review, bupropion was a recorded prescription in 53 of 128 emergency department amphetamine screens that failed confirmation.
    • Laboratory and specimen studies implicate bupropion metabolites, including hydroxybupropion and erythrohydrobupropion.
    • A separate case report describes a presumptive amphetamine result in an infant with a severe bupropion overdose.

    What each source found

  • ChloroquineAralenSeen in people taking it, and again in lab experiments.
    1 source, 2017
    • After a large ingestion, two urine samples tested positive on DRI.
    • Added chloroquine also reacted with DRI and EMIT II Plus.

    What each source found

  • CyclamateCyclohexylsulfamate, Sodium cyclamateSeen in people taking it, and again in lab experiments.
    2 sources, 1991 to 2017
    • An unconfirmed result led investigators to identify urinary cyclohexylamine, a possible cyclamate metabolite.
    • They reproduced cross-reactivity with cyclohexylamine in the TDx system.
    • The modified assay yielded 5% for cyclohexylamine, a cyclamate metabolite relative response.

    What each source found

  • DimethylamylamineDMAA, GeranamineSeen in people taking it, and again in lab experiments.
    4 sources, 2011 to 2017
    • A military investigation detected DMAA by LC-MS/MS in 92.3% of 134 selected specimens that screened positive but failed GC-MS confirmation for amphetamines.
    • A multi-ingredient Thermal Pro overdose case named DMAA or bitter orange components as possible explanations for an unconfirmed amphetamine screen.
    • In the Dimethylamylamine challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 50 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 5 µg/mL.
    • The modified assay yielded 4.2% relative response to Dimethylamylamine.

    What each source found

  • EsmololBreviblocSeen in people taking it, and again in lab experiments.
    2 sources, 2019 to 2021
    • Both esmolol and esmolol acid reacted in laboratory urine testing.
    • A separate report described a false-positive urine screen during esmolol administration.

    What each source found

  • ImatinibGleevec, GlivecSeen in people taking it, and again in lab experiments.
    2 sources, 2019 to 2021
    • The reference-standard experiment produced a positive screen at 216.6 micrograms/mL.
    • A separate patient had recurrent positive screens after restarting imatinib and negative maternal urine GC-MS.

    What each source found

  • KavaKava kava, KavainSeen in people taking it, and again in lab experiments.
    1 source, 2020
    • Three unconfirmed urine screens contained kavain, a kava constituent.
    • Tested kava powders and purified kavain reacted with the screen.
    • GC-MS found no amphetamine-type substances.

    What each source found

  • LabetalolNormodyne, TrandateSeen in people taking it, and again in lab experiments.
    6 sources, 1995 to 2026
    • The urinary metabolite 3-amino-1-phenylbutane reacted with several amphetamine screens.
    • Positive results have been reported in pregnancy.
    • In one case the urine tested positive on a cassette and negative on CEDIA.
    • A UK external quality assessment included a specimen fortified with labetalol at 5 µg/L.
    • Across the six amphetamine-interferent challenges, some laboratories reported amphetamine.

    What each source found

  • MesocarbSeen in people taking it, and again in lab experiments.
    1 source, 1996

    Both assays showed reactivity with Mesocarb in the authors’ stimulant study.

    What each source found

  • MethoxyphenamineSeen in people taking it, and again in lab experiments.
    2 sources, 1996 to 2024
    • The manufacturer observed a cutoff-equivalent response to methoxyphenamine added to drug-free urine.
    • Both assays showed reactivity with Methoxyphenamine in the authors’ stimulant study.

    What each source found

  • MethyldopaAldometSeen in people taking it, and again in lab experiments.
    2 sources, 2019 to 2026
    • An EHR-based study reproduced interference with the metabolite alpha-methyldopamine at 13.6 micrograms/mL.
    • Parent methyldopa and 3-O-methyldopa were negative under the tested conditions.

    What each source found

  • Methylene blueMethylthioninium chloride, ProvayBlueSeen in people taking it, and again in lab experiments.
    2 sources, 2025 to 2026
    • A published report describes two false-positive urine amphetamine screens associated with methylene blue.
    • In a separate laboratory study, adding more than 0.08 mg/L methylene blue to urine increased the signal on the Roche cobas c702 amphetamines assay.

    What each source found

  • MetoprololLopressor, Toprol-XLSeen in people taking it, and again in lab experiments.
    2 sources, 2020 to 2023
    • After metoprolol poisoning, two patients had positive screens with negative GC-MS confirmation.
    • In spiked urine, metoprolol and two metabolites reacted with the Abbott amphetamine screen.

    What each source found

  • MexiletineMexitilSeen in people taking it, and again in lab experiments.
    3 sources, 2009 to 2021
    • Urine from two mexiletine-treated patients screened positive on all four named assays and was negative for amphetamines by mass spectrometry.
    • Adding mexiletine to drug-free urine reproduced the reactions.
    • In a later case, a patient taking mexiletine had two positive urine screens followed by negative quantitative urine testing.

    What each source found

  • PhentermineAdipex-P, LomairaSeen in people taking it, and again in lab experiments.
    7 sources, 1996 to 2026
    • Phentermine cross-reacted in spiked urine at 7.5 micrograms/mL on EMIT II Plus.
    • Clinical studies identified phentermine in unconfirmed positives, including on an immunochromatographic screen.
    • Both assays showed reactivity with Phentermine in the authors’ stimulant study.
    • In a comparison with 50 ng/mL target standards, the assay's relative response to Phentermine was 61%.
    • Phentermine distorted quantitation of d-amphetamine on one confirmatory GC-MS method through chromatographic interference.
    • A UK external quality assessment included three specimens fortified with phentermine at 4.5 mg/L.
    • Across the six amphetamine-interferent challenges, some laboratories reported amphetamine.

    What each source found

  • ProcainamideProcan, PronestylSeen in people taking it, and again in lab experiments.
    2 sources, 2019 to 2026
    • Procainamide and N-acetyl-3-hydroxyprocainamide each triggered this screen in fortified urine.
    • A separate clinical comparison implicated procainamide in discordant samples.

    What each source found

  • PsilocinSeen in people taking it, and again in lab experiments.
    1 source, 2006
    • A urine sample containing psilocin screened positive on the combined amphetamine/methamphetamine assay.
    • A laboratory experiment also showed a small response to added psilocin.

    What each source found

  • SolriamfetolSunosiSeen in people taking it, and again in lab experiments.
    3 sources, 2023 to 2026
    • A patient taking solriamfetol had an unexpected amphetamine screen.
    • EMIT II Plus and DRI experiments reproduced cross-reactivity.
    • Mass spectrometry did not detect amphetamine in the solriamfetol-spiked samples.

    What each source found

  • TetracaineAmethocaine, PontocaineSeen in people taking it, and again in lab experiments.
    2 sources, 2021 to 2026
    • Tetracaine in urethral ointment used during catheterization was detected in many unconfirmed amphetamine-positive urine samples.
    • Spiking drug-free urine reproduced the signal above 40 mg/L.

    What each source found

  • TrazodoneDesyrel, OleptroSeen in people taking it, and again in lab experiments.
    2 sources, 2011 to 2024
    • Trazodone is converted to m-chlorophenylpiperazine (mCPP).
    • This metabolite reacted with Roche and DRI screens.
    • Patient urine with measurable mCPP tested negative for amphetamine, methamphetamine and MDMA by GC-MS.

    What each source found

  • ChlorpromazineThorazineSeen in people taking it, and a second test proved it false.
    4 sources, 1992 to 2006
    • All 13 chlorpromazine-treated patients in one study screened positive on monoclonal EMIT and negative on the polyclonal reagent.
    • Gas chromatography found no amphetamine.
    • Other work implicated urinary metabolites.

    What each source found

  • EphedraEphedra sinica, Ma huangSeen in people taking it, and a second test proved it false.
    1 source, 2001
    • Some patients receiving ephedra-containing herbal preparations screened positive for amphetamines.
    • Follow-up HPLC or GC-MS did not verify the presumptive results.

    What each source found

  • FluspirileneImapSeen in people taking it, and a second test proved it false.
    1 source, 1993
    • Five patients receiving fluspirilene had positive monoclonal screens.
    • Polyclonal testing and gas chromatography were negative.

    What each source found

  • MebeverineColofac, DuspatalinSeen in people taking it, and a second test proved it false.
    2 sources, 2001 to 2006
    • After a single oral administration, urine screened positive for amphetamines.
    • GC-MS found structurally related mebeverine metabolites, including p-methoxyamphetamine.
    • A forensic report describes mebeverine, mebeverine-alcohol and associated compounds as potential amphetamine immunoassay cross-reactants.

    What each source found

  • PipotiazinePiportil, PipothiazineSeen in people taking it, and a second test proved it false.
    1 source, 1993
    • Two of four patients receiving depot pipotiazine screened positive on the monoclonal test.
    • All four were negative on the polyclonal test.
    • Gas chromatography found no amphetamine.

    What each source found

  • BrompheniramineBrompheniramine maleateSeen in a case report about a person taking it.
    1 source, 1992

    A historical laboratory letter implicated urinary brompheniramine metabolites in false-positive amphetamine results on monoclonal EMIT.

    What each source found

  • EtryptamineAlpha-ethyltryptamine, MonaseSeen in a case report about a person taking it.
    1 source, 1986
    • A report investigating fatal etryptamine intoxication describes cross-reactivity on the EMIT-st amphetamine assay.
    • The drug had formerly been sold as an antidepressant.

    What each source found

  • FenofibrateAntara, TricorSeen in a case report about a person taking it.
    2 sources, 2012 to 2018
    • A patient taking fenofibrate repeatedly screened positive on this combined amphetamine/ecstasy test.
    • Definitive analysis excluded the screened drugs, and the results became negative after the prescription was discontinued.

    What each source found

  • Penicillin G benzathineBenzathine benzylpenicillin, Bicillin L-ASeen in a case report about a person taking it.
    2 sources, 1987 to 1998
    • Older reports describe unexpected amphetamine-positive urine results after benzathine penicillin G.
    • The investigators implicated the benzathine salt.

    What each source found

  • PerazineTaxilanSeen in a case report about a person taking it.
    1 source, 1996

    A case published in 1996 reports a false-positive amphetamine screen during perazine poisoning.

    What each source found

  • RitodrineYutoparSeen in a case report about a person taking it.
    1 source, 1989

    A 1989 clinical letter reported a false-positive urine amphetamine screen associated with ritodrine.

    What each source found

  • Thermal Pro (studied formulation)Thermal Pro, ThermalProSeen in a case report about a person taking it.
    2 sources, 2012 to 2013
    • A person who reported ThermalPro and Tisercin had an amphetamine screen that did not confirm.
    • The authors suspected ingredients in the multi-ingredient stimulant supplement.
    • A patient who took nine tablets had a positive urine screen and negative blood and urine LC-MS/MS for amphetamine.

    What each source found

  • ApomorphineApokynOnly in lab experiments so far, not in people taking it.
    1 source, 2014

    In the FDA specificity study, apomorphine at 50 micrograms/mL produced a positive amphetamine result.

    What each source found

  • AtenololTenorminOnly in lab experiments so far, not in people taking it.
    1 source, 2023

    Urine fortified with atenolol at 750 micrograms/mL screened positive.

    What each source found

  • Ceftaroline fosamilTeflaro, ZinforoOnly in lab experiments so far, not in people taking it.
    1 source, 2019

    Added ceftaroline fosamil generated a positive result at an estimated 53.1 micrograms/mL.

    What each source found

  • DiethylstilbestrolDESOnly in lab experiments so far, not in people taking it.
    1 source, 2022

    The FDA submission lists positive results for diethylstilbestrol added at 2.5 micrograms/mL on AMP 500 and 5 micrograms/mL on AMP 1000.

    What each source found

  • IsomethepteneIsometheptene mucateOnly in lab experiments so far, not in people taking it.
    3 sources, 1987 to 2024
    • A laboratory publication described EMIT cross-reactivity.
    • Siemens also documents a cutoff-equivalent response from isometheptene in fortified urine on EMIT II Plus.

    What each source found

  • MetaraminolAramineOnly in lab experiments so far, not in people taking it.
    1 source, 2023

    Metaraminol spiked into drug-free urine at 500 micrograms/mL triggered this assay.

    What each source found

  • MoxifloxacinAveloxOnly in lab experiments so far, not in people taking it.
    1 source, 2019

    Moxifloxacin added to drug-free urine cross-reacted with the Abbott amphetamine/methamphetamine assay at concentrations the authors considered relevant to urinary exposure.

    What each source found

  • QuinacrineAtabrine, MepacrineOnly in lab experiments so far, not in people taking it.
    1 source, 2024
    • Quinacrine was reactive only at very high concentrations in the manufacturer’s fortified-urine data.
    • At the lowest screen cutoff studied, the tested concentration was 2.5 mg/mL.

    What each source found

  • SertralineZoloftOnly in lab experiments so far, not in people taking it.
    1 source, 2023

    Sertraline produced a positive at 200 micrograms/mL in a spiked urine experiment.

    What each source found

  • SildenafilRevatio, ViagraOnly in lab experiments so far, not in people taking it.
    1 source, 2023

    Added sildenafil triggered a positive at 25 micrograms/mL in drug-free urine.

    What each source found

  • TranylcypromineParnateOnly in lab experiments so far, not in people taking it.
    1 source, 2016

    Tranylcypromine added to synthetic urine generated a positive screen at 20 micrograms/mL.

    What each source found

  • VerapamilCalan, VerelanOnly in lab experiments so far, not in people taking it.
    1 source, 2023

    Investigators obtained a positive result with added verapamil at 1,250 micrograms/mL.

    What each source found

Depends on the Brand of Test47

Some brands of the screen reacted to it and others did not, or the studies disagree. The lab can tell you which brand it used.

  • AmineptineIn people and in lab experiments, some brands reacted and others did not.
    1 source, 1996

    Only the Amphetamine/Methamphetamine II reagent detected Amineptine in the study.

    What each source found

  • AripiprazoleAbilifyIn people and in lab experiments, some brands reacted and others did not.
    3 sources, 2015 to 2024
    • Two children with accidental exposures screened positive with negative GC-MS.
    • An adult case reported an association at prescribed oral doses.
    • Laboratory testing with the DRI assay did not reproduce interference from the tested substances.

    What each source found

  • AtomoxetineStratteraIn people and in lab experiments, some brands reacted and others did not.
    2 sources, 2013 to 2024
    • An adult taking atomoxetine screened positive on CEDIA and negative by GC-MS.
    • Tests of atomoxetine and relevant metabolites in spiked urine did not reproduce this on DRI.

    What each source found

  • CathineNorpseudoephedrineIn people and in lab experiments, some brands reacted and others did not.
    4 sources, 1996 to 2024
    • Norpseudoephedrine added to urine produced a response equivalent to the positive calibrator.
    • The authors observed a urine response after Cathine administration on the historical amphetamine class assay.
    • The more selective Amphetamine/Methamphetamine II assay gave negative results for the group.
    • The modified assay yielded 3.6% relative response to Cathine.

    What each source found

  • DiethylpropionAmfepramone, TenuateIn people and in lab experiments, some brands reacted and others did not.
    5 sources, 1991 to 2024
    • Siemens lists negative results with added diethylpropion in both amphetamine assays.
    • The authors observed a urine response after Diethylpropion administration on the historical amphetamine class assay.
    • The more selective Amphetamine/Methamphetamine II assay gave negative results for the group.
    • A Taiwanese urine study specifically reported false-positive EMIT amphetamine reactions with Diethylpropion.
    • In the Diethylpropion challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.

    What each source found

  • DoxepinSilenor, SinequanIn people and in lab experiments, some brands reacted and others did not.
    2 sources, 1993 to 2024
    • A 1993 case letter attributed a false-positive urine amphetamine result to doxepin.
    • In separate manufacturer testing, parent doxepin at 1,000 micrograms/mL gave negative results on EMIT II Plus at all three amphetamine cutoffs.

    What each source found

  • EphedrineAkovazIn people and in lab experiments, some brands reacted and others did not.
    10 sources, 1987 to 2026
    • Ephedrine-related compounds reacted with some amphetamine reagents.
    • A later GC-MS-checked emergency study also implicated ephedrine in unconfirmed amphetamine screens.
    • The Abbott antibody showed very limited response to Ephedrine in the 1987 comparison.
    • The authors observed a urine response after Ephedrine administration on the historical amphetamine class assay.
    • The more selective Amphetamine/Methamphetamine II assay gave negative results for the group.
    • The authors identified ephedrine and pseudoephedrine as typical sympathomimetics among unconfirmed amphetamine specimens.
    • A child's urine screened positive after an ephedrine-containing cough mixture.
    • Gas chromatography detected abundant ephedrine and excluded amphetamines.
    • A UK external quality assessment included an authentic ephedrine-containing specimen (4 mg/L) and a separate mixture of 3.5 mg/L ephedrine with 1.5 mg/L phenylpropanolamine.
    • Across the six amphetamine-interferent challenges, some laboratories reported amphetamine.
    • The modified assay yielded 3.1% relative response to Ephedrine.

    What each source found

  • EtafedrineIn people and in lab experiments, some brands reacted and others did not.
    1 source, 1996
    • The authors observed a urine response after Etafedrine administration on the historical amphetamine class assay.
    • The more selective Amphetamine/Methamphetamine II assay gave negative results for the group.

    What each source found

  • FenfluramineFinteplaIn people and in lab experiments, some brands reacted and others did not.
    5 sources, 1991 to 2025
    • An unexpected amphetamine screen in a child treated for Dravet syndrome was negative for amphetamines by LC-MS, which identified fenfluramine.
    • EMIT II Plus reacted to added fenfluramine, while the First Sign AMP 1000 did not show interference at 100 micrograms/mL.
    • Both assays showed reactivity with Fenfluramine in the authors’ stimulant study.
    • A Taiwanese urine study specifically reported false-positive EMIT amphetamine reactions with Fenfluramine.

    What each source found

  • MephentermineIn people and in lab experiments, some brands reacted and others did not.
    4 sources, 1996 to 2024
    • Siemens observed a positive response from mephentermine in both amphetamine assays.
    • Lin-Zhi lists a negative result for mephentermine at 50 micrograms/mL on its test.
    • Both assays showed reactivity with Mephentermine in the authors’ stimulant study.

    What each source found

  • MetforminGlucophageIn people and in lab experiments, some brands reacted and others did not.
    2 sources, 2012 to 2023
    • An early report associated an unexpected result with metformin in a patient with diabetes.
    • In a later CEDIA experiment the parent drug did not trigger a positive even at 2,500 micrograms/mL.

    What each source found

  • MethylphenidateConcerta, MetadateIn people and in lab experiments, some brands reacted and others did not.
    5 sources, 1996 to 2026
    • One older case report implicated methylphenidate, and very high concentrations of parent drug triggered CEDIA in spiked urine.
    • A later clinical study found no interference with methylphenidate in either method it evaluated.
    • Neither test identified the exposure to Methylphenidate in the authors’ stimulant dosing study.
    • The modified assay yielded 0.31% for methylphenidate and 0.088% for ritalinic acid relative response.

    What each source found

  • MorazoneIn people and in lab experiments, some brands reacted and others did not.
    1 source, 1996
    • The authors observed a urine response after Morazone administration on the historical amphetamine class assay.
    • The more selective Amphetamine/Methamphetamine II assay gave negative results for the group.

    What each source found

  • PhendimetrazineIn people and in lab experiments, some brands reacted and others did not.
    1 source, 1996
    • The authors observed a urine response after Phendimetrazine administration on the historical amphetamine class assay.
    • The more selective Amphetamine/Methamphetamine II assay gave negative results for the group.

    What each source found

  • PhenmetrazinePreludinIn people and in lab experiments, some brands reacted and others did not.
    4 sources, 1996 to 2024
    • Two Siemens assays reacted to phenmetrazine in urine.
    • The Lin-Zhi assay listed a negative at 75 micrograms/mL.
    • The authors observed a urine response after Phenmetrazine administration on the historical amphetamine class assay.
    • The more selective Amphetamine/Methamphetamine II assay gave negative results for the group.

    What each source found

  • PhenylpropanolamineNorephedrine, PPAIn people and in lab experiments, some brands reacted and others did not.
    6 sources, 1987 to 2004
    • High-concentration phenylpropanolamine standards reacted in an older EMIT urine study.
    • At 100 mg/L all the tested assays were negative.
    • The Abbott antibody showed very limited response to Phenylpropanolamine in the 1987 comparison.
    • The authors observed a urine response after Phenylpropanolamine administration on the historical amphetamine class assay.
    • The more selective Amphetamine/Methamphetamine II assay gave negative results for the group.
    • A UK external quality assessment included a mixture of 1.5 mg/L phenylpropanolamine with 3.5 mg/L ephedrine.
    • Across the six amphetamine-interferent challenges, some laboratories reported amphetamine.

    What each source found

  • PholedrineIn people and in lab experiments, some brands reacted and others did not.
    1 source, 1996

    Only the Amphetamine/Methamphetamine II reagent detected Pholedrine in the study.

    What each source found

  • PseudoephedrineSudafedIn people and in lab experiments, some brands reacted and others did not.
    6 sources, 1992 to 2013
    • Pseudoephedrine was present in 833 unconfirmed screens containing one or more of the decongestants examined in a military study.
    • Fortified-urine experiments also demonstrated cross-reactivity on selected assays.
    • The authors observed a urine response after Pseudoephedrine administration on the historical amphetamine class assay.
    • The more selective Amphetamine/Methamphetamine II assay gave negative results for the group.
    • A published letter specifically addresses pseudoephedrine-associated false-positive amphetamine immunoassay results.
    • The authors identified ephedrine and pseudoephedrine as typical sympathomimetics among unconfirmed amphetamine specimens.
    • Urine spiking confirmed a shallower dose-response curve for Pseudoephedrine than for amphetamine or methamphetamine.

    What each source found

  • RanitidineZantacIn people and in lab experiments, some brands reacted and others did not.
    3 sources, 1991 to 2015
    • In an older study, 12 of 63 urine samples from 23 people taking ranitidine were false positive on monoclonal EMIT.
    • A later study reproduced interference on Beckman AMPH.
    • A Veterans Affairs laboratory found that urine ranitidine above 43 µg/mL yielded a positive result on its Beckman Synchron assay.

    What each source found

  • TapentadolNucynta, PalexiaIn people and in lab experiments, some brands reacted and others did not.
    2 sources, 2012 to 2023
    • All 11 patients reporting recent immediate-release tapentadol use had negative urine amphetamine screens on Syva EMIT II.
    • In a separate laboratory experiment, tapentadol added to urine at 400 micrograms/mL made the CEDIA amphetamine/ecstasy screen positive.

    What each source found

  • VilazodoneViibrydIn people and in lab experiments, some brands reacted and others did not.
    2 sources, 2019 to 2021
    • Two toddlers had unexpected positive amphetamine screens after accidental exposure.
    • Neither vilazodone nor its M17 metabolite reproduced the finding on two assays up to 100 micrograms/mL.
    • A separate toddler case had a positive Roche Amphetamines II screen with negative GC-MS confirmation.

    What each source found

  • KhatCatha edulis, KathIn people taking it, some brands reacted and others did not.
    1 source, 2002
    • After four volunteers chewed khat leaves, some urine samples screened positive on the Mahsan amphetamine kit, while the Abbott assay stayed negative.
    • GC-MS identified khat alkaloids.

    What each source found

  • PromethazinePhenerganIn people taking it, some brands reacted and others did not.
    1 source, 2006
    • Eight of 22 patients with detected promethazine had a false-positive result with one monoclonal reagent.
    • Authors suspected a metabolite.

    What each source found

  • 2,5-DimethoxyamphetamineDMA, 2,5-DMAIn lab experiments, some brands reacted and others did not.
    2 sources, 2015 to 2016
    • In the 2,5-Dimethoxyamphetamine challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 30 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 10 µg/mL.
    • 2,5-Dimethoxyamphetamine did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • 2C-B4-Bromo-2,5-dimethoxy-β-phenethylamineIn lab experiments, some brands reacted and others did not.
    2 sources, 2011 to 2015
    • The tested series including 2C-B showed less than 0.4% relative reactivity and did not reach a positive result at 50,000 ng/mL.
    • In the 2C-B challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 50 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 3 µg/mL.

    What each source found

  • 2C-I4-Iodo-2,5-dimethoxy-β-phenethylamineIn lab experiments, some brands reacted and others did not.
    2 sources, 2011 to 2015
    • The tested series including 2C-I showed less than 0.4% relative reactivity and did not reach a positive result at 50,000 ng/mL.
    • In the 2C-I challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 50 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 2 µg/mL.

    What each source found

  • 2C-T4-Methylthio-2,5-dimethoxy-β-phenethylamineIn lab experiments, some brands reacted and others did not.
    2 sources, 2015 to 2016
    • In the 2C-T challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 13 µg/mL.
    • 2C-T did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • 2C-T-24-Ethylthio-2,5-dimethoxy-β-phenethylamineIn lab experiments, some brands reacted and others did not.
    3 sources, 2011 to 2016
    • The tested series including 2C-T-2 showed less than 0.4% relative reactivity and did not reach a positive result at 50,000 ng/mL.
    • In the 2C-T-2 challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 35 µg/mL.
    • 2C-T-2 did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • 2C-T-44-Isopropylthio-2,5-dimethoxy-β-phenethylamineIn lab experiments, some brands reacted and others did not.
    2 sources, 2011 to 2015
    • The tested series including 2C-T-4 showed less than 0.4% relative reactivity and did not reach a positive result at 50,000 ng/mL.
    • In the 2C-T-4 challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 45 µg/mL.

    What each source found

  • 2C-T-74-n-Propylthio-2,5-dimethoxy-β-phenethylamineIn lab experiments, some brands reacted and others did not.
    3 sources, 2011 to 2016
    • The tested series including 2C-T-7 showed less than 0.4% relative reactivity and did not reach a positive result at 50,000 ng/mL.
    • In the 2C-T-7 challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 100 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 9 µg/mL.
    • 2C-T-7 did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • 3,4,5-TrimethoxyamphetamineTMAIn lab experiments, some brands reacted and others did not.
    2 sources, 2015 to 2016
    • In the 3,4,5-Trimethoxyamphetamine challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 40 µg/mL.
    • 3,4,5-Trimethoxyamphetamine did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • DOB4-Bromo-2,5-dimethoxyamphetamineIn lab experiments, some brands reacted and others did not.
    2 sources, 2011 to 2015
    • The tested series including DOB showed less than 0.4% relative reactivity and did not reach a positive result at 50,000 ng/mL.
    • In the DOB challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 20 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 3 µg/mL.

    What each source found

  • DOC4-Chloro-2,5-dimethoxyamphetamineIn lab experiments, some brands reacted and others did not.
    2 sources, 2015 to 2016
    • In the DOC challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 5 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 1 µg/mL.
    • DOC did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • DOET2,5-Dimethoxy-4-ethylamphetamineIn lab experiments, some brands reacted and others did not.
    3 sources, 2011 to 2016
    • The tested series including DOET showed less than 0.4% relative reactivity and did not reach a positive result at 50,000 ng/mL.
    • In the DOET challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 30 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 4.5 µg/mL.
    • DOET did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • DOI4-Iodo-2,5-dimethoxyamphetamineIn lab experiments, some brands reacted and others did not.
    3 sources, 2011 to 2016
    • The tested series including DOI showed less than 0.4% relative reactivity and did not reach a positive result at 50,000 ng/mL.
    • In the DOI challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 30 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 4 µg/mL.
    • DOI did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • DOM2,5-Dimethoxy-4-methylamphetamineIn lab experiments, some brands reacted and others did not.
    2 sources, 2011 to 2015
    • The tested series including DOM showed less than 0.4% relative reactivity and did not reach a positive result at 50,000 ng/mL.
    • In the DOM challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 40 µg/mL, while Syva EMIT II Plus Amphetamines gave a positive result at 5.5 µg/mL.

    What each source found

  • DonepezilAriceptIn lab experiments, some brands reacted and others did not.
    2 sources, 2019 to 2024
    • Siemens reports a measurable cutoff-equivalent response to donepezil.
    • A separate study testing Abbott MULTIGENT did not reproduce a positive from added donepezil.

    What each source found

  • Flephedrone4-Fluoromethcathinone, 4-FMCIn lab experiments, some brands reacted and others did not.
    2 sources, 2015 to 2017
    • In the Flephedrone challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
    • The modified assay yielded 0.92% relative response to Flephedrone.

    What each source found

  • IsoxsuprineVasodilanIn lab experiments, some brands reacted and others did not.
    2 sources, 2024
    • Isoxsuprine is listed as reactive on the class reagent at 6 micrograms/mL.
    • The II Plus test remained negative in the manufacturer’s comparison.

    What each source found

  • Meta-chlorophenylpiperazineChlorophenylpiperazine, mCPPIn lab experiments, some brands reacted and others did not.
    3 sources, 2014 to 2017
    • At a Meta-chlorophenylpiperazine spike of 5,600 ng/mL, the mean assay response was 528 ng/mL equivalent (9.4% cross-reactivity), above the 500 ng/mL cutoff.
    • In the Meta-chlorophenylpiperazine challenge, CEDIA DAU Amphetamine/Ecstasy gave a positive result at 7 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.
    • The modified assay yielded 26% relative response to Meta-chlorophenylpiperazine.

    What each source found

  • MethcathinoneEphedroneIn lab experiments, some brands reacted and others did not.
    2 sources, 2009 to 2015
    • The 2009 comparison lists reactivity at 75,000 ng/mL for Methcathinone on the Biosite Triage screen.
    • In the Methcathinone challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.

    What each source found

  • NylidrinBuphenineIn lab experiments, some brands reacted and others did not.
    2 sources, 2024
    • The class reagent lists a positive response at 2 micrograms/mL.
    • The II Plus instructions list a negative result at 750 micrograms/mL.

    What each source found

  • PhenelzineNardilIn lab experiments, some brands reacted and others did not.
    2 sources, 2024
    • The class-assay instructions name phenelzine as a possible source of a positive.
    • The II Plus specificity study lists the parent compound as negative at the concentrations tested.

    What each source found

  • Phenethylamine2-PhenylethylamineIn lab experiments, some brands reacted and others did not.
    3 sources, 1993 to 2017
    • The 2009 comparison lists reactivity at 50,000 ng/mL for Phenethylamine on the Biosite Triage screen.
    • At least one other reagent in the same table showed no reaction.
    • Phenethylamine produced a positive amphetamine line when added to drug-free urine at 100 mg/L.
    • The modified assay yielded 7.6% relative response to Phenethylamine.

    What each source found

  • PropranololInderalIn lab experiments, some brands reacted and others did not.
    2 sources, 2016 to 2023
    • Propranolol triggered EMIT II Plus in fortified urine at 41 micrograms/mL.
    • Another group reported a negative CEDIA result with a much higher parent-drug concentration.

    What each source found

  • PropylhexedrineBenzedrexIn lab experiments, some brands reacted and others did not.
    3 sources, 1977 to 2024
    • An early EMIT study demonstrated reactivity with propylhexedrine hydrochloride in urine.
    • The II Plus instructions list negative results for the concentrations used on that newer reagent.

    What each source found

  • TrimethobenzamideTiganIn lab experiments, some brands reacted and others did not.
    3 sources, 1993 to 2024
    • A laboratory letter documented interference on older reagents.
    • A separate DRI methamphetamine-calibrated assay reacted strongly in fortified urine, while EMIT II Plus was negative with parent trimethobenzamide at 500 micrograms/mL.

    What each source found

The Test Is Made to Find It14

It is the drug the test looks for, contains it, or the body turns it into it. A positive here can be real.

  • AmphetaminilA positive here is expected, not a false positive.
    1 source, 1996

    After Amphetaminil administration the investigators detected amphetamine formed by metabolism in urine.

    What each source found

  • ClobenzorexAsenlixA positive here is expected, not a false positive.
    3 sources, 1996 to 1999
    • A controlled study identified d-amphetamine in urine after clobenzorex administration.
    • After Clobenzorex administration the investigators detected amphetamine formed by metabolism in urine.
    • After 60 mg clobenzorex the authors attributed the positive TDx results to genuine amphetamine in urine.
    • The parent drug did not cross-react on that reagent.

    What each source found

  • DimethylamphetamineA positive here is expected, not a false positive.
    1 source, 1996

    After Dimethylamphetamine administration the investigators detected amphetamine formed by metabolism in urine.

    What each source found

  • FenetyllineCaptagon, FenethyllineA positive here is expected, not a false positive.
    3 sources, 1977 to 1996
    • Researchers measured actual amphetamine in human urine after fenetylline administration.
    • An older spiking experiment also demonstrated EMIT reactivity with parent fenetylline.
    • After Fenetylline administration the investigators detected amphetamine formed by metabolism in urine.

    What each source found

  • FenproporexFemproporexA positive here is expected, not a false positive.
    2 sources, 1996 to 1999
    • After fenproporex administration, researchers detected amphetamine in urine, including both enantiomers.
    • After Fenproporex administration the investigators detected amphetamine formed by metabolism in urine.

    What each source found

  • LevomethamphetamineLevmetamfetamine, Levmetamfetamine-containing nasal inhalerA positive here is expected, not a false positive.
    5 sources, 1993 to 2014
    • The nasal inhalers studied contained l-methamphetamine.
    • In one six-person study, some urine samples were positive on an EMIT amphetamine class screen while every sample was negative on the monoclonal assay.
    • Another study found all seven participants’ samples negative on EMIT II at its 1,000 ng/mL cutoff.
    • Levomethamphetamine showed 2.4% relative cross-reactivity; the antibody’s response was much stronger to d-methamphetamine.

    What each source found

  • MefenorexA positive here is expected, not a false positive.
    1 source, 1996

    After Mefenorex administration the investigators detected amphetamine formed by metabolism in urine.

    What each source found

  • Amphetamine/dextroamphetamine mixed saltsAdderall, Adderall XRA positive here is expected, not a false positive.
    2 sources, 2003 to 2004
    • Prescribed mixed salts contain amphetamine.
    • After controlled administration, GC-MS identified amphetamine in urine.
    • After five daily 20 mg doses, urine contained genuine amphetamine; some samples with at least 500 ng/mL by confirmation remained immunoassay-negative.

    What each source found

  • BenzphetamineDidrex, RegimexA positive here is expected, not a false positive.
    1 source, 1998
    • After benzphetamine administration, d-amphetamine was found as a metabolite.
    • Some participants remained below the study cutoff.

    What each source found

  • DextroamphetamineD-amphetamine, DexamphetamineA positive here is expected, not a false positive.
    2 sources, 1998 to 2025
    • Dextroamphetamine is the d-isomer of amphetamine.
    • Controlled oral doses produced measurable urinary amphetamine.

    What each source found

  • FamprofazoneA positive here is expected, not a false positive.
    1 source, 1996

    A volunteer study measured both amphetamine isomers after famprofazone.

    What each source found

  • LisdexamfetamineElvanse, VyvanseA positive here is expected, not a false positive.
    2 sources, 2021 to 2022
    • Lisdexamfetamine is converted into d-amphetamine.
    • Studies in treated patients and controlled administration detected amphetamine in urine.

    What each source found

  • MethamphetamineD-methamphetamine, DesoxynA positive here is expected, not a false positive.
    1 source, 2004
    • Amphetamine is a metabolite of methamphetamine.
    • Both were measured after supervised oral methamphetamine administration.

    What each source found

  • SelegilineDeprenyl, EldeprylA positive here is expected, not a false positive.
    2 sources, 1997 to 1999
    • Selegiline can produce l-amphetamine and l-methamphetamine.
    • Human metabolic studies identified both in urine.
    • A patient taking selegiline had R-amphetamine and R-methamphetamine identified in urine by enantiomer-specific analysis.

    What each source found

Tested With No False Positive, or Not Proven (81)

Suspected, but Not Proven8

A report, a list or a study names it, but no study we found showed it makes the screen read positive.

  • DesipramineNorpraminSuspected, but the studies did not show it.
    2 sources, 1993 to 2024
    • An older case report names both amantadine and desipramine.
    • EMIT II Plus parent-drug studies gave negative results for desipramine at concentrations of 300 to 800 micrograms/mL, depending on cutoff.

    What each source found

  • FluoxetineProzacSuspected, but the studies did not show it.
    3 sources, 2004 to 2024
    • Fluoxetine was co-detected in some unconfirmed screens, but the independent fortified-urine study did not list it among AMP-positive standards.
    • Siemens reports a negative result for parent fluoxetine at 500 micrograms/mL across three cutoffs.
    • A Swiss laboratory also identified fluoxetine in discordant AxSYM specimens.
    • The authors described it as a previously reported cross-reactant.
    • They did not demonstrate that it caused an individual result.

    What each source found

  • TolmetinTolectinSuspected, but the studies did not show it.
    1 source, 1995

    The older EMIT method produced an instrument alarm on specimens containing amphetamines.

    What each source found

  • TramadolConZip, UltramSuspected, but the studies did not show it.
    1 source, 2023

    Tramadol was found in some patients with unconfirmed screens, but added tramadol at 2,500 micrograms/mL remained negative.

    What each source found

  • Bitter orangeBitter-orange extract, Citrus aurantiumFound alongside false positives, but not shown to cause them.
    2 sources, 2006 to 2013
    • Urine from six volunteers remained negative after one 900 mg dose of bitter-orange extract standardized to 6% synephrine.
    • A multi-ingredient Thermal Pro overdose case named DMAA or bitter orange components as possible explanations for an unconfirmed amphetamine screen.

    What each source found

  • AmantadineGocovri, SymmetrelSuspected in a case report, but not shown to cause it.
    1 source, 1993

    A historical case report names both amantadine and desipramine in connection with a false-positive result.

    What each source found

  • OfloxacinFloxinSuspected, but lab experiments did not show it.
    1 source, 2024
    • Siemens found no EMIT II Plus interference at 100 micrograms/mL of parent ofloxacin across three cutoffs.
    • A separate 2004 study is cited as reporting interference on the older Abbott TDxFLx assay.

    What each source found

  • TryptamineSuspected, but lab experiments did not show it.
    1 source, 2017

    The modified assay yielded 3.3% relative response to Tryptamine.

    What each source found

Tested: No False Positive Found73

It was tested and did not make the screen read positive. Other brands of the test can differ.

  • GabapentinNeurontinIn people and in lab experiments, this test stayed negative.
    3 sources, 2018 to 2025
    • The urine amphetamine dip card did not react with 100 µg/mL of gabapentin.
    • In a different method, concentrated gabapentin produced a fragment that could be mistaken for amphetamine by mass spectrometry.

    What each source found

  • HydroxychloroquinePlaquenilIn people and in lab experiments, this test stayed negative.
    1 source, 2017
    • Therapeutically treated patients did not have false positives.
    • Parent hydroxychloroquine did not trigger DRI even when added to urine at 1,000 micrograms/mL.

    What each source found

  • AmiphenazoleIn people taking it, this test stayed negative.
    1 source, 1996

    Neither test identified the exposure to Amiphenazole in the authors’ stimulant dosing study.

    What each source found

  • Cropropamide and crotetamideMicorenIn people taking it, this test stayed negative.
    1 source, 1996

    Neither test identified the exposure to Cropropamide and crotetamide in the authors’ stimulant dosing study.

    What each source found

  • Energy drinks in the strip studyAdrenaline RUSH, BurnIn people taking it, this test stayed negative.
    1 source, 2012

    No urine amphetamine result was detected with this strip after participants consumed 0.5 L of one of the three specified energy drinks.

    What each source found

  • EthamivanIn people taking it, this test stayed negative.
    1 source, 1996

    Neither test identified the exposure to Ethamivan in the authors’ stimulant dosing study.

    What each source found

  • FencamfaminFencamfamineIn people taking it, this test stayed negative.
    1 source, 1996

    Neither test identified the exposure to Fencamfamin in the authors’ stimulant dosing study.

    What each source found

  • Ginkgo bilobaGinkgoIn people taking it, this test stayed negative.
    1 source, 2004
    • One volunteer taking ginkgo screened positive for amphetamine.
    • GC-MS then identified amphetamine in the sample.
    • The authors found no evidence that ginkgo caused a false positive.

    What each source found

  • NikethamideNiketamideIn people taking it, this test stayed negative.
    1 source, 1996

    Neither test identified the exposure to Nikethamide in the authors’ stimulant dosing study.

    What each source found

  • PipradrolIn people taking it, this test stayed negative.
    1 source, 1996

    Neither test identified the exposure to Pipradrol in the authors’ stimulant dosing study.

    What each source found

  • ProlintaneIn people taking it, this test stayed negative.
    1 source, 1996

    Neither test identified the exposure to Prolintane in the authors’ stimulant dosing study.

    What each source found

  • StrychnineIn people taking it, this test stayed negative.
    1 source, 1996

    Neither test identified the exposure to Strychnine in the authors’ stimulant dosing study.

    What each source found

  • ThioridazineMellarilIn people taking it, this test stayed negative.
    1 source, 1993

    All 12 thioridazine-treated patients in a comparison of antipsychotics screened negative on both amphetamine tests.

    What each source found

  • 2-DPMPDesoxypipradrol, 2-DiphenylmethylpiperidineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 2-DPMP challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.

    What each source found

  • 25B-NBOMe4-Bromo-2,5-dimethoxy-N-[ methyl]-benzenethanamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 25B-NBOMe challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.

    What each source found

  • 25C-NBOMe2C-C-NBOMeIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 25C-NBOMe challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.

    What each source found

  • 25I-NBOMeIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 25I-NBOMe challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.

    What each source found

  • 2C-HIn lab experiments, this test stayed negative.
    1 source, 2011

    The tested series including 2C-H showed less than 0.4% relative reactivity and did not reach a positive result at 50,000 ng/mL.

    What each source found

  • 2C-NIn lab experiments, this test stayed negative.
    1 source, 2016

    2C-N did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • 2C-T-13In lab experiments, this test stayed negative.
    1 source, 2016

    2C-T-13 did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • 2C-T-17In lab experiments, this test stayed negative.
    1 source, 2016

    2C-T-17 did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • 2C-T-5In lab experiments, this test stayed negative.
    1 source, 2016

    2C-T-5 did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • 3,4-DimethylmethcathinoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 3,4-Dimethylmethcathinone challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.

    What each source found

  • 4-HO-DET4-Hydroxy-diethyl-tryptamine, 4-OH-DETIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 4-HO-DET challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.

    What each source found

  • 4-MePPP4-Methyl-alpha-pyrrolidinopropiophenone, 4-Methyl-α-pyrrolidinopropiophenoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 4-MePPP challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.

    What each source found

  • 4-Methoxyphencyclidine4-MeO-PCPIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 4-Methoxyphencyclidine challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.

    What each source found

  • 4-MPBP4-Methyl-α-pyrrolidinobutiophenoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 4-MPBP challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.

    What each source found

  • 5-MeO-DALTN,N-Diallyl-5-methoxytryptamine, 5-Methoxy-DALTIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 5-MeO-DALT challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.

    What each source found

  • 5-MeO-DiPTN,N-Diisopropyl-5-methoxytryptamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 5-MeO-DiPT challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.

    What each source found

  • 5-MeO-DMTN,N-Dimethyl-5-methoxytryptamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 5-MeO-DMT challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.

    What each source found

  • AcetaminophenParacetamol, TylenolIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Acetaminophen at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • ALEPHIn lab experiments, this test stayed negative.
    1 source, 2016

    ALEPH did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • ALEPH-13In lab experiments, this test stayed negative.
    1 source, 2016

    ALEPH-13 did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • ALEPH-17In lab experiments, this test stayed negative.
    1 source, 2016

    ALEPH-17 did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • ALEPH-2In lab experiments, this test stayed negative.
    1 source, 2016

    ALEPH-2 did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • ALEPH-5In lab experiments, this test stayed negative.
    1 source, 2016

    ALEPH-5 did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • ALEPH-7In lab experiments, this test stayed negative.
    1 source, 2016

    ALEPH-7 did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • Alpha-PBPα-PBP, α-PyrrolidinobutiophenoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Alpha-PBP challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.

    What each source found

  • Alpha-PPPAlpha-pyrrolidinopropiophenone, α-PPPIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Alpha-PPP challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.

    What each source found

  • Alpha-PVPα-PVP, α-PyrrolidinopentiophenoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Alpha-PVP challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.

    What each source found

  • Alpha-PVTα-PVT, α-PyrrolidinopentiothiophenoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Alpha-PVT challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.

    What each source found

  • BenocyclidineBCP, BenzothiophenylcyclohexylpiperidineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Benocyclidine challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.

    What each source found

  • BOBIn lab experiments, this test stayed negative.
    1 source, 2016

    BOB did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • BODIn lab experiments, this test stayed negative.
    1 source, 2016

    BOD did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • BOHIn lab experiments, this test stayed negative.
    1 source, 2016

    BOH did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • BOHDIn lab experiments, this test stayed negative.
    1 source, 2016

    BOHD did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • CathinoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Cathinone challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.

    What each source found

  • CiprofloxacinCiproIn lab experiments, this test stayed negative.
    1 source, 2019

    Ciprofloxacin added to drug-free urine produced no cross-reaction on the amphetamine/methamphetamine screen in a ten-assay study.

    What each source found

  • D2PMα,α-Diphenyl-2R-pyrrolidinemethanolIn lab experiments, this test stayed negative.
    1 source, 2015

    In the D2PM challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.

    What each source found

  • DextromethorphanDelsym, DXMIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Dextromethorphan at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • DiphenhydramineBenadryl, Unisom SleepGelsIn lab experiments, this test stayed negative.
    2 sources, 2013 to 2025
    • The authors observed no interference from Diphenhydramine at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.
    • Diphenhydramine did not cross the amphetamine cutoff when added at 1,000 ng/mL in one cup study, or at 100 µg/mL in Healgen’s urine dip-card study.

    What each source found

  • DiPTN,N-DiisopropyltryptamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the DiPT challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.

    What each source found

  • DONIn lab experiments, this test stayed negative.
    1 source, 2016

    DON did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • DOPRIn lab experiments, this test stayed negative.
    1 source, 2016

    DOPR did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • EpinephrineAdrenalineIn lab experiments, this test stayed negative.
    1 source, 2020

    The prototype amphetamine strip stayed negative when challenged with epinephrine (adrenaline).

    What each source found

  • EscalineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Escaline challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.

    What each source found

  • MDBZIn lab experiments, this test stayed negative.
    1 source, 2016

    MDBZ did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • MDCPMIn lab experiments, this test stayed negative.
    1 source, 2016

    MDCPM did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • MDIPIn lab experiments, this test stayed negative.
    1 source, 2016

    MDIP did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • MeprobamateEquanil, MiltownIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Meprobamate at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • MescalineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Mescaline challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.

    What each source found

  • MethoxetamineMXEIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Methoxetamine challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.

    What each source found

  • MPHP (study designation)In lab experiments, this test stayed negative.
    1 source, 2015

    In the MPHP challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.

    What each source found

  • MT-451-Cyclohexyl-4- -piperazine, dihydrochlorideIn lab experiments, this test stayed negative.
    1 source, 2015

    In the MT-45 challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.

    What each source found

  • N,N-DimethylcathinoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the N,N-Dimethylcathinone challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.

    What each source found

  • PhenylephrineNeo-Synephrine, Sudafed PEIn lab experiments, this test stayed negative.
    3 sources, 2006 to 2012
    • Three amphetamine-class screens in the laboratory comparison showed no reaction to phenylephrine.
    • There is separate evidence for a positive on a methamphetamine-specific screen.

    What each source found

  • PyrovaleroneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Pyrovalerone challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.

    What each source found

  • TMA-2In lab experiments, this test stayed negative.
    1 source, 2016

    TMA-2 did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • TMA-3In lab experiments, this test stayed negative.
    1 source, 2016

    TMA-3 did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • TMA-6In lab experiments, this test stayed negative.
    1 source, 2016

    TMA-6 did not give a positive Neogen Amphetamine Specific urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • TrimipramineSurmontilIn lab experiments, this test stayed negative.
    1 source, 2014

    The FDA submission lists trimipramine among the compounds that did not interfere at 100 micrograms/mL on the amphetamine test.

    What each source found

  • VenlafaxineEffexor, Effexor XRIn lab experiments, this test stayed negative.
    1 source, 2023

    The parent drug tested negative at 2,500 micrograms/mL in a CEDIA experiment.

    What each source found

  • WIN 35,428CFTIn lab experiments, this test stayed negative.
    1 source, 2015

    In the WIN 35,428 challenge, CEDIA DAU Amphetamine/Ecstasy stayed negative at 100 µg/mL, while Syva EMIT II Plus Amphetamines stayed negative at 100 µg/mL.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Opiates Test?

Opiates (morphine or codeine screen)

“Opiates” on a report usually refers to a morphine-directed assay. Fentanyl, methadone, buprenorphine and oxycodone often have their own test lines.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 6 kinds of results in this list

Has Caused a False Positive10

Studies or case reports found it can make the screen read positive for a drug that was not there. How often that happens at a usual dose is not known.

  • DoxylamineUnisom SleepTabsSeen in people taking it, and again in lab experiments.
    2 sources, 1983 to 2000
    • An opiate screen was positive during doxylamine poisoning.
    • An alternative opiate radioimmunoassay was negative.
    • Adding 1 mg/mL of Doxylamine to urine already containing 300 ng/mL morphine significantly increased the apparent morphine signal on EMIT, CEDIA and Abbott AxSYM.

    What each source found

  • GatifloxacinSeen in people taking it, and again in lab experiments.
    2 sources, 2001 to 2006
    • Added gatifloxacin reacted on EMIT II.
    • A patient receiving systemic gatifloxacin also had two positive screens with negative follow-up testing by another method.

    What each source found

  • LevofloxacinLevaquinSeen in people taking it, and again in lab experiments.
    4 sources, 2001 to 2019
    • Oral levofloxacin yielded presumptive opiate positives in controlled volunteer testing.
    • A modern spiking study reproduced the effect with Abbott MULTIGENT at concentrations achievable during treatment.

    What each source found

  • OfloxacinFloxinSeen in people taking it, and again in lab experiments.
    4 sources, 1997 to 2009
    • Several patients taking therapeutic oral ofloxacin and two volunteers after a single dose had false positives on EMIT II.
    • Spiked urine also reacted, and a separate multi-assay study confirmed the association.

    What each source found

  • PerazineTaxilanSeen in a case report about a person taking it.
    1 source, 1996

    A 1996 case described positive opiate and amphetamine immunoassays during perazine intoxication.

    What each source found

  • EnoxacinOnly in lab experiments so far, not in people taking it.
    1 source, 2001
    • Added enoxacin reached the opiate cutoff in two of five assay systems.
    • The required concentrations exceeded the expected peak with standard dosing in that paper.

    What each source found

  • HordenineOnly in lab experiments so far, not in people taking it.
    1 source, 1992

    Hordenine reacted most strongly with the morphine ELISA among the opioid tests compared.

    What each source found

  • LomefloxacinOnly in lab experiments so far, not in people taking it.
    1 source, 2001

    Of five opiate methods studied, only Roche OnLine became positive with high concentrations of added lomefloxacin.

    What each source found

  • PefloxacinOnly in lab experiments so far, not in people taking it.
    1 source, 2001
    • Pefloxacin crossed the positive threshold on three assays in spiked urine.
    • Of these, the authors considered the CEDIA reaction the most relevant at predicted urine concentrations.

    What each source found

  • RanitidineZantacOnly in lab experiments so far, not in people taking it.
    1 source, 2022

    The opiates strip became positive with ranitidine added at 1,600 micrograms/mL.

    What each source found

Depends on the Brand of Test11

Some brands of the screen reacted to it and others did not, or the studies disagree. The lab can tell you which brand it used.

  • CiprofloxacinCiproIn people and in lab experiments, some brands reacted and others did not.
    3 sources, 1997 to 2019
    • Only a high-concentration Roche laboratory challenge turned positive.
    • Urine from three patients taking ciprofloxacin was negative on EMIT II.
    • A 2019 panel showed no ciprofloxacin reactivity.

    What each source found

  • DextromethorphanDelsym, DXMIn people and in lab experiments, some brands reacted and others did not.
    6 sources, 1983 to 2025
    • A high-dose case and spiking experiments support interference on some reagents.
    • In a crossover study of 20 adults, urine EMIT screens were negative six hours after 20 or 40 mg of dextromethorphan.
    • Very high concentrations of dextromethorphan reacted weakly with this experimental morphine test.
    • Adding 1 mg/mL of Dextromethorphan to urine already containing 300 ng/mL morphine significantly increased the apparent morphine signal on Roche OnLine, EMIT, CEDIA and Abbott AxSYM.
    • The authors observed no interference from Dextromethorphan at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • DiphenhydramineBenadryl, Unisom SleepGelsIn people and in lab experiments, some brands reacted and others did not.
    3 sources, 2000 to 2022
    • A Clinical Toxicology report identified an opiate-screen false positive associated with diphenhydramine.
    • Adding 1 mg/mL of Diphenhydramine to urine already containing 300 ng/mL morphine significantly increased the apparent morphine signal on EMIT, CEDIA and Abbott AxSYM.
    • The authors observed no interference from Diphenhydramine at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • NaloxoneKloxxado, NarcanIn people and in lab experiments, some brands reacted and others did not.
    5 sources, 1983 to 2026
    • A child's urine contained enough naloxone to reproduce the CEDIA signal in spiking experiments.
    • A separate controlled EMIT study found no positives in 14 adults given single IV doses of 2 or 4 mg.
    • The historical hemagglutination antibody series had less than 0.1% relative reactivity to Naloxone.
    • The modified assay yielded 0.1% relative response to Naloxone.

    What each source found

  • NorfloxacinIn people and in lab experiments, some brands reacted and others did not.
    2 sources, 1997 to 2001
    • An older Roche assay became positive at high spiked concentrations.
    • EMIT II was negative in three patients on norfloxacin and in the corresponding spiking experiment.

    What each source found

  • OxycodoneOxyContin, RoxicodoneIn people and in lab experiments, some brands reacted and others did not.
    6 sources, 1983 to 2017
    • After a controlled dose of oxycodone, two general opiates tests (TDx and EMIT at a 300 ng/mL cutoff) detected the prescribed opioid in urine.
    • Abuscreen and Coat-A-Count missed oxycodone.
    • The Instant-View device showed low sensitivity for oxycodone-positive urine in this comparison.
    • The historical hemagglutination antibody series had less than 0.1% relative reactivity to Oxycodone.
    • Codeine, oxycodone and morphine-6-glucuronide showed more than 50% relative reaction at 1 µg/mL in the experimental system.
    • The study compared Oxycodone in fortified urine against morphine.
    • At 300 ng/mL, reactivity varied by reagent and generally favored codeine or hydrocodone over oxycodone or oxymorphone.
    • The modified assay yielded 0.37% relative response to Oxycodone.

    What each source found

  • OxymorphoneOpanaIn people and in lab experiments, some brands reacted and others did not.
    3 sources, 1995 to 2017
    • After a single dose of oxymorphone, none of four morphine-directed opiates screens detected it in the collected urine samples.
    • GC-MS measured the drug.
    • The study compared Oxymorphone in fortified urine against morphine.
    • At 300 ng/mL, reactivity varied by reagent and generally favored codeine or hydrocodone over oxycodone or oxymorphone.
    • The modified assay yielded 0.32% relative response to Oxymorphone.

    What each source found

  • RifampinRifadin, RimactaneIn people and in lab experiments, some brands reacted and others did not.
    5 sources, 1995 to 2023
    • Rifampin produced unconfirmed opiates screens with Roche KIMS, including a child whose urine tested negative by LC-MS/MS.
    • Adding rifampin to drug-free urine reproduced the signal.
    • In a separate study, two patients tested positive on Syva and Genix after a rifampin dose, while Biosite Triage and GC-MS were negative.

    What each source found

  • ImipramineTofranilIn lab experiments, some brands reacted and others did not.
    1 source, 2009
    • The 2009 comparison lists 2.3% cross-reactivity for Imipramine on the Microgenics CEDIA screen.
    • At least one other reagent in the same table showed no reaction.

    What each source found

  • MeperidineDemerol, PethidineIn lab experiments, some brands reacted and others did not.
    2 sources, 2009 to 2017
    • The 2009 comparison lists reactivity at 169,660 ng/mL for Meperidine on the Abbott Architect screen.
    • At least one other reagent in the same table showed no reaction.
    • The modified assay yielded 0.32% relative response to Meperidine.

    What each source found

  • MoxifloxacinAveloxIn lab experiments, some brands reacted and others did not.
    2 sources, 2001 to 2019
    • High spiked concentrations reacted on an older Roche assay.
    • A contemporary comparison found clinically relevant reactivity only on the amphetamine assay, not the opiate screen it tested.

    What each source found

The Test Is Made to Find It4

It is the drug the test looks for, contains it, or the body turns it into it. A positive here can be real.

  • Codeinecodeine phosphateA positive here is expected, not a false positive.
    9 sources, 1983 to 2022
    • Codeine-containing medicines can make an opiate screen positive.
    • Codeine and its metabolite morphine can be found by specific testing.
    • The authors measured reactivity of Codeine with both historical morphine methods.
    • Codeine and ethylmorphine were particularly well recognized.
    • RapiTest MOP recognized Codeine on the urine morphine screen.
    • Codeine, oxycodone and morphine-6-glucuronide showed more than 50% relative reaction at 1 µg/mL in the experimental system.
    • The study compared Codeine in fortified urine against morphine.
    • At 300 ng/mL, reactivity varied by reagent and generally favored codeine or hydrocodone over oxycodone or oxymorphone.
    • The modified assay yielded 99% for codeine, 61% for codeine-6-glucuronide and 2.3% for norcodeine relative response.
    • In a separate prototype strip experiment, parent codeine did not yield a positive morphine result.

    What each source found

  • Heroindiacetylmorphine, diamorphineA positive here is expected, not a false positive.
    3 sources, 1991 to 2017
    • Heroin is rapidly metabolized to 6-MAM and then morphine; its use can produce an expected opiate-class screen.
    • The modified assay yielded 68% for heroin and 71% for 6-acetylmorphine relative response.

    What each source found

  • MorphineMS Contin, RoxanolA positive here is expected, not a false positive.
    5 sources, 1992 to 2022
    • Prescribed morphine is a target of routine opiate screening.
    • Controlled dosing produced positive urine opiate results.
    • All four assays detected morphine in urine; the Coat-A-Count reagent was more selective for free morphine than the other three.
    • Codeine, oxycodone and morphine-6-glucuronide showed more than 50% relative reaction at 1 µg/mL in the experimental system.
    • The modified assay yielded 38% for morphine-3-glucuronide, 47% for morphine-6-glucuronide and 0.19% for normorphine relative response.

    What each source found

  • Poppy seedsPapaver somniferum, poppy seed foodsA positive here is expected, not a false positive.
    1 source, 2014
    • Controlled ingestion of raw seeds containing measured morphine and codeine produced genuine urine morphine and codeine.
    • Which samples were positive varied with the cutoff.

    What each source found

Tested With No False Positive, or Not Proven (16)

Suspected, but Not Proven7

A report, a list or a study names it, but no study we found showed it makes the screen read positive.

  • TolmetinTolectinSuspected, but the studies did not show it.
    1 source, 1995

    Adding tolmetin to specimens containing opiates lowered the EMIT signal enough for samples to be called negative.

    What each source found

  • QuinineQualaquin, tonic waterFound alongside false positives, but not shown to cause them.
    1 source, 1989
    • Tonic water produced detectable urinary quinine in an older study.
    • Quinine had been used as an indirect marker of illicit exposure.

    What each source found

  • BrompheniramineBrompheniramine maleateSuspected, but lab experiments did not show it.
    1 source, 2000

    Adding 1 mg/mL of Brompheniramine to urine already containing 300 ng/mL morphine significantly increased the apparent morphine signal on EMIT and Abbott AxSYM.

    What each source found

  • BuprenorphineBelbuca, ButransSuspected, but lab experiments did not show it.
    1 source, 2017

    The modified assay yielded 0.24% for buprenorphine and 0.1% for norbuprenorphine relative response.

    What each source found

  • ChlorpheniramineSuspected, but lab experiments did not show it.
    1 source, 2000

    Adding 1 mg/mL of Chlorpheniramine to urine already containing 300 ng/mL morphine significantly increased the apparent morphine signal on EMIT and Abbott AxSYM.

    What each source found

  • EphedrineAkovazSuspected, but lab experiments did not show it.
    1 source, 2000

    Adding 1 mg/mL of Ephedrine to urine already containing 300 ng/mL morphine significantly increased the apparent morphine signal on EMIT.

    What each source found

  • PseudoephedrineSudafedSuspected, but lab experiments did not show it.
    1 source, 2000

    Adding 1 mg/mL of Pseudoephedrine to urine already containing 300 ng/mL morphine significantly increased the apparent morphine signal on EMIT.

    What each source found

Tested: No False Positive Found9

It was tested and did not make the screen read positive. Other brands of the test can differ.

  • TapentadolNucynta, PalexiaIn people taking it, this test stayed negative.
    1 source, 2015
    • Among 11 patients taking therapeutic doses of tapentadol, the researchers found no false-positive results on this general opiates screen.
    • Some patients also took other opioid medicines that accounted for positive screens.

    What each source found

  • AcetaminophenParacetamol, TylenolIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Acetaminophen at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • ClinafloxacinIn lab experiments, this test stayed negative.
    1 source, 2001
    • Clinafloxacin did not produce a positive by itself on any of the five tested assays.
    • There was a small below-cutoff response on CEDIA and EMIT II.

    What each source found

  • MeprobamateEquanil, MiltownIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Meprobamate at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • MethadoneDolophine, MethadoseIn lab experiments, this test stayed negative.
    2 sources, 1983 to 2000
    • The historical hemagglutination antibody series had less than 0.1% relative reactivity to Methadone.
    • The authors reported less than 5% response to methadone on this experimental opiates assay.

    What each source found

  • Nalidixic acidNegGramIn lab experiments, this test stayed negative.
    2 sources, 1997 to 2001
    • Nalidixic acid did not produce a positive by itself on any of the five tested assays.
    • The table reports no measurable assay activity.
    • An independent EMIT II study was also negative.

    What each source found

  • PrednisoneDeltasoneIn lab experiments, this test stayed negative.
    1 source, 2025

    Prednisone at 100 µg/mL did not cause a positive result in drug-free urine or change the result of urine just below or above this channel’s cutoff.

    What each source found

  • SparfloxacinZagamIn lab experiments, this test stayed negative.
    1 source, 2001
    • Sparfloxacin did not produce a positive by itself on any of the five tested assays.
    • There was a small below-cutoff response on CEDIA, EMIT II and Roche OnLine.

    What each source found

  • TrovafloxacinTrovanIn lab experiments, this test stayed negative.
    1 source, 2001
    • Trovafloxacin did not produce a positive by itself on any of the five tested assays.
    • The table reports no measurable assay activity.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Benzodiazepines Test?

The test may react to several members of the class or to other medicines. Some common benzodiazepines are also missed by certain assays.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 5 kinds of results in this list

Has Caused a False Positive11

Studies or case reports found it can make the screen read positive for a drug that was not there. How often that happens at a usual dose is not known.

  • EfavirenzSustivaSeen in people taking it, and again in lab experiments.
    1 source, 2009
    • Among 50 people taking efavirenz, 49 screened positive on at least one test, compared with one of 50 who were not taking it.
    • The investigators identified 8-hydroxyefavirenz as the cross-reacting metabolite.

    What each source found

  • OxaprozinDayproSeen in people taking it, and again in lab experiments.
    5 sources, 1995 to 2009
    • After a single 1,200 mg dose of oxaprozin, 36 of 36 specimens from 12 people screened positive on EMIT and CEDIA.
    • Abbott FPIA was positive in 35 of 36.
    • Oxaprozin also reacted when added to drug-free urine.
    • A separate letter reported interference on urine benzodiazepine immunoassays and no interference on a receptor assay.

    What each source found

  • PirfenidoneEsbrietSeen in people taking it, and again in lab experiments.
    2 sources, 2018 to 2026
    • A lung transplant evaluation prompted investigation of a positive benzodiazepine screen in a patient on pirfenidone.
    • The drug also produced a positive response when added to urine in the laboratory.

    What each source found

  • FluoxetineProzacSeen in a case report about a person taking it.
    2 sources, 2021 to 2026

    A case report described an unexpected benzodiazepine result in a child taking fluoxetine.

    What each source found

  • DiazoxideOnly in lab experiments so far, not in people taking it.
    1 source, 2009

    The 2009 comparison lists reactivity at 300 ng/mL for Diazoxide on the Biosite Triage screen.

    What each source found

  • FlurbiprofenAnsaidOnly in lab experiments so far, not in people taking it.
    1 source, 1995

    Testing urine with high concentrations of flurbiprofen produced a signal the authors flagged as a potential cause of false-positive TDx benzodiazepine results.

    What each source found

  • FluspirileneImapOnly in lab experiments so far, not in people taking it.
    1 source, 2009

    The 2009 comparison lists reactivity at 100,000 ng/mL for Fluspirilene on the Biosite Triage screen.

    What each source found

  • IndomethacinIndocinOnly in lab experiments so far, not in people taking it.
    1 source, 1995

    Testing urine with high concentrations of indomethacin produced a signal the authors flagged as a potential cause of false-positive TDx benzodiazepine results.

    What each source found

  • KetoprofenOrudisOnly in lab experiments so far, not in people taking it.
    2 sources, 1995 to 2009

    Testing urine with high concentrations of ketoprofen produced a signal the authors flagged as a potential cause of false-positive TDx benzodiazepine results.

    What each source found

  • ModafinilOnly in lab experiments so far, not in people taking it.
    1 source, 2009

    The 2009 comparison lists reactivity at 80,000 ng/mL for Modafinil on the Biosite Triage screen.

    What each source found

  • TolmetinTolectinOnly in lab experiments so far, not in people taking it.
    1 source, 1995

    Testing urine with high concentrations of tolmetin produced a signal the authors flagged as a potential cause of false-positive TDx benzodiazepine results.

    What each source found

Depends on the Brand of Test5

Some brands of the screen reacted to it and others did not, or the studies disagree. The lab can tell you which brand it used.

  • NefopamIn people and in lab experiments, some brands reacted and others did not.
    3 sources, 2008 to 2020
    • In one case, repeated benzodiazepine screens became negative after nefopam was stopped.
    • A separate patient screened positive on EMIT Atellica, while chromatography found nefopam and its metabolites and no benzodiazepine.
    • In the three-assay study, two of three treated patients’ specimens interfered on Architect, while CEDIA results were negative.

    What each source found

  • SertralineZoloftIn people and in lab experiments, some brands reacted and others did not.
    3 sources, 1997 to 2009
    • Sertraline metabolites cross-reacted with the original CEDIA assay.
    • The manufacturer’s improved reagent eliminated that problem in a comparative evaluation.
    • Separately, a chart study found 26 sertraline prescriptions among 98 unconfirmed positive screens in people without a benzodiazepine prescription.

    What each source found

  • FenoprofenNalfonIn lab experiments, some brands reacted and others did not.
    2 sources, 1990 to 1995
    • Testing urine with high concentrations of fenoprofen produced a signal the authors flagged as a potential cause of false-positive TDx benzodiazepine results.
    • A separate prospective study including people taking fenoprofen found no false-positive benzodiazepine screens.

    What each source found

  • HydroxyzineAtarax, VistarilIn lab experiments, some brands reacted and others did not.
    6 sources, 2009 to 2025
    • Lin-Zhi reports that high urine concentrations of hydroxyzine can produce a false-positive benzodiazepine screen.
    • On the DRI assay, even 100,000 ng/mL of added hydroxyzine left the negative control negative.

    What each source found

  • LovastatinIn lab experiments, some brands reacted and others did not.
    1 source, 2009
    • The 2009 comparison lists reactivity at 100,000 ng/mL for Lovastatin on the Abbott AxSYM screen.
    • At least one other reagent in the same table showed no reaction.

    What each source found

The Test Is Made to Find It30

It is the drug the test looks for, contains it, or the body turns it into it. A positive here can be real.

  • AlprazolamXanaxA positive here is expected, not a false positive.
    6 sources, 1994 to 2019
    • Alprazolam belongs to the benzodiazepine class and is among the drugs that reacted in urine in the FDA-reviewed assay data.
    • An oxazepam-only confirmation can miss the metabolites targeted by broader benzodiazepine confirmation, including metabolites of Alprazolam.
    • In the single-dose comparison the Triage device missed all urine specimens collected after Alprazolam; lowering thresholds and hydrolyzing conjugates improved detection on selected laboratory assays.
    • The strip recognized the 4-hydroxy metabolite of Alprazolam but missed the corresponding alpha-hydroxy metabolite in its challenge panel.
    • The modified assay yielded 93% for alprazolam and 92% for its alpha-hydroxy metabolite relative response.

    What each source found

  • ClonazepamKlonopinA positive here is expected, not a false positive.
    6 sources, 2009 to 2024
    • Clonazepam belongs to the benzodiazepine class and is among the drugs that reacted in urine in the FDA-reviewed assay data.
    • Participants excreted the genuine 7-amino metabolite after receiving clonazepam.
    • The ARK assay was more responsive for lorazepam, 7-aminoclonazepam and oxazepam than the comparison assay in single-analyte clinical specimens.
    • The newer BNZ2 method improved detection of lorazepam and clonazepam metabolites in urine from the emergency department and a compliance-monitoring program.
    • The modified assay yielded 75% for clonazepam and 58% for its 7-amino metabolite relative response.

    What each source found

  • ClonazolamA positive here is expected, not a false positive.
    2 sources, 2017 to 2021
    • The investigators challenged the assays with Clonazolam as a benzodiazepine-class analyte.
    • Recognition across the panel was generally strong but depended on reagent; flutazolam was the least detectable of the parent compounds.
    • In the two fortified-urine assays, Clonazolam gave relative responses of 100% (EMIT) and 40% (ARK).

    What each source found

  • DeschloroetizolamA positive here is expected, not a false positive.
    1 source, 2017
    • The investigators challenged the assays with Deschloroetizolam as a benzodiazepine-class analyte.
    • Recognition across the panel was generally strong but depended on reagent; flutazolam was the least detectable of the parent compounds.

    What each source found

  • DiclazepamA positive here is expected, not a false positive.
    2 sources, 2017 to 2021
    • The investigators challenged the assays with Diclazepam as a benzodiazepine-class analyte.
    • Recognition across the panel was generally strong but depended on reagent; flutazolam was the least detectable of the parent compounds.
    • In the two fortified-urine assays, Diclazepam gave relative responses of >1,000% (EMIT) and >1,000% (ARK).

    What each source found

  • EstazolamProSomA positive here is expected, not a false positive.
    3 sources, 2009 to 2019
    • Estazolam belongs to the benzodiazepine class and is among the drugs that reacted in urine in the FDA-reviewed assay data.
    • The investigators challenged the assays with Estazolam as a benzodiazepine-class analyte.
    • Recognition across the panel was generally strong but depended on reagent; flutazolam was the least detectable of the parent compounds.

    What each source found

  • EtizolamA positive here is expected, not a false positive.
    4 sources, 2014 to 2021
    • The investigators challenged the assays with Etizolam as a benzodiazepine-class analyte.
    • Recognition across the panel was generally strong but depended on reagent; flutazolam was the least detectable of the parent compounds.
    • At a Etizolam spike of 115 ng/mL, the mean assay response was 272 ng/mL equivalent (237% cross-reactivity), above the 200 ng/mL cutoff.
    • Instant-View M-1 failed to detect etizolam and 7-amino metabolites such as 7-aminonitrazepam in this study.
    • In the two fortified-urine assays, Etizolam gave relative responses of 60% (EMIT) and 100% (ARK).

    What each source found

  • FlubromazepamA positive here is expected, not a false positive.
    1 source, 2017
    • The investigators challenged the assays with Flubromazepam as a benzodiazepine-class analyte.
    • Recognition across the panel was generally strong but depended on reagent; flutazolam was the least detectable of the parent compounds.

    What each source found

  • FlubromazolamA positive here is expected, not a false positive.
    3 sources, 2017 to 2021
    • The investigators challenged the assays with Flubromazolam as a benzodiazepine-class analyte.
    • Recognition across the panel was generally strong but depended on reagent; flutazolam was the least detectable of the parent compounds.
    • In the two fortified-urine assays, Flubromazolam gave relative responses of 300% (EMIT) and 400% (ARK).
    • The modified assay yielded 91% relative response to Flubromazolam.

    What each source found

  • FlunitrazepamRohypnolA positive here is expected, not a false positive.
    3 sources, 2001 to 2017
    • After a single 2 mg dose SBENZ detected more serial urine samples than TDx.
    • The authors attributed the difference partly to recognition of 7-aminoflunitrazepam.
    • The investigators found weak responses for 3-hydroxyflunitrazepam, 7-aminonitrazepam and alpha-hydroxymidazolam, the metabolites evaluated from these respective drugs.
    • The modified assay yielded 68% for flunitrazepam and 66% for its 7-amino metabolite relative response.

    What each source found

  • FlurazepamDalmaneA positive here is expected, not a false positive.
    4 sources, 1994 to 2019
    • Flurazepam belongs to the benzodiazepine class and is among the drugs that reacted in urine in the FDA-reviewed assay data.
    • An oxazepam-only confirmation can miss the metabolites targeted by broader benzodiazepine confirmation, including metabolites of Flurazepam.
    • The investigators found no appreciable reaction to Flurazepam at concentrations reported in urine on this experimental antibody.

    What each source found

  • FlutazolamA positive here is expected, not a false positive.
    1 source, 2017
    • The investigators challenged the assays with Flutazolam as a benzodiazepine-class analyte.
    • Recognition across the panel was generally strong but depended on reagent; flutazolam was the least detectable of the parent compounds.

    What each source found

  • LorazepamAtivanA positive here is expected, not a false positive.
    8 sources, 1998 to 2026
    • Definitive testing confirmed lorazepam in urine.
    • After the laboratory changed to BNZ2, the screen detected more of the glucuronidated benzodiazepine and more lorazepam-only specimens.
    • Adding hydrolysis improved detection of lorazepam glucuronide in urine.
    • After introduction of the modified Roche method the laboratory saw more confirmed lorazepam results.
    • The hydrolysis-capable assays detected glucuronidated benzodiazepines more sensitively than Benzodiazepines Plus in urine.
    • In 500 submitted urines, the CEDIA assay was more sensitive to lorazepam than EMIT II.
    • The glucuronide of Lorazepam showed less than 1% reactivity without hydrolysis and 20% after hydrolysis in this study.
    • The ARK assay was more responsive for lorazepam, 7-aminoclonazepam and oxazepam than the comparison assay in single-analyte clinical specimens.
    • The newer BNZ2 method improved detection of lorazepam and clonazepam metabolites in urine from the emergency department and a compliance-monitoring program.
    • The modified assay yielded 70% relative response to Lorazepam.

    What each source found

  • MeclonazepamA positive here is expected, not a false positive.
    1 source, 2017
    • The investigators challenged the assays with Meclonazepam as a benzodiazepine-class analyte.
    • Recognition across the panel was generally strong but depended on reagent; flutazolam was the least detectable of the parent compounds.

    What each source found

  • NifoxipamA positive here is expected, not a false positive.
    1 source, 2017
    • The investigators challenged the assays with Nifoxipam as a benzodiazepine-class analyte.
    • Recognition across the panel was generally strong but depended on reagent; flutazolam was the least detectable of the parent compounds.

    What each source found

  • OxazepamSeraxA positive here is expected, not a false positive.
    5 sources, 2005 to 2021
    • Oxazepam belongs to the benzodiazepine class and is among the drugs that reacted in urine in the FDA-reviewed assay data.
    • The glucuronide of Oxazepam showed less than 1% reactivity without hydrolysis and 15% after hydrolysis in this study.
    • The ARK assay was more responsive for lorazepam, 7-aminoclonazepam and oxazepam than the comparison assay in single-analyte clinical specimens.
    • The modified assay yielded 76% relative response to Oxazepam.

    What each source found

  • PhenazepamA positive here is expected, not a false positive.
    2 sources, 2017 to 2021
    • The investigators challenged the assays with Phenazepam as a benzodiazepine-class analyte.
    • Recognition across the panel was generally strong but depended on reagent; flutazolam was the least detectable of the parent compounds.
    • In the two fortified-urine assays, Phenazepam gave relative responses of 200% (EMIT) and >1,000% (ARK).

    What each source found

  • PyrazolamA positive here is expected, not a false positive.
    1 source, 2017
    • The investigators challenged the assays with Pyrazolam as a benzodiazepine-class analyte.
    • Recognition across the panel was generally strong but depended on reagent; flutazolam was the least detectable of the parent compounds.

    What each source found

  • TemazepamRestorilA positive here is expected, not a false positive.
    3 sources, 1997 to 2017
    • The benzodiazepine temazepam served as the positive control.
    • A single oral dose produced positive results in some volunteers.
    • The glucuronide of Temazepam showed less than 1% reactivity without hydrolysis and 25% after hydrolysis in this study.
    • The modified assay yielded 82% relative response to Temazepam.

    What each source found

  • TriazolamHalcionA positive here is expected, not a false positive.
    6 sources, 1994 to 2019
    • Triazolam belongs to the benzodiazepine class and is among the drugs that reacted in urine in the FDA-reviewed assay data.
    • An oxazepam-only confirmation can miss the metabolites targeted by broader benzodiazepine confirmation, including metabolites of Triazolam.
    • In the single-dose comparison the Triage device missed all urine specimens collected after Triazolam; lowering thresholds and hydrolyzing conjugates improved detection on selected laboratory assays.
    • The strip recognized the 4-hydroxy metabolite of Triazolam but missed the corresponding alpha-hydroxy metabolite in its challenge panel.
    • The modified assay yielded 69% relative response to Triazolam.

    What each source found

  • ClobazamOnfi, SympazanA positive here is expected, not a false positive.
    1 source, 2019
    • The screening assay detected clobazam, a prescribed benzodiazepine.
    • The center’s confirmation panel omitted it, creating apparent false positives.

    What each source found

  • BromazepamA positive here is expected, not a false positive.
    1 source, 2017

    The modified assay yielded 110% for bromazepam and 75% for its alpha-hydroxy metabolite relative response.

    What each source found

  • BrotizolamA positive here is expected, not a false positive.
    1 source, 2013

    Brotizolam was among the more reactive benzodiazepines in this six-compound comparison using LC-MS/MS-verified spiked urine.

    What each source found

  • ChlordiazepoxideLibriumA positive here is expected, not a false positive.
    3 sources, 1996 to 2019
    • Chlordiazepoxide belongs to the benzodiazepine class and is among the drugs that reacted in urine in the FDA-reviewed assay data.
    • The investigators found no appreciable reaction to Chlordiazepoxide at concentrations reported in urine on this experimental antibody.

    What each source found

  • ClorazepateTranxeneA positive here is expected, not a false positive.
    2 sources, 2009 to 2019

    Clorazepate belongs to the benzodiazepine class and is among the drugs that reacted in urine in the FDA-reviewed assay data.

    What each source found

  • DelorazepamA positive here is expected, not a false positive.
    1 source, 2013

    Delorazepam was among the more reactive benzodiazepines in this six-compound comparison using LC-MS/MS-verified spiked urine.

    What each source found

  • DiazepamValiumA positive here is expected, not a false positive.
    4 sources, 1991 to 2019
    • Diazepam belongs to the benzodiazepine class and is among the drugs that reacted in urine in the FDA-reviewed assay data.
    • Diazepam showed stronger recognition than the other 33 benzodiazepine relatives compared with the reference compound, nordiazepam.
    • The modified assay yielded 87% for diazepam and 100% for nordiazepam relative response.

    What each source found

  • MidazolamVersedA positive here is expected, not a false positive.
    4 sources, 2009 to 2019
    • Midazolam belongs to the benzodiazepine class and is among the drugs that reacted in urine in the FDA-reviewed assay data.
    • The investigators found weak responses for 3-hydroxyflunitrazepam, 7-aminonitrazepam and alpha-hydroxymidazolam, the metabolites evaluated from these respective drugs.
    • The modified assay yielded 84% for midazolam and 82% for its alpha-hydroxy metabolite relative response.

    What each source found

  • NitrazepamA positive here is expected, not a false positive.
    2 sources, 2013 to 2014
    • The investigators found weak responses for 3-hydroxyflunitrazepam, 7-aminonitrazepam and alpha-hydroxymidazolam, the metabolites evaluated from these respective drugs.
    • Instant-View M-1 failed to detect etizolam and 7-amino metabolites such as 7-aminonitrazepam in this study.

    What each source found

  • PinazepamA positive here is expected, not a false positive.
    1 source, 2013

    Pinazepam was among the more reactive benzodiazepines in this six-compound comparison using LC-MS/MS-verified spiked urine.

    What each source found

Tested With No False Positive, or Not Proven (7)

Tested: No False Positive Found7

It was tested and did not make the screen read positive. Other brands of the test can differ.

  • ZolpidemAmbien, Ambien CRIn people and in lab experiments, this test stayed negative.
    2 sources, 1997 to 2017
    • Healthy volunteers given 10 mg of zolpidem had negative benzodiazepine screens on both systems during the following day.
    • The modified assay yielded less than 0.01% relative response to Zolpidem.

    What each source found

  • FlumazenilIn people taking it, this test stayed negative.
    1 source, 1990
    • Investigators tested whether flumazenil or its metabolites interfered with benzodiazepine screening.
    • They reported no interference on the three methods studied, including testing after oral flumazenil.

    What each source found

  • AcetaminophenParacetamol, TylenolIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Acetaminophen at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • DextromethorphanDelsym, DXMIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Dextromethorphan at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • DiphenhydramineBenadryl, Unisom SleepGelsIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Diphenhydramine at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • MeprobamateEquanil, MiltownIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Meprobamate at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • PrednisoneDeltasoneIn lab experiments, this test stayed negative.
    1 source, 2025

    Prednisone at 100 µg/mL did not cause a positive result in drug-free urine or change the result of urine just below or above this channel’s cutoff.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive THC (Marijuana) Test?

THC (cannabis or marijuana metabolites)

A routine urine cannabis test usually looks for a THC metabolite. The source of a confirmed metabolite and whether a person is impaired are separate questions.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 7 kinds of results in this list

Has Caused a False Positive6

Studies or case reports found it can make the screen read positive for a drug that was not there. How often that happens at a usual dose is not known.

  • Methoxyisoflavone5-methyl-7-methoxyisoflavoneSeen in people taking it, and again in lab experiments.
    2 sources, 2012 to 2014
    • A bodybuilding supplement produced positive cannabinoid screens in three volunteers after repeated doses.
    • Analysis identified the 5-methyl-7-hydroxyisoflavone metabolite.

    What each source found

  • IbuprofenAdvil, MotrinSeen in people taking it, and a second test proved it false.
    1 source, 1990

    A prospective study of 510 urine samples from 102 NSAID users found one false-positive cannabinoid result after a total of 1,200 mg taken over one day and one with a different NSAID.

    What each source found

  • NaproxenAleve, NaprosynSeen in people taking it, and a second test proved it false.
    1 source, 1990

    A prospective study of 510 urine samples from 102 NSAID users found one false-positive cannabinoid result in a patient taking naproxen regularly and one with a different NSAID.

    What each source found

  • CannabinolCBNOnly in lab experiments so far, not in people taking it.
    2 sources, 2017 to 2020
    • Cannabinol added to urine reacted on both assays.
    • It also increased the signal in samples containing small amounts of actual THC metabolite.
    • The modified assay yielded 0.92% relative response to Cannabinol.

    What each source found

  • RaltegravirIsentressOnly in lab experiments so far, not in people taking it.
    1 source, 2019

    Drug-free urine spiked with raltegravir reached the cannabinoid screening cutoff at an estimated 339.5 micrograms/mL.

    What each source found

  • RotigotineNeuproOnly in lab experiments so far, not in people taking it.
    1 source, 2019

    Drug-free urine spiked with rotigotine reached the cannabinoid screening cutoff at an estimated 415.1 micrograms/mL.

    What each source found

Depends on the Brand of Test4

Some brands of the screen reacted to it and others did not, or the studies disagree. The lab can tell you which brand it used.

  • CannabidiolCBD, EpidiolexIn people and in lab experiments, some brands reacted and others did not.
    5 sources, 2017 to 2025
    • Pure CBD did not convert to THC in a controlled study that included prescription cannabidiol.
    • In a separate spiking study, six cannabinoid kits did not react to CBD itself, although some reacted to its 6-hydroxy or 7-hydroxy metabolites.
    • The modified assay yielded 0.08% relative response to Cannabidiol.

    What each source found

  • EfavirenzSustivaIn people and in lab experiments, some brands reacted and others did not.
    4 sources, 1998 to 2013
    • Among 30 people taking efavirenz, 28 samples reacted on Rapid Response strips.
    • All 30 were negative by GC-MS and on the three comparison immunoassays.
    • The findings implicated a glucuronidated efavirenz metabolite.
    • In a separate AxSYM study, 50 of 51 efavirenz-treated participants screened negative.
    • The one who screened positive reported using cannabis the previous day.
    • A historical drug bulletin reported that the manufacturer had observed unconfirmed THC screens during efavirenz use.

    What each source found

  • Niflumic acidNiflumateIn people and in lab experiments, some brands reacted and others did not.
    2 sources, 2009 to 2010
    • All 55 urine specimens from five people receiving niflumic acid reacted on KIMS and were negative on EMIT.
    • Spiking supported the same difference.
    • An earlier pediatric case had negative confirmatory chromatography.

    What each source found

  • PantoprazoleProtonixIn people and in lab experiments, some brands reacted and others did not.
    4 sources, 2015 to 2020
    • All eight pediatric samples collected at the start of pantoprazole treatment screened positive on Alere Triage.
    • One reacted on KIMS and none on DRI.
    • Pantoprazole also reacted on Alere in spiked urine.
    • Separate EMIT II Plus and THC One Step studies found no interference under their test conditions.
    • A pediatric case report described an unexpected cannabinoid screen after a dose of intravenous pantoprazole.

    What each source found

The Test Is Made to Find It2

It is the drug the test looks for, contains it, or the body turns it into it. A positive here can be real.

  • DronabinolMarinol, SyndrosA positive here is expected, not a false positive.
    2 sources, 2017 to 2020
    • Five dronabinol-treated patients provided urine in which the study detected THC metabolites.
    • The prescription medicine supplies delta-9 THC, the substance a cannabis test is designed to detect.
    • The modified assay yielded 1.3% for delta-9-THC, 14% for 11-hydroxy-THC and 34% for THC-COOH glucuronide relative response.

    What each source found

  • CBD products containing delta-9 THCCBD-dominant cannabis containing delta-9 THC, THC-containing hempA positive here is expected, not a false positive.
    2 sources, 2021 to 2022
    • After vaporized CBD-dominant cannabis containing measured delta-9 THC, three of 18 participants produced samples meeting the study’s confirmatory THC-metabolite cutoff.
    • The product supplied real THC.
    • Some users of commercial CBD products excreted actual THC metabolites.
    • A positive urine result can therefore reflect THC exposure from the product.

    What each source found

Tested With No False Positive, or Not Proven (18)

A Problem With the Urine Sample1

Something already in the urine, or what happened to the sample after it was collected, affected the result.

  • Baby wash contaminationBaby soap, newborn washSomething in the urine sample, not a medicine, changed the result.
    1 source, 2012
    • Adding certain baby wash products to drug-free urine generated a THC screening signal.
    • Investigators traced the effect to specific surfactants.

    What each source found

Suspected, but Not Proven4

A report, a list or a study names it, but no study we found showed it makes the screen read positive.

  • FurosemideLasixSuspected, but the studies did not show it.
    1 source, 2022
    • Patients with a record of furosemide use had more unconfirmed positive screens in one hospital study.
    • Adding furosemide to urine did not produce a positive on the same device, even at 1,600 micrograms/mL.

    What each source found

  • MeloxicamMobicSuspected, but the studies did not show it.
    1 source, 2022
    • Patients with a record of meloxicam use had more unconfirmed positive screens in one hospital study.
    • Adding meloxicam to urine did not produce a positive on the same device, even at 1,600 micrograms/mL.
    • Its 5′-carboxy metabolite also tested negative up to 800 micrograms/mL.

    What each source found

  • TolmetinTolectinSuspected, but the studies did not show it.
    1 source, 1995

    On the older EMIT method, known-positive cannabinoid samples containing tolmetin could read negative.

    What each source found

  • RifampinRifadin, RimactaneNamed in a list, but no study we found shows it.
    1 source, 2006
    • A clinical drug reference lists rifampin.
    • A phase 1 report involved efavirenz and rifampin, and the indexed record does not isolate a rifampin effect on the THC test.

    What each source found

Tested: No False Positive Found13

It was tested and did not make the screen read positive. Other brands of the test can differ.

  • HexahydrocannabiphorolHHC-P, HHCPIn people and in lab experiments, this test stayed negative.
    2 sources, 2024 to 2025
    • One volunteer’s urine had HHCP metabolites on mass spectrometry and negative cannabinoid immunoassays.
    • The researchers reported no cross-reactivity for the HHC analogues HHC-O or HHC-P, or H4-CBD, on the tested devices.

    What each source found

  • EsomeprazoleNexiumIn people taking it, this test stayed negative.
    1 source, 2020

    Urine samples stayed negative in the volunteers assigned to esomeprazole after five days of oral treatment in a small study of proton pump inhibitors.

    What each source found

  • LansoprazolePrevacidIn people taking it, this test stayed negative.
    1 source, 2020

    Urine samples stayed negative in the volunteers assigned to lansoprazole after five days of oral treatment in a small study of proton pump inhibitors.

    What each source found

  • OmeprazolePrilosecIn people taking it, this test stayed negative.
    1 source, 2020

    Urine samples stayed negative in the volunteers assigned to omeprazole after five days of oral treatment in a small study of proton pump inhibitors.

    What each source found

  • AcetaminophenParacetamol, TylenolIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Acetaminophen at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • Chocolate-associated ethanolamidesAnandamide, ChocolateIn lab experiments, this test stayed negative.
    1 source, 2000

    None of three chocolate-associated lipids produced a positive result when added to urine.

    What each source found

  • DextromethorphanDelsym, DXMIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Dextromethorphan at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • DiphenhydramineBenadryl, Unisom SleepGelsIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Diphenhydramine at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • Hexahydrocannabinol acetateHHC-OIn lab experiments, this test stayed negative.
    1 source, 2024

    The researchers reported no cross-reactivity for the HHC analogues HHC-O or HHC-P, or H4-CBD, on the tested devices.

    What each source found

  • MeprobamateEquanil, MiltownIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Meprobamate at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • NabiloneCesametIn lab experiments, this test stayed negative.
    1 source, 1989
    • The original publication reported no interference by nabilone with these urine cannabinoid methods.
    • Nabilone and dronabinol are different medicines.

    What each source found

  • PrednisoneDeltasoneIn lab experiments, this test stayed negative.
    1 source, 2025

    Prednisone at 100 µg/mL did not cause a positive result in drug-free urine or change the result of urine just below or above this channel’s cutoff.

    What each source found

  • TetrahydrocannabidiolH4-CBDIn lab experiments, this test stayed negative.
    1 source, 2024

    The researchers reported no cross-reactivity for the HHC analogues HHC-O or HHC-P, or H4-CBD, on the tested devices.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Methamphetamine Test?

Some reports name methamphetamine separately. Distinguishing the d- and l-forms can require a further test.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 5 kinds of results in this list

Has Caused a False Positive11

Studies or case reports found it can make the screen read positive for a drug that was not there. How often that happens at a usual dose is not known.

  • PhenylephrineNeo-Synephrine, Sudafed PESeen in people taking it, and again in lab experiments.
    2 sources, 2006 to 2012
    • An ICU patient screened positive after intravenous phenylephrine, and a follow-up investigation implicated the drug or its metabolites.
    • In a separate FDA submission, l-phenylephrine at 50 micrograms/mL triggered the evaluated strip in fortified urine.

    What each source found

  • RanitidineZantacSeen in people taking it, and again in lab experiments.
    2 sources, 2006 to 2022
    • Preliminary clinical associations prompted an Alere cup experiment that reproduced a positive with 50 micrograms/mL of added ranitidine.
    • A separate FDA submission documented a positive at 25 micrograms/mL on a different methamphetamine strip.

    What each source found

  • EphedraEphedra sinica, Ma huangSeen in a case report about a person taking it.
    1 source, 2003

    A published report describes a false-positive methamphetamine radioimmunoassay after an ephedra-derived herbal product.

    What each source found

  • EphedrineAkovazOnly in lab experiments so far, not in people taking it.
    3 sources, 1985 to 2007
    • In a multi-assay experiment, urine fortified with the l-ephedrine isomer reacted on some methamphetamine assays at 1,000 mg/L.
    • The assay reacted to added Ephedrine in the analogue challenge.
    • In a comparison with 50 ng/mL target standards, the assay's relative response to Ephedrine was 9%.

    What each source found

  • FenfluramineFinteplaOnly in lab experiments so far, not in people taking it.
    1 source, 2006

    Fenfluramine spiked into negative urine triggered this methamphetamine strip at 2 micrograms/mL.

    What each source found

  • Meta-chlorophenylpiperazineChlorophenylpiperazine, mCPPOnly in lab experiments so far, not in people taking it.
    1 source, 2015

    In the Meta-chlorophenylpiperazine challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL gave a positive result at 1.5 µg/mL.

    What each source found

  • MethoxyphenamineOnly in lab experiments so far, not in people taking it.
    1 source, 1985

    The assay reacted to added Methoxyphenamine in the analogue challenge.

    What each source found

  • MethylephedrineOnly in lab experiments so far, not in people taking it.
    1 source, 1985

    The assay reacted to added Methylephedrine in the analogue challenge.

    What each source found

  • PropylhexedrineBenzedrexOnly in lab experiments so far, not in people taking it.
    1 source, 2006

    The FDA decision summary reports positive screens at 2 micrograms/mL of added propylhexedrine on the evaluated strip.

    What each source found

  • PseudoephedrineSudafedOnly in lab experiments so far, not in people taking it.
    2 sources, 1992 to 2007
    • Drug-free urine containing high concentrations of d-pseudoephedrine reacted on certain methamphetamine-specific assays.
    • In a comparison with 50 ng/mL target standards, the assay's relative response to Pseudoephedrine was 19%.

    What each source found

  • TrimethobenzamideTiganOnly in lab experiments so far, not in people taking it.
    1 source, 1999

    In a drug-free urine experiment, adding 500 micrograms/mL of trimethobenzamide produced an apparent methamphetamine concentration above 4,000 ng/mL.

    What each source found

Depends on the Brand of Test3

Some brands of the screen reacted to it and others did not, or the studies disagree. The lab can tell you which brand it used.

  • DextroamphetamineD-amphetamine, DexamphetamineIn people and in lab experiments, some brands reacted and others did not.
    4 sources, 2013 to 2025
    • Added dextroamphetamine produced a positive methamphetamine-specific Wondfo result at 50,000 ng/mL.
    • ACCU NEWS remained below cutoff at 100,000 ng/mL.

    What each source found

  • LisdexamfetamineElvanse, VyvanseIn people and in lab experiments, some brands reacted and others did not.
    4 sources, 2013 to 2025
    • The body converts lisdexamfetamine to dextroamphetamine.
    • Added dextroamphetamine triggered the Wondfo methamphetamine strip at 50,000 ng/mL.
    • ACCU NEWS remained below cutoff at 100,000 ng/mL.

    What each source found

  • PhentermineAdipex-P, LomairaIn lab experiments, some brands reacted and others did not.
    2 sources, 1985 to 2016
    • The assay reacted to added Phentermine in the analogue challenge.
    • Phentermine remained negative on the dedicated Immunalysis methamphetamine assay even at 1,000,000 ng/mL in the laboratory.

    What each source found

The Test Is Made to Find It6

It is the drug the test looks for, contains it, or the body turns it into it. A positive here can be real.

  • Amphetamine/dextroamphetamine mixed saltsAdderall, Adderall XRA positive here is expected, not a false positive.
    4 sources, 1992 to 2025
    • In a pharmaceutical impurity investigation, LC-MS/MS measured trace methamphetamine in an Adderall XR preparation and in some specimens from people prescribed amphetamine.
    • Separate researchers reported evidence consistent with a minor metabolic contribution.
    • The 1991 prototype showed less than 7% relative antibody response to amphetamine.
    • RapiTest MET also reacted with amphetamine.

    What each source found

  • BenzphetamineDidrex, RegimexA positive here is expected, not a false positive.
    2 sources, 1995 to 1998
    • Benzphetamine can produce d-methamphetamine and d-amphetamine.
    • The amounts differed among people in a controlled study.
    • The assay intentionally recognized the parent benzphetamine, with a reported detection limit of 0.05 ppm.

    What each source found

  • LevomethamphetamineLevmetamfetamine, Levmetamfetamine-containing nasal inhalerA positive here is expected, not a false positive.
    2 sources, 2014
    • A controlled study of a nasal inhaler formulation containing levmetamfetamine detected real l-methamphetamine in urine and no d-methamphetamine.
    • At high l-methamphetamine concentrations, the integration software could misassign a peak as d-methamphetamine on this GC-MS method.

    What each source found

  • FamprofazoneA positive here is expected, not a false positive.
    1 source, 1996

    Famprofazone metabolism yielded d- and l-methamphetamine in urine.

    What each source found

  • MethamphetamineD-methamphetamine, DesoxynA positive here is expected, not a false positive.
    1 source, 2004
    • A prescription containing methamphetamine supplies the actual test target.
    • Controlled administration produced urinary methamphetamine.

    What each source found

  • SelegilineDeprenyl, EldeprylA positive here is expected, not a false positive.
    2 sources, 1997 to 1999
    • Selegiline produces l-methamphetamine as a genuine metabolite.
    • A test that does not distinguish isomers may report methamphetamine.
    • The authors confirmed the R isomer of methamphetamine in urine from a patient taking selegiline.

    What each source found

Tested With No False Positive, or Not Proven (84)

Tested: No False Positive Found84

It was tested and did not make the screen read positive. Other brands of the test can differ.

  • 2,5-DimethoxyamphetamineDMA, 2,5-DMAIn lab experiments, this test stayed negative.
    2 sources, 2015 to 2016
    • In the 2,5-Dimethoxyamphetamine challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.
    • 2,5-Dimethoxyamphetamine did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • 2-Aminoindane2-AIIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 2-Aminoindane challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • 2-DPMPDesoxypipradrol, 2-DiphenylmethylpiperidineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 2-DPMP challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • 25B-NBOMe4-Bromo-2,5-dimethoxy-N-[ methyl]-benzenethanamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 25B-NBOMe challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • 25C-NBOMe2C-C-NBOMeIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 25C-NBOMe challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • 25I-NBOMeIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 25I-NBOMe challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • 2C-B4-Bromo-2,5-dimethoxy-β-phenethylamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 2C-B challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • 2C-C4-Chloro-2,5-dimethoxy-β-phenethylamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 2C-C challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • 2C-E4-Ethyl-2,5-dimethoxy-β-phenethylamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 2C-E challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • 2C-I4-Iodo-2,5-dimethoxy-β-phenethylamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 2C-I challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • 2C-NIn lab experiments, this test stayed negative.
    1 source, 2016

    2C-N did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • 2C-T4-Methylthio-2,5-dimethoxy-β-phenethylamineIn lab experiments, this test stayed negative.
    2 sources, 2015 to 2016
    • In the 2C-T challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.
    • 2C-T did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • 2C-T-13In lab experiments, this test stayed negative.
    1 source, 2016

    2C-T-13 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • 2C-T-17In lab experiments, this test stayed negative.
    1 source, 2016

    2C-T-17 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • 2C-T-24-Ethylthio-2,5-dimethoxy-β-phenethylamineIn lab experiments, this test stayed negative.
    2 sources, 2015 to 2016
    • In the 2C-T-2 challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.
    • 2C-T-2 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • 2C-T-44-Isopropylthio-2,5-dimethoxy-β-phenethylamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 2C-T-4 challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • 2C-T-5In lab experiments, this test stayed negative.
    1 source, 2016

    2C-T-5 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • 2C-T-74-n-Propylthio-2,5-dimethoxy-β-phenethylamineIn lab experiments, this test stayed negative.
    2 sources, 2015 to 2016
    • In the 2C-T-7 challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.
    • 2C-T-7 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • 3,4,5-TrimethoxyamphetamineTMAIn lab experiments, this test stayed negative.
    2 sources, 2015 to 2016
    • In the 3,4,5-Trimethoxyamphetamine challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.
    • 3,4,5-Trimethoxyamphetamine did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • 4-HO-DET4-Hydroxy-diethyl-tryptamine, 4-OH-DETIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 4-HO-DET challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • 4-Methoxyphencyclidine4-MeO-PCPIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 4-Methoxyphencyclidine challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • 4-TFMPP1- phenyl)piperazine, 1-In lab experiments, this test stayed negative.
    1 source, 2015

    In the 4-TFMPP challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • 5-IAI5-Iodo-2-aminoindanIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 5-IAI challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • 5-MeO-AMTα-Methyl-5-methoxytryptamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 5-MeO-AMT challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • 5-MeO-DALTN,N-Diallyl-5-methoxytryptamine, 5-Methoxy-DALTIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 5-MeO-DALT challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • 5-MeO-DiPTN,N-Diisopropyl-5-methoxytryptamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 5-MeO-DiPT challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • 5-MeO-DMTN,N-Dimethyl-5-methoxytryptamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 5-MeO-DMT challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • 5-MeO-MiPT5-Methoxy-N-methyl-N-isopropyltryptamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 5-MeO-MiPT challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • AcetaminophenParacetamol, TylenolIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Acetaminophen at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • ALEPHIn lab experiments, this test stayed negative.
    1 source, 2016

    ALEPH did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • ALEPH-13In lab experiments, this test stayed negative.
    1 source, 2016

    ALEPH-13 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • ALEPH-17In lab experiments, this test stayed negative.
    1 source, 2016

    ALEPH-17 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • ALEPH-2In lab experiments, this test stayed negative.
    1 source, 2016

    ALEPH-2 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • ALEPH-5In lab experiments, this test stayed negative.
    1 source, 2016

    ALEPH-5 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • ALEPH-7In lab experiments, this test stayed negative.
    1 source, 2016

    ALEPH-7 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • Alpha-methyltryptamineAMT, α-MethyltryptamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Alpha-methyltryptamine challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • Alpha-PPPAlpha-pyrrolidinopropiophenone, α-PPPIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Alpha-PPP challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • Alpha-PVPα-PVP, α-PyrrolidinopentiophenoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Alpha-PVP challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • Alpha-PVTα-PVT, α-PyrrolidinopentiothiophenoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Alpha-PVT challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • BenocyclidineBCP, BenzothiophenylcyclohexylpiperidineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Benocyclidine challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • Benzedrone2- -1- propan-1-one, 4-MBCIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Benzedrone challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • BOBIn lab experiments, this test stayed negative.
    1 source, 2016

    BOB did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • BODIn lab experiments, this test stayed negative.
    1 source, 2016

    BOD did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • BOHIn lab experiments, this test stayed negative.
    1 source, 2016

    BOH did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • BOHDIn lab experiments, this test stayed negative.
    1 source, 2016

    BOHD did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • Bromo-DragonFLYBDF, 1- -2-aminopropaneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Bromo-DragonFLY challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • BupropionAplenzin, WellbutrinIn lab experiments, this test stayed negative.
    2 sources, 2011 to 2025

    Bupropion added at 100 µg/mL did not change the methamphetamine result on this urine device.

    What each source found

  • CathinoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Cathinone challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • D2PMα,α-Diphenyl-2R-pyrrolidinemethanolIn lab experiments, this test stayed negative.
    1 source, 2015

    In the D2PM challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • DextromethorphanDelsym, DXMIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Dextromethorphan at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • DibenzylpiperazineDBZP, 1,4-DibenzylpiperazineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Dibenzylpiperazine challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • DiethylpropionAmfepramone, TenuateIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Diethylpropion challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • DimethylamylamineDMAA, GeranamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Dimethylamylamine challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • DiphenhydramineBenadryl, Unisom SleepGelsIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Diphenhydramine at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • DipropyltryptamineDPT, N,N-DipropyltryptamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Dipropyltryptamine challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • DiPTN,N-DiisopropyltryptamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the DiPT challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • DOB4-Bromo-2,5-dimethoxyamphetamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the DOB challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • DOC4-Chloro-2,5-dimethoxyamphetamineIn lab experiments, this test stayed negative.
    2 sources, 2015 to 2016
    • In the DOC challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.
    • DOC did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • DOET2,5-Dimethoxy-4-ethylamphetamineIn lab experiments, this test stayed negative.
    2 sources, 2015 to 2016
    • In the DOET challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.
    • DOET did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • DOI4-Iodo-2,5-dimethoxyamphetamineIn lab experiments, this test stayed negative.
    2 sources, 2015 to 2016
    • In the DOI challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.
    • DOI did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • DOM2,5-Dimethoxy-4-methylamphetamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the DOM challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • DONIn lab experiments, this test stayed negative.
    1 source, 2016

    DON did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • DOPRIn lab experiments, this test stayed negative.
    1 source, 2016

    DOPR did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • EscalineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Escaline challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • Flephedrone4-Fluoromethcathinone, 4-FMCIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Flephedrone challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • MDAI5,6-Methylenedioxy-2-aminoindaneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the MDAI challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • MDBZIn lab experiments, this test stayed negative.
    1 source, 2016

    MDBZ did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • MDCPMIn lab experiments, this test stayed negative.
    1 source, 2016

    MDCPM did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • MDIPIn lab experiments, this test stayed negative.
    1 source, 2016

    MDIP did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • MDPPP3,4-Methylenedioxy-α-pyrrolidinopropiophenoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the MDPPP challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • MeprobamateEquanil, MiltownIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Meprobamate at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • MescalineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Mescaline challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • MethoxetamineMXEIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Methoxetamine challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • MethylenedioxypyrovaleroneMDPV, 3,4-methylenedioxypyrovaleroneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Methylenedioxypyrovalerone challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • MOPPP4-Methoxy-α-pyrrolidinopropiophenoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the MOPPP challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • MPHP (study designation)In lab experiments, this test stayed negative.
    1 source, 2015

    In the MPHP challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • MT-451-Cyclohexyl-4- -piperazine, dihydrochlorideIn lab experiments, this test stayed negative.
    1 source, 2015

    In the MT-45 challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • Naphyrone2-NaphthylpyrovaleroneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Naphyrone challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • Pentylone1- -2- -1-pentanoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Pentylone challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • PyrovaleroneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Pyrovalerone challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

  • TMA-2In lab experiments, this test stayed negative.
    1 source, 2016

    TMA-2 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • TMA-3In lab experiments, this test stayed negative.
    1 source, 2016

    TMA-3 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • TMA-6In lab experiments, this test stayed negative.
    1 source, 2016

    TMA-6 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • WIN 35,428CFTIn lab experiments, this test stayed negative.
    1 source, 2015

    In the WIN 35,428 challenge, Lin-Zhi Methamphetamine, calibrated at 250 ng/mL stayed negative at 100 µg/mL.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive MDMA (Ecstasy) Test?

MDMA (ecstasy)

An MDMA-specific screen and a combined amphetamine/ecstasy screen can have different cross-reactions.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 5 kinds of results in this list

Has Caused a False Positive9

Studies or case reports found it can make the screen read positive for a drug that was not there. How often that happens at a usual dose is not known.

  • 3,4-Methylenedioxy-alpha-pyrrolidinohexanophenoneMDPHP, 3,4-MDPHPSeen in people taking it, and again in lab experiments.
    1 source, 2026
    • In a study of this synthetic cathinone, investigators found evidence that metabolites may trigger the ecstasy screen.
    • Adding the unchanged drug did not itself produce a positive.

    What each source found

  • FenofibrateAntara, TricorSeen in people taking it, and again in lab experiments.
    3 sources, 2012 to 2016
    • In a French military cohort, 22 of 15,169 urine screens were positive for MDMA.
    • GC-MS confirmed none.
    • The investigators identified fenofibric acid, a fenofibrate metabolite, in the investigation.

    What each source found

  • LabetalolNormodyne, TrandateSeen in people taking it, and again in lab experiments.
    1 source, 2022
    • A clinical-record signal prompted laboratory testing.
    • Urine spiked with labetalol at 200 micrograms/mL produced a positive MDMA result on this cup.

    What each source found

  • MebeverineColofac, DuspatalinSeen in people taking it, and again in lab experiments.
    2 sources, 2021 to 2026
    • Three treated patients screened positive while GC-MS detected neither MDMA nor MDA.
    • Controlled administration reproduced positive screens.
    • Mebeverine O-desmethyl-butanol was consistently present.

    What each source found

  • MetoprololLopressor, Toprol-XLSeen in people taking it, and again in lab experiments.
    1 source, 2020
    • After metoprolol poisoning, the reported MDMA results did not confirm by GC-MS.
    • Metoprolol added to urine also triggered the MDMA screen.

    What each source found

  • StiripentolDiacomitSeen in people taking it, and again in lab experiments.
    1 source, 2025
    • In a child receiving stiripentol, two MDMA-positive screens failed GC-MS confirmation.
    • Laboratory testing reproduced the reaction with stiripentol.
    • The third sample, at a lower drug concentration, screened negative.

    What each source found

  • TrazodoneDesyrel, OleptroSeen in people taking it, and again in lab experiments.
    2 sources, 2010 to 2016
    • Patient samples positive on the ecstasy screen contained trazodone and mCPP.
    • LC-MS/MS found no MDMA.
    • Tests with reference material showed that both trazodone and mCPP could trigger the assay.

    What each source found

  • BupropionAplenzin, WellbutrinOnly in lab experiments so far, not in people taking it.
    1 source, 2016

    A bupropion metabolite, erythrohydrobupropion, triggered a positive MDMA result at 10.5 micrograms/mL in synthetic urine.

    What each source found

  • Fenofibric acidCholine fenofibrate, TrilipixOnly in lab experiments so far, not in people taking it.
    2 sources, 2015 to 2016
    • Testing identified fenofibric acid as a cross-reactant in a study prompted by patients taking fenofibrate.
    • Fenofibric acid is also an active medicinal ingredient.

    What each source found

Depends on the Brand of Test1

Some brands of the screen reacted to it and others did not, or the studies disagree. The lab can tell you which brand it used.

  • Meta-chlorophenylpiperazineChlorophenylpiperazine, mCPPIn people and in lab experiments, some brands reacted and others did not.
    2 sources, 2010 to 2015
    • The two ecstasy assays disagreed.
    • On the Microgenics DRI Ecstasy assay, m-CPP added to drug-free urine stayed negative at 100 µg/mL.
    • On the EMIT II Ecstasy assay, an m-CPP standard cross-reacted, and urine from patients taking trazodone that screened positive contained trazodone and m-CPP with no MDMA by LC-MS/MS.

    What each source found

The Test Is Made to Find It1

It is the drug the test looks for, contains it, or the body turns it into it. A positive here can be real.

  • MDMAEcstasy, MollyA positive here is expected, not a false positive.
    1 source, 2009

    The 2009 comparison lists 100% cross-reactivity for MDMA on the Microgenics DRI screen.

    What each source found

Tested With No False Positive, or Not Proven (101)

Tested: No False Positive Found101

It was tested and did not make the screen read positive. Other brands of the test can differ.

  • 2,5-DimethoxyamphetamineDMA, 2,5-DMAIn lab experiments, this test stayed negative.
    2 sources, 2015 to 2016
    • In the 2,5-Dimethoxyamphetamine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
    • 2,5-Dimethoxyamphetamine did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • 2-Aminoindane2-AIIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 2-Aminoindane challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • 2-DPMPDesoxypipradrol, 2-DiphenylmethylpiperidineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 2-DPMP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • 25B-NBOMe4-Bromo-2,5-dimethoxy-N-[ methyl]-benzenethanamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 25B-NBOMe challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • 25C-NBOMe2C-C-NBOMeIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 25C-NBOMe challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • 25I-NBOMeIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 25I-NBOMe challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • 2C-B4-Bromo-2,5-dimethoxy-β-phenethylamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 2C-B challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • 2C-C4-Chloro-2,5-dimethoxy-β-phenethylamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 2C-C challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • 2C-E4-Ethyl-2,5-dimethoxy-β-phenethylamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 2C-E challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • 2C-I4-Iodo-2,5-dimethoxy-β-phenethylamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 2C-I challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • 2C-NIn lab experiments, this test stayed negative.
    1 source, 2016

    2C-N did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • 2C-T4-Methylthio-2,5-dimethoxy-β-phenethylamineIn lab experiments, this test stayed negative.
    2 sources, 2015 to 2016
    • In the 2C-T challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
    • 2C-T did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • 2C-T-13In lab experiments, this test stayed negative.
    1 source, 2016

    2C-T-13 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • 2C-T-17In lab experiments, this test stayed negative.
    1 source, 2016

    2C-T-17 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • 2C-T-24-Ethylthio-2,5-dimethoxy-β-phenethylamineIn lab experiments, this test stayed negative.
    2 sources, 2015 to 2016
    • In the 2C-T-2 challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
    • 2C-T-2 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • 2C-T-44-Isopropylthio-2,5-dimethoxy-β-phenethylamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 2C-T-4 challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • 2C-T-5In lab experiments, this test stayed negative.
    1 source, 2016

    2C-T-5 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • 2C-T-74-n-Propylthio-2,5-dimethoxy-β-phenethylamineIn lab experiments, this test stayed negative.
    2 sources, 2015 to 2016
    • In the 2C-T-7 challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
    • 2C-T-7 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • 3,4,5-TrimethoxyamphetamineTMAIn lab experiments, this test stayed negative.
    2 sources, 2015 to 2016
    • In the 3,4,5-Trimethoxyamphetamine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
    • 3,4,5-Trimethoxyamphetamine did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • 3,4-DimethylmethcathinoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 3,4-Dimethylmethcathinone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • 3-TrifluoromethylphenylpiperazineTFMPP, TrifluoromethylphenylpiperazineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 3-TFMPP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • 4-EEC4-EthylethcathinoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 4-EEC challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • 4-HO-DET4-Hydroxy-diethyl-tryptamine, 4-OH-DETIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 4-HO-DET challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • 4-MEC4-MethylethcathinoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 4-MEC challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • 4-MePPP4-Methyl-alpha-pyrrolidinopropiophenone, 4-Methyl-α-pyrrolidinopropiophenoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 4-MePPP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • 4-Methoxyphencyclidine4-MeO-PCPIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 4-Methoxyphencyclidine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • 4-MPBP4-Methyl-α-pyrrolidinobutiophenoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 4-MPBP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • 4-TFMPP1- phenyl)piperazine, 1-In lab experiments, this test stayed negative.
    1 source, 2015

    In the 4-TFMPP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • 5-IAI5-Iodo-2-aminoindanIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 5-IAI challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • 5-IT5- indoleIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 5-IT challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • 5-MeO-AMTα-Methyl-5-methoxytryptamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 5-MeO-AMT challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • 5-MeO-DALTN,N-Diallyl-5-methoxytryptamine, 5-Methoxy-DALTIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 5-MeO-DALT challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • 5-MeO-DiPTN,N-Diisopropyl-5-methoxytryptamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 5-MeO-DiPT challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • 5-MeO-DMTN,N-Dimethyl-5-methoxytryptamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 5-MeO-DMT challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • 5-MeO-MiPT5-Methoxy-N-methyl-N-isopropyltryptamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 5-MeO-MiPT challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • AcetaminophenParacetamol, TylenolIn lab experiments, this test stayed negative.
    1 source, 2013

    The study found no cup interference from Acetaminophen at 1,000 ng/mL in drug-free urine.

    What each source found

  • ALEPHIn lab experiments, this test stayed negative.
    1 source, 2016

    ALEPH did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • ALEPH-13In lab experiments, this test stayed negative.
    1 source, 2016

    ALEPH-13 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • ALEPH-17In lab experiments, this test stayed negative.
    1 source, 2016

    ALEPH-17 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • ALEPH-2In lab experiments, this test stayed negative.
    1 source, 2016

    ALEPH-2 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • ALEPH-5In lab experiments, this test stayed negative.
    1 source, 2016

    ALEPH-5 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • ALEPH-7In lab experiments, this test stayed negative.
    1 source, 2016

    ALEPH-7 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • Alpha-methyltryptamineAMT, α-MethyltryptamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Alpha-methyltryptamine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • Alpha-PBPα-PBP, α-PyrrolidinobutiophenoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Alpha-PBP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • Alpha-PPPAlpha-pyrrolidinopropiophenone, α-PPPIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Alpha-PPP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • Alpha-PVPα-PVP, α-PyrrolidinopentiophenoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Alpha-PVP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • Alpha-PVTα-PVT, α-PyrrolidinopentiothiophenoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Alpha-PVT challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • BenocyclidineBCP, BenzothiophenylcyclohexylpiperidineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Benocyclidine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • Benzedrone2- -1- propan-1-one, 4-MBCIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Benzedrone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • BenzylpiperazineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Benzylpiperazine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • BOBIn lab experiments, this test stayed negative.
    1 source, 2016

    BOB did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • BODIn lab experiments, this test stayed negative.
    1 source, 2016

    BOD did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • BOHIn lab experiments, this test stayed negative.
    1 source, 2016

    BOH did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • BOHDIn lab experiments, this test stayed negative.
    1 source, 2016

    BOHD did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • Bromo-DragonFLYBDF, 1- -2-aminopropaneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Bromo-DragonFLY challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • BuphedroneMABP, α-Methylamino-butyrophenoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Buphedrone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • CathinoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Cathinone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • D2PMα,α-Diphenyl-2R-pyrrolidinemethanolIn lab experiments, this test stayed negative.
    1 source, 2015

    In the D2PM challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • DextromethorphanDelsym, DXMIn lab experiments, this test stayed negative.
    1 source, 2013

    The study found no cup interference from Dextromethorphan at 1,000 ng/mL in drug-free urine.

    What each source found

  • DibenzylpiperazineDBZP, 1,4-DibenzylpiperazineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Dibenzylpiperazine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • DiethylpropionAmfepramone, TenuateIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Diethylpropion challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • DimethylamylamineDMAA, GeranamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Dimethylamylamine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • Dimethyloneβ-keto-MDDMAIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Dimethylone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • DimethyltryptamineDMT, N,N-DimethyltryptamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Dimethyltryptamine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • DiphenhydramineBenadryl, Unisom SleepGelsIn lab experiments, this test stayed negative.
    1 source, 2013

    The study found no cup interference from Diphenhydramine at 1,000 ng/mL in drug-free urine.

    What each source found

  • DipropyltryptamineDPT, N,N-DipropyltryptamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Dipropyltryptamine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • DiPTN,N-DiisopropyltryptamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the DiPT challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • DOB4-Bromo-2,5-dimethoxyamphetamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the DOB challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • DOC4-Chloro-2,5-dimethoxyamphetamineIn lab experiments, this test stayed negative.
    2 sources, 2015 to 2016
    • In the DOC challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
    • DOC did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • DOET2,5-Dimethoxy-4-ethylamphetamineIn lab experiments, this test stayed negative.
    2 sources, 2015 to 2016
    • In the DOET challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
    • DOET did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • DOI4-Iodo-2,5-dimethoxyamphetamineIn lab experiments, this test stayed negative.
    2 sources, 2015 to 2016
    • In the DOI challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.
    • DOI did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • DOM2,5-Dimethoxy-4-methylamphetamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the DOM challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • DONIn lab experiments, this test stayed negative.
    1 source, 2016

    DON did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • DOPRIn lab experiments, this test stayed negative.
    1 source, 2016

    DOPR did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • EscalineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Escaline challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • Ethcathinonen-EthylcathinoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Ethcathinone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • Flephedrone4-Fluoromethcathinone, 4-FMCIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Flephedrone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • MDAI5,6-Methylenedioxy-2-aminoindaneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the MDAI challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • MDBZIn lab experiments, this test stayed negative.
    1 source, 2016

    MDBZ did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • MDCPMIn lab experiments, this test stayed negative.
    1 source, 2016

    MDCPM did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • MDIPIn lab experiments, this test stayed negative.
    1 source, 2016

    MDIP did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • MDPBP3,4-Methylenedioxy-α-pyrrolidinobutiophenoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the MDPBP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • Mephedrone4-methylmethcathinone, 4-MMCIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Mephedrone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • MeprobamateEquanil, MiltownIn lab experiments, this test stayed negative.
    1 source, 2013

    The study found no cup interference from Meprobamate at 1,000 ng/mL in drug-free urine.

    What each source found

  • MescalineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Mescaline challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • MethcathinoneEphedroneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Methcathinone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • MethiopropamineMPAIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Methiopropamine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • MethoxetamineMXEIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Methoxetamine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • MethylenedioxypyrovaleroneMDPV, 3,4-methylenedioxypyrovaleroneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Methylenedioxypyrovalerone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • MOPPP4-Methoxy-α-pyrrolidinopropiophenoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the MOPPP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • MPHP (study designation)In lab experiments, this test stayed negative.
    1 source, 2015

    In the MPHP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • MT-451-Cyclohexyl-4- -piperazine, dihydrochlorideIn lab experiments, this test stayed negative.
    1 source, 2015

    In the MT-45 challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • N,N-DimethylcathinoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the N,N-Dimethylcathinone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • Naphyrone2-NaphthylpyrovaleroneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Naphyrone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • Pentedroneα-Methylamino-valerophenoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Pentedrone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • Pentylone1- -2- -1-pentanoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Pentylone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • PyrovaleroneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Pyrovalerone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

  • TMA-2In lab experiments, this test stayed negative.
    1 source, 2016

    TMA-2 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • TMA-3In lab experiments, this test stayed negative.
    1 source, 2016

    TMA-3 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • TMA-6In lab experiments, this test stayed negative.
    1 source, 2016

    TMA-6 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

    What each source found

  • WIN 35,428CFTIn lab experiments, this test stayed negative.
    1 source, 2015

    In the WIN 35,428 challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Cocaine Test?

Cocaine metabolite (benzoylecgonine)

An explanation for a true cocaine metabolite result, such as prescribed topical cocaine, belongs alongside the laboratory evidence for suspected cross-reactions.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 5 kinds of results in this list

Has Caused a False Positive3

Studies or case reports found it can make the screen read positive for a drug that was not there. How often that happens at a usual dose is not known.

  • ClozapineClozarilSeen in people taking it, and a second test proved it false.
    1 source, 1998
    • In a multicenter evaluation, the authors attributed some unexpected cocaine results on the FRONTLINE strip to metabolites of clozapine.
    • Discrepant specimens underwent GC-MS testing.

    What each source found

  • MethadoneDolophine, MethadoseSeen in people taking it, and a second test proved it false.
    1 source, 1998
    • In a multicenter evaluation, the authors attributed some unexpected cocaine results on the FRONTLINE strip to metabolites of methadone.
    • Discrepant specimens underwent GC-MS testing.

    What each source found

  • Alpha-PPPAlpha-pyrrolidinopropiophenone, α-PPPOnly in lab experiments so far, not in people taking it.
    1 source, 2014

    At a Alpha-pyrrolidinopropiophenone spike of 3,500 ng/mL, the mean assay response was 189 ng/mL equivalent (5.4% cross-reactivity), above the 150 ng/mL cutoff.

    What each source found

Depends on the Brand of Test2

Some brands of the screen reacted to it and others did not, or the studies disagree. The lab can tell you which brand it used.

  • 4-MePPP4-Methyl-alpha-pyrrolidinopropiophenone, 4-Methyl-α-pyrrolidinopropiophenoneIn lab experiments, some brands reacted and others did not.
    1 source, 2014

    At a 4-Methyl-alpha-pyrrolidinopropiophenone spike of 12,000 ng/mL, the mean assay response was 140 ng/mL equivalent (1.2% cross-reactivity), below the 150 ng/mL cutoff.

    What each source found

  • ProcaineNovocain, NovocaineIn lab experiments, some brands reacted and others did not.
    2 sources, 2006 to 2018
    • Procaine produced a positive result at 75,000 ng/mL on RapidOne.
    • On First Sign, 100,000 ng/mL did not change the result of drug-free urine or samples near the cutoff.

    What each source found

The Test Is Made to Find It2

It is the drug the test looks for, contains it, or the body turns it into it. A positive here can be real.

  • Cocaine (medical topical use)Cocaine hydrochloride, Intranasal cocaineA positive here is expected, not a false positive.
    3 sources, 1990 to 2017
    • Medically applied cocaine can produce a urine result positive for benzoylecgonine.
    • This has been documented after intranasal use and cocaine-containing topical anesthetic.
    • The modified assay yielded 0.94% for cocaine, 76% for benzoylecgonine and 0.0033% for ecgonine methyl ester relative response.

    What each source found

  • Coca leaf teaCoca tea, Mate de cocaA positive here is expected, not a false positive.
    2 sources, 1996 to 2006
    • Coca-leaf tea contains cocaine alkaloids.
    • After consumption, studies detected benzoylecgonine in urine, including GC-MS identification after a cup of tea.

    What each source found

Tested With No False Positive, or Not Proven (20)

Suspected, but Not Proven1

A report, a list or a study names it, but no study we found showed it makes the screen read positive.

  • TolmetinTolectinSuspected, but the studies did not show it.
    1 source, 1995
    • Specific GC-MS measurement of the cocaine metabolite benzoylecgonine succeeded in urine containing tolmetin.
    • The EMIT experiments demonstrated optical interference and instrument errors.

    What each source found

Tested: No False Positive Found19

It was tested and did not make the screen read positive. Other brands of the test can differ.

  • BenzocaineAnbesol, Anbesol Maximum StrengthIn people and in lab experiments, this test stayed negative.
    10 sources, 2006 to 2022
    • Benzocaine did not trigger the tested urine cocaine assays when added in the laboratory.
    • A separate oral-fluid test also showed no interference, which addresses the oral-swab question in the HelloPharmacist answer.

    What each source found

  • HydroxyzineAtarax, VistarilIn people and in lab experiments, this test stayed negative.
    5 sources, 2009 to 2022
    • In the manufacturer’s test, hydroxyzine at 500,000 ng/mL gave a negative urine cocaine screen.
    • A separate hospital study recorded one unconfirmed cocaine screen after documented hydroxyzine exposure, too few to establish an association.

    What each source found

  • LidocaineLignocaine, XylocaineIn people and in lab experiments, this test stayed negative.
    2 sources, 2012 to 2019
    • None of 121 urine samples containing lidocaine after routine care screened positive for cocaine.
    • The main lidocaine metabolite was present in 114.
    • A separate spiking study also found no interference.

    What each source found

  • AmoxicillinAmoxilIn people taking it, this test stayed negative.
    1 source, 2008
    • Thirty-three people provided urine during amoxicillin treatment.
    • The two positive screens contained benzoylecgonine by GC-MS.
    • The study found no amoxicillin-induced false positive.

    What each source found

  • AcetaminophenParacetamol, TylenolIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Acetaminophen at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • AtropineIn lab experiments, this test stayed negative.
    1 source, 2017

    The modified assay yielded 0.0037% relative response to Atropine.

    What each source found

  • BupivacaineMarcaineIn lab experiments, this test stayed negative.
    1 source, 2012

    Bupivacaine added at 10 micrograms/mL did not trigger either cocaine metabolite assay.

    What each source found

  • DextromethorphanDelsym, DXMIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Dextromethorphan at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • DimethocaineIn lab experiments, this test stayed negative.
    1 source, 2017

    The modified assay yielded 0.003% relative response to Dimethocaine.

    What each source found

  • DiphenhydramineBenadryl, Unisom SleepGelsIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Diphenhydramine at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • FexofenadineAllegraIn lab experiments, this test stayed negative.
    1 source, 2008

    Fexofenadine did not trigger either cocaine-metabolite cutoff when added at 1,000 µg/mL.

    What each source found

  • FluconazoleDiflucanIn lab experiments, this test stayed negative.
    1 source, 1996
    • Researchers described a historical interference during one GC-MS confirmation procedure that could obscure benzoylecgonine.
    • They reported no EMIT cocaine-screen interference.

    What each source found

  • MepivacaineCarbocaineIn lab experiments, this test stayed negative.
    1 source, 2012

    Mepivacaine added at 10 micrograms/mL did not trigger either cocaine metabolite assay.

    What each source found

  • MeprobamateEquanil, MiltownIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Meprobamate at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • PrednisoneDeltasoneIn lab experiments, this test stayed negative.
    2 sources, 2018 to 2025

    Prednisone at 100 µg/mL did not cause a positive result in drug-free urine or change the result of urine just below or above this channel’s cutoff.

    What each source found

  • QuinineQualaquin, tonic waterIn lab experiments, this test stayed negative.
    1 source, 2017

    The modified assay yielded 0.003% relative response to Quinine.

    What each source found

  • RopivacaineNaropinIn lab experiments, this test stayed negative.
    1 source, 2012

    Ropivacaine added at 10 micrograms/mL did not trigger either cocaine metabolite assay.

    What each source found

  • ScopolamineIn lab experiments, this test stayed negative.
    1 source, 2017

    The modified assay yielded 0.0043% relative response to Scopolamine.

    What each source found

  • TetracaineAmethocaine, PontocaineIn lab experiments, this test stayed negative.
    1 source, 2012

    Tetracaine added at 10 micrograms/mL did not trigger either cocaine metabolite assay.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Oxycodone Test?

Oxycodone / oxymorphone

A dedicated oxycodone test differs from the general opiates screen. Oxymorphone can be present after oxycodone use.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 5 kinds of results in this list

Has Caused a False Positive2

Studies or case reports found it can make the screen read positive for a drug that was not there. How often that happens at a usual dose is not known.

  • NaloxoneKloxxado, NarcanSeen in people taking it, and again in lab experiments.
    3 sources, 2009 to 2026

    Naloxone can cross-react with certain oxycodone tests, including during investigation of samples from people receiving buprenorphine/naloxone.

    What each source found

  • NaltrexoneReviaSeen in people taking it, and a second test proved it false.
    3 sources, 2020 to 2024
    • Oral naltrexone was associated with repeated unexpected oxycodone screens.
    • Detailed testing identified noroxymorphone, a minor naltrexone metabolite also formed downstream from oxycodone.

    What each source found

Depends on the Brand of Test2

Some brands of the screen reacted to it and others did not, or the studies disagree. The lab can tell you which brand it used.

  • Codeinecodeine phosphateIn people taking it, some brands reacted and others did not.
    2 sources, 2005 to 2006
    • The authors found no DRI interference from Codeine.
    • Codeine or hydrocodone was present in most specimens with a false-positive or indeterminate Monitect POC result.
    • Patient urine with Codeine above 75,000 ng/mL could remain negative on this oxycodone-specific assay.

    What each source found

  • HydrocodoneHysingla ERIn people taking it, some brands reacted and others did not.
    2 sources, 2005 to 2006
    • The authors found no DRI interference from Hydrocodone.
    • Codeine or hydrocodone was present in most specimens with a false-positive or indeterminate Monitect POC result.
    • Patient urine with Hydrocodone above 75,000 ng/mL could remain negative on this oxycodone-specific assay.

    What each source found

The Test Is Made to Find It2

It is the drug the test looks for, contains it, or the body turns it into it. A positive here can be real.

  • OxycodoneOxyContin, RoxicodoneA positive here is expected, not a false positive.
    4 sources, 2006 to 2022
    • Oxycodone and its metabolite oxymorphone are targets of commonly used dedicated oxycodone screens.
    • Two oxycodone screen-positive urines containing less than 50 ng/mL free oxycodone contained oxymorphone and oxycodone glucuronide above 100 ng/mL.
    • Urines containing only noroxycodone were best detected by the oxycodone EIA in this pain-clinic comparison.

    What each source found

  • OxymorphoneOpanaA positive here is expected, not a false positive.
    2 sources, 2010 to 2022
    • This oxycodone assay was designed to recognize oxymorphone as well.
    • A person taking oxymorphone may have a positive oxycodone-class screen.

    What each source found

Tested With No False Positive, or Not Proven (10)

Suspected, but Not Proven1

A report, a list or a study names it, but no study we found showed it makes the screen read positive.

  • HydroxychloroquinePlaquenilSuspected in a case report, but not shown to cause it.
    1 source, 2019
    • After a large overdose, the urine sample caused an absorbance alarm on the oxycodone screen.
    • Spiking showed that high levels could affect several urine assays.

    What each source found

Tested: No False Positive Found9

It was tested and did not make the screen read positive. Other brands of the test can differ.

  • HydromorphoneDilaudidIn people and in lab experiments, this test stayed negative.
    2 sources, 2005 to 2006
    • The authors found no DRI oxycodone interference from Hydromorphone.
    • Patient urine with Hydromorphone above 12,000 ng/mL could remain negative on this oxycodone-specific assay.

    What each source found

  • MorphineMS Contin, RoxanolIn people and in lab experiments, this test stayed negative.
    2 sources, 2005 to 2006
    • The authors found no DRI oxycodone interference from Morphine.
    • Patient urine with Morphine above 163,000 ng/mL could remain negative on this oxycodone-specific assay.

    What each source found

  • AcetaminophenParacetamol, TylenolIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Acetaminophen at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • DextromethorphanDelsym, DXMIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Dextromethorphan at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • DihydrocodeineIn lab experiments, this test stayed negative.
    1 source, 2006

    The authors found no DRI oxycodone interference from Dihydrocodeine.

    What each source found

  • DiphenhydramineBenadryl, Unisom SleepGelsIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Diphenhydramine at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • Heroindiacetylmorphine, diamorphineIn lab experiments, this test stayed negative.
    1 source, 2006

    The authors found no DRI oxycodone interference from 6-monoacetylmorphine, the heroin metabolite.

    What each source found

  • LevofloxacinLevaquinIn lab experiments, this test stayed negative.
    1 source, 2019

    Levofloxacin did not cross-react with the oxycodone assay in the same study in which it reacted with the morphine-class opiate and buprenorphine reagents.

    What each source found

  • MeprobamateEquanil, MiltownIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Meprobamate at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Buprenorphine Test?

Buprenorphine has its own urine screen. The method and the cutoff matter when comparing it with research.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 4 kinds of results in this list

Has Caused a False Positive18

Studies or case reports found it can make the screen read positive for a drug that was not there. How often that happens at a usual dose is not known.

  • AmisulprideBarhemsys, SolianSeen in people taking it, and again in lab experiments.
    1 source, 2013
    • Two patients receiving amisulpride had unconfirmed buprenorphine screens.
    • LC-MS/MS detected amisulpride and excluded buprenorphine and its metabolites.
    • Laboratory testing documented weak cross-reactivity.

    What each source found

  • LoperamideImodiumSeen in people taking it, and again in lab experiments.
    1 source, 2022
    • The N-desmethyl metabolite of loperamide produced positive buprenorphine screens above 12.2 mg/L in spiked urine.
    • A clinical specimen contained an interfering concentration.

    What each source found

  • Steviasteviol glucuronide, steviol glycosidesSeen in people taking it, and again in lab experiments.
    1 source, 2021
    • A study of unexpected screens investigated steviol glucuronide, a urinary metabolite of stevia sweeteners.
    • It cross-reacted above 15 mg/L.

    What each source found

  • BenzylpiperazineOnly in lab experiments so far, not in people taking it.
    1 source, 2014

    At a Benzylpiperazine spike of 29,000 ng/mL, the mean assay response was 6.1 ng/mL equivalent (0.02% cross-reactivity), above the 5 ng/mL cutoff.

    What each source found

  • Butyloneβ-keto-MBDBOnly in lab experiments so far, not in people taking it.
    1 source, 2014

    At a Butylone spike of 29,000 ng/mL, the mean assay response was 6 ng/mL equivalent (0.02% cross-reactivity), above the 5 ng/mL cutoff.

    What each source found

  • Ceftaroline fosamilTeflaro, ZinforoOnly in lab experiments so far, not in people taking it.
    1 source, 2019

    In a clinical-records study followed by laboratory testing, added ceftaroline fosamil produced a presumptive buprenorphine result at an estimated 681.5 micrograms/mL.

    What each source found

  • ChloroquineAralenOnly in lab experiments so far, not in people taking it.
    1 source, 2012

    Laboratory comparison of CEDIA and the Lin-Zhi buprenorphine assay identified chloroquine interference with CEDIA.

    What each source found

  • DonepezilAriceptOnly in lab experiments so far, not in people taking it.
    1 source, 2019

    In a clinical-records study followed by laboratory testing, added donepezil produced a presumptive buprenorphine result at an estimated 709.6 micrograms/mL.

    What each source found

  • Flephedrone4-Fluoromethcathinone, 4-FMCOnly in lab experiments so far, not in people taking it.
    1 source, 2014

    At a 4-Fluoromethcathinone spike of 27,000 ng/mL, the mean assay response was 5.8 ng/mL equivalent (0.02% cross-reactivity), above the 5 ng/mL cutoff.

    What each source found

  • HydroxychloroquinePlaquenilOnly in lab experiments so far, not in people taking it.
    2 sources, 2012 to 2019
    • A method-comparison study identified interference with this reagent.
    • Hydroxychloroquine also affected selected assays at high concentrations in an overdose investigation.

    What each source found

  • LevofloxacinLevaquinOnly in lab experiments so far, not in people taking it.
    1 source, 2019

    When levofloxacin was added to drug-free urine at concentrations considered achievable during treatment, this assay produced a presumptive positive.

    What each source found

  • MethoxetamineMXEOnly in lab experiments so far, not in people taking it.
    1 source, 2014

    At a Methoxetamine spike of 28,000 ng/mL, the mean assay response was 5.9 ng/mL equivalent (0.02% cross-reactivity), above the 5 ng/mL cutoff.

    What each source found

  • MethylenedioxypyrovaleroneMDPV, 3,4-methylenedioxypyrovaleroneOnly in lab experiments so far, not in people taking it.
    1 source, 2014

    At a Methylenedioxypyrovalerone spike of 21,000 ng/mL, the mean assay response was 6 ng/mL equivalent (0.03% cross-reactivity), above the 5 ng/mL cutoff.

    What each source found

  • ProcainamideProcan, PronestylOnly in lab experiments so far, not in people taking it.
    1 source, 2019
    • In a clinical-records study followed by laboratory testing, added procainamide produced a presumptive buprenorphine result at an estimated 92.8 micrograms/mL.
    • An N-acetyl hydroxy metabolite also reacted.

    What each source found

  • PropafenoneRythmolOnly in lab experiments so far, not in people taking it.
    1 source, 2019

    In a clinical-records study followed by laboratory testing, added propafenone produced a presumptive buprenorphine result at an estimated 180.7 micrograms/mL.

    What each source found

  • RotigotineNeuproOnly in lab experiments so far, not in people taking it.
    1 source, 2019

    In a clinical-records study followed by laboratory testing, added rotigotine produced a presumptive buprenorphine result at an estimated 0.13 micrograms/mL.

    What each source found

  • SulpirideDogmatilOnly in lab experiments so far, not in people taking it.
    1 source, 2013
    • The investigators demonstrated low but measurable analytical cross-reactivity with sulpiride.
    • High urinary levels relative to the assay cutoff could make it relevant.

    What each source found

  • TrimethoprimOnly in lab experiments so far, not in people taking it.
    1 source, 2019
    • In a clinical-records study followed by laboratory testing, added trimethoprim produced a presumptive buprenorphine result at an estimated 47.2 micrograms/mL.
    • Its frequent partner sulfamethoxazole did not react in this experiment.

    What each source found

Depends on the Brand of Test6

Some brands of the screen reacted to it and others did not, or the studies disagree. The lab can tell you which brand it used.

  • Codeinecodeine phosphateIn people and in lab experiments, some brands reacted and others did not.
    5 sources, 2003 to 2015
    • One healthy volunteer screened positive after a therapeutic 60 mg codeine dose with acetaminophen.
    • Spiking and patient urine data implicated codeine and its metabolites, which can have additive effects.
    • No cross-reaction was reported with Codeine at 1 or 10 mg/L in the Singlestep assay.
    • The recombinant assay showed less than 1% relative cross-reactivity with Codeine.
    • The IDS validation reports no cross-reactivity with Codeine.

    What each source found

  • DihydrocodeineIn people and in lab experiments, some brands reacted and others did not.
    6 sources, 2003 to 2007
    • Dihydrocodeine reacted above 60 mg/L in the reported CEDIA assay.
    • An Immunalysis microplate ELISA did not react at the lower concentrations studied, up to 10 mg/L.
    • No cross-reaction was reported with Dihydrocodeine at 1 or 10 mg/L in the Singlestep assay.
    • Unconfirmed buprenorphine screens occurred in patients who had been prescribed dihydrocodeine.
    • The recombinant assay showed less than 1% relative cross-reactivity with Dihydrocodeine.
    • The validation reports no cross-reaction with Dihydrocodeine at 1 or 10 mg/L.

    What each source found

  • MorphineMS Contin, RoxanolIn people and in lab experiments, some brands reacted and others did not.
    7 sources, 2003 to 2019
    • Repeated screens became positive with high-dose morphine, negative when it was stopped, then positive again when restarted.
    • GC-MS excluded buprenorphine.
    • An earlier analytical study demonstrated morphine cross-reactivity.
    • No cross-reaction was reported with Morphine at 1 or 10 mg/L in the Singlestep assay.
    • The recombinant assay showed less than 1% relative cross-reactivity with Morphine.
    • The IDS validation reports no cross-reactivity with Morphine.
    • In an opioid-maintenance cohort including high-dose morphine, the newer reagent had substantially better specificity.
    • Its one borderline unconfirmed result had no identified interferent.

    What each source found

  • TramadolConZip, UltramIn people taking it, some brands reacted and others did not.
    1 source, 2008
    • Among 29 urine samples from patients on tramadol, seven positive buprenorphine screens were shown false by LC-MS/MS.
    • No false positives were found on ACON at 10 ng/mL or CEDIA at 20 ng/mL.

    What each source found

  • MethadoneDolophine, MethadoseIn lab experiments, some brands reacted and others did not.
    4 sources, 2003 to 2006
    • A CEDIA study found interference above 320 mg/L of methadone.
    • A different ELISA did not react at its tested upper concentration of 10 mg/L.
    • No cross-reaction was reported with Methadone at 1 or 10 mg/L in the Singlestep assay.
    • The IDS validation reports no cross-reactivity with Methadone.
    • EDDP, its metabolite, was also tested without a reaction.

    What each source found

  • Methylone3,4-Methylenedioxy-N-methylcathinone, β-keto-MDMAIn lab experiments, some brands reacted and others did not.
    1 source, 2014

    At a Methylone spike of 23,000 ng/mL, the mean assay response was 3.7 ng/mL equivalent (0.02% cross-reactivity), below the 5 ng/mL cutoff.

    What each source found

The Test Is Made to Find It1

It is the drug the test looks for, contains it, or the body turns it into it. A positive here can be real.

  • BuprenorphineBelbuca, ButransA positive here is expected, not a false positive.
    4 sources, 1993 to 2012
    • Prescribed buprenorphine can appropriately trigger this test.
    • Suboxone contains two active ingredients: buprenorphine explains expected buprenorphine detection; the separate naloxone entry describes interference on some other tests.
    • The assay antibody showed up to about 90% reactivity with norbuprenorphine, the N-dealkylated metabolite, while its glucuronide responses were low.
    • The antibody recognized free buprenorphine and norbuprenorphine nearly equally.

    What each source found

Tested With No False Positive, or Not Proven (8)

Tested: No False Positive Found8

It was tested and did not make the screen read positive. Other brands of the test can differ.

  • CytarabineIn lab experiments, this test stayed negative.
    1 source, 2019
    • An association in medical records did not reproduce when cytarabine was added to drug-free urine.
    • Concomitant levofloxacin was common.

    What each source found

  • DextromethorphanDelsym, DXMIn lab experiments, this test stayed negative.
    2 sources, 2003 to 2004
    • No cross-reaction was reported with Dextromethorphan at 1 or 10 mg/L in the Singlestep assay.
    • The validation reports no cross-reaction with Dextromethorphan at 1 or 10 mg/L.

    What each source found

  • DextromoramidePalfiumIn lab experiments, this test stayed negative.
    2 sources, 2003 to 2004
    • No cross-reaction was reported with Dextromoramide at 1 or 10 mg/L in the Singlestep assay.
    • The validation reports no cross-reaction with Dextromoramide at 1 or 10 mg/L.

    What each source found

  • EthylmorphineDionineIn lab experiments, this test stayed negative.
    2 sources, 2003 to 2004
    • No cross-reaction was reported with Ethylmorphine at 1 or 10 mg/L in the Singlestep assay.
    • The validation reports no cross-reaction with Ethylmorphine at 1 or 10 mg/L.

    What each source found

  • Heroindiacetylmorphine, diamorphineIn lab experiments, this test stayed negative.
    2 sources, 2003 to 2004
    • No cross-reaction was reported with 6-monoacetylmorphine, the heroin metabolite at 1 or 10 mg/L in the Singlestep assay.
    • The IDS validation reported no cross-reaction with 6-monoacetylmorphine, the primary heroin metabolite, at 1 or 10 mg/L.

    What each source found

  • PholcodinepholcodinIn lab experiments, this test stayed negative.
    2 sources, 2003 to 2004
    • No cross-reaction was reported with Pholcodine at 1 or 10 mg/L in the Singlestep assay.
    • The validation reports no cross-reaction with Pholcodine at 1 or 10 mg/L.

    What each source found

  • PropoxypheneDarvon, DextropropoxypheneIn lab experiments, this test stayed negative.
    2 sources, 2003 to 2004
    • No cross-reaction was reported with Propoxyphene at 1 or 10 mg/L in the Singlestep assay.
    • The validation reports no cross-reaction with Propoxyphene at 1 or 10 mg/L.

    What each source found

  • SulfamethoxazoleIn lab experiments, this test stayed negative.
    1 source, 2019
    • An apparent association in medical records was investigated by testing the two ingredients of trimethoprim/sulfamethoxazole separately.
    • Trimethoprim reacted but sulfamethoxazole did not.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Methadone Test?

Methadone (parent drug)

Check whether the report says methadone or EDDP. The latter is a breakdown product tested on a different assay.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 7 kinds of results in this list

Has Caused a False Positive16

Studies or case reports found it can make the screen read positive for a drug that was not there. How often that happens at a usual dose is not known.

  • CyamemazineTercian, cyamepromazineSeen in people taking it, and again in lab experiments.
    3 sources, 2005 to 2017
    • Cyamemazine appeared in many patients with unconfirmed methadone screens and produced positivity when added to drug-free urine.
    • The modified assay yielded 0.05% relative response to Cyamemazine.

    What each source found

  • LevomepromazineNozinan, methotrimeprazineSeen in people taking it, and again in lab experiments.
    3 sources, 2005 to 2017
    • Patients receiving levomepromazine were among those with unconfirmed screens.
    • A spiked concentration of 5 mg/L gave a positive signal.
    • The modified assay yielded 4.3% relative response to Levomepromazine.

    What each source found

  • QuetiapineSeroquelSeen in people taking it, and a second test proved it false.
    4 sources, 2007 to 2026
    • Ten quetiapine-treated patients had unexpected positive screens.
    • The four urine samples checked by GC-MS contained no methadone.
    • In an earlier series, three people on quetiapine alone repeatedly screened positive in urine despite negative plasma methadone by LC-MS/MS.
    • Quetiapine was also common in a later audit of unconfirmed screens.

    What each source found

  • DoxylamineUnisom SleepTabsSeen in a case report about a person taking it.
    2 sources, 1983 to 2009
    • Doxylamine poisoning produced a positive methadone screen although mass spectrometry excluded methadone.
    • Another overdose case reported a similar finding.

    What each source found

  • AlimemazinetrimeprazineOnly in lab experiments so far, not in people taking it.
    1 source, 2005
    • Alimemazine cross-reacted in spiked urine.
    • It was also a co-medication in some clinical cases.

    What each source found

  • AmitriptylineElavilOnly in lab experiments so far, not in people taking it.
    1 source, 2009

    The 2009 comparison lists reactivity at 75,000 ng/mL for 10-hydroxyamitriptyline (a metabolite of amitriptyline) on the Biosite Triage screen.

    What each source found

  • BrompheniramineBrompheniramine maleateOnly in lab experiments so far, not in people taking it.
    1 source, 2009

    The 2009 comparison lists reactivity at 75,000 ng/mL for Brompheniramine on the Biosite Triage screen.

    What each source found

  • ChlorpromazineThorazineOnly in lab experiments so far, not in people taking it.
    3 sources, 2005 to 2017
    • A spiked concentration of 20 mg/L of chlorpromazine gave a positive methadone result.
    • The modified assay yielded 1.3% relative response to Chlorpromazine.

    What each source found

  • ClemastineTavistOnly in lab experiments so far, not in people taking it.
    1 source, 2009

    The 2009 comparison lists reactivity at 50,000 ng/mL for Clemastine on the Biosite Triage screen.

    What each source found

  • ClomipramineAnafranilOnly in lab experiments so far, not in people taking it.
    3 sources, 2005 to 2017
    • A spiked concentration of 100 mg/L of clomipramine gave a positive methadone result.
    • The modified assay yielded 0.22% relative response to Clomipramine.

    What each source found

  • LoperamideImodiumOnly in lab experiments so far, not in people taking it.
    1 source, 2009

    The 2009 comparison lists reactivity at 75,000 ng/mL for Loperamide on the Biosite Triage screen.

    What each source found

  • PazopanibVotrientOnly in lab experiments so far, not in people taking it.
    1 source, 2019

    In laboratory follow-up of a medical-records study, pazopanib gave a presumptive positive at an estimated 198.4 micrograms/mL.

    What each source found

  • PentazocineTalwinOnly in lab experiments so far, not in people taking it.
    1 source, 2009

    The 2009 comparison lists reactivity at 100,000 ng/mL for Pentazocine on the Biosite Triage screen.

    What each source found

  • PheniramineOnly in lab experiments so far, not in people taking it.
    1 source, 2009

    The 2009 comparison lists reactivity at 25,000 ng/mL for Pheniramine on the Biosite Triage screen.

    What each source found

  • PropafenoneRythmolOnly in lab experiments so far, not in people taking it.
    1 source, 2019

    In laboratory follow-up of a medical-records study, propafenone gave a presumptive positive at an estimated 83.2 micrograms/mL.

    What each source found

  • ThioridazineMellarilOnly in lab experiments so far, not in people taking it.
    1 source, 2005

    A spiked concentration of 100 mg/L of thioridazine gave a positive methadone result.

    What each source found

Depends on the Brand of Test11

Some brands of the screen reacted to it and others did not, or the studies disagree. The lab can tell you which brand it used.

  • DiphenhydramineBenadryl, Unisom SleepGelsIn people and in lab experiments, some brands reacted and others did not.
    2 sources, 2010 to 2013
    • A child with suspected diphenhydramine ingestion screened positive for methadone.
    • GC/MS excluded methadone.
    • Added diphenhydramine, but not two tested metabolites, reacted on the same device.
    • The authors observed no interference from Diphenhydramine at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • TapentadolNucynta, PalexiaIn people and in lab experiments, some brands reacted and others did not.
    3 sources, 2012 to 2020
    • Tapentadol and several metabolites reacted on DRI.
    • In one series, all 97 selected unexpected positives contained tapentadol without confirmed methadone.
    • A second DRI series found five patients with the same discrepancy.
    • A separate study of 11 patients taking prescribed doses found no false positives on EMIT II.

    What each source found

  • VerapamilCalan, VerelanIn people and in lab experiments, some brands reacted and others did not.
    2 sources, 1998
    • A laboratory traced unexpected methadone screens to verapamil metabolites with the earlier reagent.
    • The manufacturer later reported that replacing its antibody in June 1997 corrected the interference.

    What each source found

  • VortioxetineBrintellix, TrintellixIn people and in lab experiments, some brands reacted and others did not.
    2 sources, 2019 to 2026
    • Seven patients taking typical vortioxetine doses were positive on MDN2 and negative by GC/MS and on two other immunoassays.
    • A metabolite was implicated.

    What each source found

  • ChlorpheniramineIn lab experiments, some brands reacted and others did not.
    1 source, 2009
    • The 2009 comparison lists reactivity at 100,000 ng/mL for Chlorpheniramine on the Biosite Triage screen.
    • At least one other reagent in the same table showed no reaction.

    What each source found

  • CyclobenzaprineAmrix, FlexerilIn lab experiments, some brands reacted and others did not.
    1 source, 2009
    • The 2009 comparison lists reactivity at 50,000 ng/mL for Cyclobenzaprine on the Biosite Triage screen.
    • At least one other reagent in the same table showed no reaction.

    What each source found

  • DisopyramideIn lab experiments, some brands reacted and others did not.
    1 source, 2009
    • The 2009 comparison lists reactivity at 10,000 ng/mL for Disopyramide on the Biosite Triage screen.
    • At least one other reagent in the same table showed no reaction.

    What each source found

  • LevacetylmethadolLAAM, Levomethadyl acetateIn lab experiments, some brands reacted and others did not.
    2 sources, 1999 to 2009
    • The 2009 comparison lists 1.5% cross-reactivity for Levacetylmethadol on the Microgenics CEDIA screen.
    • At least one other reagent in the same table showed no reaction.
    • Levomethadyl (LAAM) added to urine produced strong cross-reactivity in five methadone assays, ranging from 75.3% to 318.3%.
    • Its metabolite methadol also reacted strongly in several methods.

    What each source found

  • MesoridazineSerentil, thioridazine sulfoxideIn lab experiments, some brands reacted and others did not.
    1 source, 2009
    • The 2009 comparison lists reactivity at 20,000 ng/mL for Mesoridazine on the Biosite Triage screen.
    • At least one other reagent in the same table showed no reaction.

    What each source found

  • PhencyclidinePCPIn lab experiments, some brands reacted and others did not.
    1 source, 2009
    • The 2009 comparison lists reactivity at 75,000 ng/mL for Phencyclidine on the Biosite Triage screen.
    • At least one other reagent in the same table showed no reaction.

    What each source found

  • PromazineSparineIn lab experiments, some brands reacted and others did not.
    2 sources, 2009 to 2017
    • The 2009 comparison lists reactivity at 50,000 ng/mL for Promazine on the Biosite Triage screen.
    • At least one other reagent in the same table showed no reaction.
    • The modified assay yielded 0.19% relative response to Promazine.

    What each source found

The Test Is Made to Find It1

It is the drug the test looks for, contains it, or the body turns it into it. A positive here can be real.

  • MethadoneDolophine, MethadoseA positive here is expected, not a false positive.
    3 sources, 2014 to 2026
    • A prescribed methadone dose can give an expected positive on a dedicated methadone test.
    • Laboratories may also measure EDDP separately.
    • The modified assay yielded 110% for racemic methadone and 1.8% for EDDP relative response.

    What each source found

Tested With No False Positive, or Not Proven (8)

A Problem With the Urine Sample1

Something already in the urine, or what happened to the sample after it was collected, affected the result.

  • CreatinineUrinary creatinineSomething in the urine sample, not a medicine, changed the result.
    1 source, 2005

    A case report attributed a false-positive methadone screen to creatinine, a normal constituent of urine.

    What each source found

Suspected, but Not Proven3

A report, a list or a study names it, but no study we found showed it makes the screen read positive.

  • LabetalolNormodyne, TrandateSuspected, but the studies did not show it.
    1 source, 2022
    • Patients with a record of labetalol use had more unconfirmed positive screens in one hospital study.
    • Adding labetalol to urine did not produce a positive on the same device, even at 1,600 micrograms/mL.

    What each source found

  • PrazosinMinipressSuspected, but the studies did not show it.
    1 source, 2022
    • Patients with a record of prazosin use had more unconfirmed positive screens in one hospital study.
    • Adding prazosin to urine did not produce a positive on the same device, even at 1,600 micrograms/mL.

    What each source found

  • ChlorprothixeneTruxalSuspected, but lab experiments did not show it.
    1 source, 2017

    The modified assay yielded 0.1% relative response to Chlorprothixene.

    What each source found

Tested: No False Positive Found4

It was tested and did not make the screen read positive. Other brands of the test can differ.

  • AcetaminophenParacetamol, TylenolIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Acetaminophen at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • DextromethorphanDelsym, DXMIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Dextromethorphan at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • LevofloxacinLevaquinIn lab experiments, this test stayed negative.
    1 source, 2019

    Levofloxacin did not react with this dedicated methadone reagent in the modern fluoroquinolone comparison.

    What each source found

  • MeprobamateEquanil, MiltownIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Meprobamate at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive PCP Test?

PCP (phencyclidine)

A number of medicines have been evaluated on PCP screens. Check the particular assay, study setting, and confirmation method in each entry.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 5 kinds of results in this list

Has Caused a False Positive25

Studies or case reports found it can make the screen read positive for a drug that was not there. How often that happens at a usual dose is not known.

  • MesoridazineSerentil, thioridazine sulfoxideSeen in people taking it, and again in lab experiments.
    3 sources, 1996 to 2009
    • A patient’s urine screened positive for PCP by EMIT II and was negative by GC-MS.
    • Both thioridazine and its metabolite mesoridazine were present.
    • Separate specificity data found cross-reactivity to mesoridazine on three assays.

    What each source found

  • MethylenedioxypyrovaleroneMDPV, 3,4-methylenedioxypyrovaleroneSeen in people taking it, and again in lab experiments.
    2 sources, 2013 to 2015
    • A published report attributed false-positive PCP immunoassay results to MDPV, a synthetic cathinone.
    • In the Methylenedioxypyrovalerone challenge, Microgenics DRI Phencyclidine gave a positive result at 3.5 µg/mL.

    What each source found

  • ThioridazineMellarilSeen in people taking it, and again in lab experiments.
    3 sources, 1996 to 2009
    • A patient’s urine screened positive for PCP by EMIT II and was negative by GC-MS.
    • Both thioridazine and its metabolite mesoridazine were present.
    • In separate manufacturer data, thioridazine reacted on Abbott AxSYM at a very high concentration.

    What each source found

  • TramadolConZip, UltramSeen in people taking it, and again in lab experiments.
    3 sources, 2006 to 2013
    • Several overdose cases produced PCP-positive urine.
    • Laboratory experiments with tramadol and its metabolites supported cross-reactivity.
    • A separate emergency department study found tramadol was associated with unconfirmed screens.

    What each source found

  • VenlafaxineEffexor, Effexor XRSeen in people taking it, and again in lab experiments.
    4 sources, 2002 to 2023
    • A venlafaxine overdose produced a positive Abbott AxSYM result with no PCP by GC-MS.
    • Adding venlafaxine and its active metabolite to urine reproduced the result.
    • Separate reports describe possible interference during prescribed use.
    • Two patients taking prescribed venlafaxine repeatedly screened positive for PCP in a rehabilitation center.

    What each source found

  • DesvenlafaxineKhedezla, O-desmethylvenlafaxineSeen in a case report about a person taking it.
    2 sources, 2002 to 2017
    • A case report linked a presumptive PCP result with prescribed desvenlafaxine.
    • Desvenlafaxine is also the active metabolite implicated in studies of venlafaxine.

    What each source found

  • LamotrigineLamictalSeen in a case report about a person taking it.
    4 sources, 2010 to 2022
    • Several reports describe positive rapid PCP screens in people taking lamotrigine.
    • In an early two-patient report, broader testing was negative in one patient and the other was assessed from history.
    • Further reports describe the finding on other rapid systems.

    What each source found

  • 4-MePPP4-Methyl-alpha-pyrrolidinopropiophenone, 4-Methyl-α-pyrrolidinopropiophenoneOnly in lab experiments so far, not in people taking it.
    1 source, 2015

    In the 4-MePPP challenge, Microgenics DRI Phencyclidine gave a positive result at 18.5 µg/mL.

    What each source found

  • 4-MPBP4-Methyl-α-pyrrolidinobutiophenoneOnly in lab experiments so far, not in people taking it.
    1 source, 2015

    In the 4-MPBP challenge, Microgenics DRI Phencyclidine gave a positive result at 9 µg/mL.

    What each source found

  • 5-MeO-DALTN,N-Diallyl-5-methoxytryptamine, 5-Methoxy-DALTOnly in lab experiments so far, not in people taking it.
    1 source, 2015

    In the 5-MeO-DALT challenge, Microgenics DRI Phencyclidine gave a positive result at 78 µg/mL.

    What each source found

  • Alpha-PBPα-PBP, α-PyrrolidinobutiophenoneOnly in lab experiments so far, not in people taking it.
    1 source, 2015

    In the Alpha-PBP challenge, Microgenics DRI Phencyclidine gave a positive result at 4.6 µg/mL.

    What each source found

  • Alpha-PPPAlpha-pyrrolidinopropiophenone, α-PPPOnly in lab experiments so far, not in people taking it.
    1 source, 2015

    In the Alpha-PPP challenge, Microgenics DRI Phencyclidine gave a positive result at 7 µg/mL.

    What each source found

  • Alpha-PVPα-PVP, α-PyrrolidinopentiophenoneOnly in lab experiments so far, not in people taking it.
    1 source, 2015

    In the Alpha-PVP challenge, Microgenics DRI Phencyclidine gave a positive result at 1.45 µg/mL.

    What each source found

  • Alpha-PVTα-PVT, α-PyrrolidinopentiothiophenoneOnly in lab experiments so far, not in people taking it.
    1 source, 2015

    In the Alpha-PVT challenge, Microgenics DRI Phencyclidine gave a positive result at 0.6 µg/mL.

    What each source found

  • D2PMα,α-Diphenyl-2R-pyrrolidinemethanolOnly in lab experiments so far, not in people taking it.
    1 source, 2015

    In the D2PM challenge, Microgenics DRI Phencyclidine gave a positive result at 65 µg/mL.

    What each source found

  • MDPBP3,4-Methylenedioxy-α-pyrrolidinobutiophenoneOnly in lab experiments so far, not in people taking it.
    1 source, 2015

    In the MDPBP challenge, Microgenics DRI Phencyclidine gave a positive result at 24 µg/mL.

    What each source found

  • MDPPP3,4-Methylenedioxy-α-pyrrolidinopropiophenoneOnly in lab experiments so far, not in people taking it.
    1 source, 2015

    In the MDPPP challenge, Microgenics DRI Phencyclidine gave a positive result at 60 µg/mL.

    What each source found

  • MeperidineDemerol, PethidineOnly in lab experiments so far, not in people taking it.
    3 sources, 1993 to 2009
    • The assay comparison reported meperidine cross-reactivity at high urine concentrations.
    • One unconfirmed Syva EMIT positive contained high levels of both meperidine and dextromethorphan.
    • The original Advisor study obtained a positive PCP result from Meperidine at 100 mg/L of drug-free urine, with no reaction at 10 mg/L.

    What each source found

  • MethoxetamineMXEOnly in lab experiments so far, not in people taking it.
    2 sources, 2015 to 2019
    • The ketamine analog methoxetamine showed weak cross-reactivity in a laboratory comparison of PCP screens.
    • In the Methoxetamine challenge, Microgenics DRI Phencyclidine gave a positive result at 90 µg/mL.

    What each source found

  • MetronidazoleFlagylOnly in lab experiments so far, not in people taking it.
    2 sources, 2018 to 2026
    • A report identified metronidazole interference on a PCP screen.
    • Added metronidazole produced a positive response in urine on the tested device.

    What each source found

  • MOPPP4-Methoxy-α-pyrrolidinopropiophenoneOnly in lab experiments so far, not in people taking it.
    1 source, 2015

    In the MOPPP challenge, Microgenics DRI Phencyclidine gave a positive result at 26 µg/mL.

    What each source found

  • MPHP (study designation)Only in lab experiments so far, not in people taking it.
    1 source, 2015

    In the MPHP challenge, Microgenics DRI Phencyclidine gave a positive result at 1.7 µg/mL.

    What each source found

  • Naphyrone2-NaphthylpyrovaleroneOnly in lab experiments so far, not in people taking it.
    1 source, 2015

    In the Naphyrone challenge, Microgenics DRI Phencyclidine gave a positive result at 11 µg/mL.

    What each source found

  • PyrovaleroneOnly in lab experiments so far, not in people taking it.
    1 source, 2015

    In the Pyrovalerone challenge, Microgenics DRI Phencyclidine gave a positive result at 2 µg/mL.

    What each source found

  • TrihexyphenidylOnly in lab experiments so far, not in people taking it.
    1 source, 1993

    The original Advisor study obtained a positive PCP result from Trihexyphenidyl at 100 mg/L of drug-free urine, with no reaction at 10 mg/L.

    What each source found

Depends on the Brand of Test4

Some brands of the screen reacted to it and others did not, or the studies disagree. The lab can tell you which brand it used.

  • DextromethorphanDelsym, DXMIn people and in lab experiments, some brands reacted and others did not.
    5 sources, 2000 to 2013
    • Eight unconfirmed Syva EMIT positives in one series had high urine dextromethorphan concentrations.
    • A separate emergency department study found dextromethorphan was more often recorded when a positive PCP screen failed GC-MS confirmation.
    • A separate original letter describes a dextromethorphan-associated presumptive PCP urine result.
    • The authors observed no interference from Dextromethorphan at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • DiphenhydramineBenadryl, Unisom SleepGelsIn people and in lab experiments, some brands reacted and others did not.
    3 sources, 2009 to 2013
    • One Triage-positive specimen contained a high urine diphenhydramine concentration without GC-MS evidence of PCP.
    • In another study diphenhydramine was more common in unconfirmed screens, but the difference was statistically inconclusive.
    • The authors observed no interference from Diphenhydramine at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • KetamineKetalar, Racemic ketamineIn people and in lab experiments, some brands reacted and others did not.
    2 sources, 1998 to 2019
    • An early clinical letter reported a PCP-positive screen after ketamine administration.
    • In a later laboratory evaluation, ketamine did not react on any of five PCP immunoassays.
    • Some related designer drugs did react.

    What each source found

  • 2-DPMPDesoxypipradrol, 2-DiphenylmethylpiperidineIn lab experiments, some brands reacted and others did not.
    2 sources, 2014 to 2015
    • At a Desoxypipradrol spike of 4,500 ng/mL, the mean assay response was 26 ng/mL equivalent (0.6% cross-reactivity), above the 25 ng/mL cutoff.
    • In the 2-DPMP challenge, Microgenics DRI Phencyclidine gave a positive result at 21 µg/mL.

    What each source found

Tested With No False Positive, or Not Proven (86)

Suspected, but Not Proven5

A report, a list or a study names it, but no study we found showed it makes the screen read positive.

  • AlprazolamXanaxFound alongside false positives, but not shown to cause them.
    1 source, 2013

    In an emergency department chart study, this medicine was more commonly recorded among PCP screens that failed GC-MS confirmation.

    What each source found

  • CarvedilolCoregFound alongside false positives, but not shown to cause them.
    1 source, 2013

    In an emergency department chart study, this medicine was more commonly recorded among PCP screens that failed GC-MS confirmation.

    What each source found

  • ClonazepamKlonopinFound alongside false positives, but not shown to cause them.
    1 source, 2013

    In an emergency department chart study, this medicine was more commonly recorded among PCP screens that failed GC-MS confirmation.

    What each source found

  • IbuprofenAdvil, MotrinSuspected in a case report, but not shown to cause it.
    2 sources, 2007 to 2011
    • A child who had taken therapeutic ibuprofen had a positive MPD Screen 12 result.
    • GC-MS detected ibuprofen and excluded PCP.
    • A separate Instant-View report involved an overdose with ibuprofen, metamizole and dextromethorphan.

    What each source found

  • MetamizoleDipyrone, metamizolSuspected in a case report, but not shown to cause it.
    1 source, 2007

    A letter investigated an overdose involving ibuprofen, metamizole and dextromethorphan in connection with a PCP-positive screen.

    What each source found

Tested: No False Positive Found81

It was tested and did not make the screen read positive. Other brands of the test can differ.

  • DoxylamineUnisom SleepTabsIn a case report, this test stayed negative.
    1 source, 1981
    • In a doxylamine intoxication, the PCP immunoassay was negative.
    • A separate gas chromatographic method falsely identified PCP.

    What each source found

  • 2,5-DimethoxyamphetamineDMA, 2,5-DMAIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 2,5-Dimethoxyamphetamine challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 2-Aminoindane2-AIIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 2-Aminoindane challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 25B-NBOMe4-Bromo-2,5-dimethoxy-N-[ methyl]-benzenethanamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 25B-NBOMe challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 25C-NBOMe2C-C-NBOMeIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 25C-NBOMe challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 25I-NBOMeIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 25I-NBOMe challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 2C-B4-Bromo-2,5-dimethoxy-β-phenethylamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 2C-B challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 2C-C4-Chloro-2,5-dimethoxy-β-phenethylamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 2C-C challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 2C-E4-Ethyl-2,5-dimethoxy-β-phenethylamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 2C-E challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 2C-I4-Iodo-2,5-dimethoxy-β-phenethylamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 2C-I challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 2C-T4-Methylthio-2,5-dimethoxy-β-phenethylamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 2C-T challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 2C-T-24-Ethylthio-2,5-dimethoxy-β-phenethylamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 2C-T-2 challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 2C-T-44-Isopropylthio-2,5-dimethoxy-β-phenethylamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 2C-T-4 challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 2C-T-74-n-Propylthio-2,5-dimethoxy-β-phenethylamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 2C-T-7 challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 3,4,5-TrimethoxyamphetamineTMAIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 3,4,5-Trimethoxyamphetamine challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 3,4-DimethylmethcathinoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 3,4-Dimethylmethcathinone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 3-TrifluoromethylphenylpiperazineTFMPP, TrifluoromethylphenylpiperazineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 3-TFMPP challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 4-CAP4-Chloro-α-ethylphenethylamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 4-CAP challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 4-EEC4-EthylethcathinoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 4-EEC challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 4-Fluoroamphetamine4-FA, p-FluoroamphetamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 4-Fluoroamphetamine challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 4-Fluoromethamphetamine4-FMAIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 4-Fluoromethamphetamine challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 4-HO-DET4-Hydroxy-diethyl-tryptamine, 4-OH-DETIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 4-HO-DET challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 4-MEC4-MethylethcathinoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 4-MEC challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 4-Methylamphetamine4-MAIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 4-Methylamphetamine challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 4-Methylthioamphetamine4-MTAIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 4-Methylthioamphetamine challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 4-TFMPP1- phenyl)piperazine, 1-In lab experiments, this test stayed negative.
    1 source, 2015

    In the 4-TFMPP challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 5-APB5- benzofuranIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 5-APB challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 5-APDB5- -2,3-dihydrobenzofuranIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 5-APDB challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 5-APDI5- -2,3-dihydro-1H-indeneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 5-APDI challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 5-IAI5-Iodo-2-aminoindanIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 5-IAI challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 5-IT5- indoleIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 5-IT challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 5-MeO-AMTα-Methyl-5-methoxytryptamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 5-MeO-AMT challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 5-MeO-DiPTN,N-Diisopropyl-5-methoxytryptamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 5-MeO-DiPT challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 5-MeO-DMTN,N-Dimethyl-5-methoxytryptamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 5-MeO-DMT challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 5-MeO-MiPT5-Methoxy-N-methyl-N-isopropyltryptamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 5-MeO-MiPT challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • 6-APB6- benzofuranIn lab experiments, this test stayed negative.
    1 source, 2015

    In the 6-APB challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • AcetaminophenParacetamol, TylenolIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Acetaminophen at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • Alpha-methyltryptamineAMT, α-MethyltryptamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Alpha-methyltryptamine challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • Benzedrone2- -1- propan-1-one, 4-MBCIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Benzedrone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • BenzylpiperazineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Benzylpiperazine challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • Bromo-DragonFLYBDF, 1- -2-aminopropaneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Bromo-DragonFLY challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • BrompheniramineBrompheniramine maleateIn lab experiments, this test stayed negative.
    1 source, 2025

    Adding 50,000 ng/mL of brompheniramine did not produce a positive PCP result on this assay.

    What each source found

  • BuphedroneMABP, α-Methylamino-butyrophenoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Buphedrone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • Butyloneβ-keto-MBDBIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Butylone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • CathinoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Cathinone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • DibenzylpiperazineDBZP, 1,4-DibenzylpiperazineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Dibenzylpiperazine challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • DiethylpropionAmfepramone, TenuateIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Diethylpropion challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • DimethylamylamineDMAA, GeranamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Dimethylamylamine challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • Dimethyloneβ-keto-MDDMAIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Dimethylone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • DimethyltryptamineDMT, N,N-DimethyltryptamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Dimethyltryptamine challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • DipropyltryptamineDPT, N,N-DipropyltryptamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Dipropyltryptamine challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • DiPTN,N-DiisopropyltryptamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the DiPT challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • DOB4-Bromo-2,5-dimethoxyamphetamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the DOB challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • DOC4-Chloro-2,5-dimethoxyamphetamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the DOC challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • DOET2,5-Dimethoxy-4-ethylamphetamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the DOET challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • DOI4-Iodo-2,5-dimethoxyamphetamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the DOI challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • DOM2,5-Dimethoxy-4-methylamphetamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the DOM challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • EscalineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Escaline challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • Ethcathinonen-EthylcathinoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Ethcathinone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • Ethylone3,4-Methylenedioxy-N-ethylcathinone, β-keto-MDEAIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Ethylone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • Eutyloneβ-keto-EBDB, β-Keto-ethylbenzodioxolylbutanamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Eutylone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • Flephedrone4-Fluoromethcathinone, 4-FMCIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Flephedrone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • ImipramineTofranilIn lab experiments, this test stayed negative.
    1 source, 2009

    Five PCP screening reagents in the published comparison showed no reaction to imipramine.

    What each source found

  • MDAI5,6-Methylenedioxy-2-aminoindaneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the MDAI challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • MDEA3,4-MethylenedioxyethylamphetamineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the MDEA challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • Mephedrone4-methylmethcathinone, 4-MMCIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Mephedrone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • MeprobamateEquanil, MiltownIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Meprobamate at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • MescalineIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Mescaline challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • Meta-chlorophenylpiperazineChlorophenylpiperazine, mCPPIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Meta-chlorophenylpiperazine challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • MethcathinoneEphedroneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Methcathinone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • Methedrone4-MethoxymethcathinoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Methedrone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • MethiopropamineMPAIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Methiopropamine challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • Methylone3,4-Methylenedioxy-N-methylcathinone, β-keto-MDMAIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Methylone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • MT-451-Cyclohexyl-4- -piperazine, dihydrochlorideIn lab experiments, this test stayed negative.
    1 source, 2015

    In the MT-45 challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • N,N-DimethylcathinoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the N,N-Dimethylcathinone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • Pentedroneα-Methylamino-valerophenoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Pentedrone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • Pentylone1- -2- -1-pentanoneIn lab experiments, this test stayed negative.
    1 source, 2015

    In the Pentylone challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • PMAIn lab experiments, this test stayed negative.
    1 source, 2015

    In the PMA challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • PMMAIn lab experiments, this test stayed negative.
    1 source, 2015

    In the PMMA challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

  • PrednisoneDeltasoneIn lab experiments, this test stayed negative.
    1 source, 2025

    Prednisone at 100 µg/mL did not cause a positive result in drug-free urine or change the result of urine just below or above this channel’s cutoff.

    What each source found

  • WIN 35,428CFTIn lab experiments, this test stayed negative.
    1 source, 2015

    In the WIN 35,428 challenge, Microgenics DRI Phencyclidine stayed negative at 100 µg/mL.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Barbiturates Test?

Several commonly repeated claims trace to older assays. Check the test and how many samples were actually affected.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 4 kinds of results in this list

Has Caused a False Positive5

Studies or case reports found it can make the screen read positive for a drug that was not there. How often that happens at a usual dose is not known.

  • EthosuximideZarontinSeen in people taking it, and again in lab experiments.
    2 sources, 2018 to 2026
    • A patient taking ethosuximide had an unexpected barbiturate screen.
    • The investigators also reproduced the reaction with added ethosuximide.

    What each source found

  • IbuprofenAdvil, MotrinSeen in people taking it, and a second test proved it false.
    1 source, 1990

    One sample from a person taking ibuprofen gave a false-positive barbiturate result in a prospective study of 510 specimens across three NSAIDs.

    What each source found

  • NaproxenAleve, NaprosynSeen in people taking it, and a second test proved it false.
    1 source, 1990

    One sample from a person taking naproxen gave a false-positive barbiturate result in a prospective study of 510 specimens across three NSAIDs.

    What each source found

  • GlutethimideOnly in lab experiments so far, not in people taking it.
    2 sources, 1975 to 1981
    • Researchers comparing urine testing methods reported a false-positive barbiturate result from glutethimide on the radioimmunoassay.
    • Allen and Stiles independently confirmed a glutethimide reaction in pooled drug-free human urine.

    What each source found

  • AminoglutethimideCytadrenListed by a test maker or a medical reference.
    2 sources, 2009

    The study’s supplementary comparison lists aminoglutethimide as a weak barbiturate cross-reactant on Abbott AxSYM and Biosite Triage at 100 micrograms/mL.

    What each source found

The Test Is Made to Find It5

It is the drug the test looks for, contains it, or the body turns it into it. A positive here can be real.

  • ButalbitalA positive here is expected, not a false positive.
    2 sources, 2011 to 2019
    • Participants given butalbital, itself a barbiturate, excreted the drug in urine.
    • The Quidel urine screening panel also detects it in analytical testing.

    What each source found

  • PhenobarbitalLuminal, PhenobarbitoneA positive here is expected, not a false positive.
    2 sources, 2011 to 2019
    • Participants given phenobarbital, itself a barbiturate, excreted the drug in urine.
    • The Quidel urine screening panel also detects it in analytical testing.

    What each source found

  • PrimidoneMysolineA positive here is expected, not a false positive.
    1 source, 1977
    • Children receiving long-term primidone excreted phenobarbital, an active metabolite.
    • A drug test that identifies phenobarbital can therefore reflect prescribed primidone.

    What each source found

  • SecobarbitalSeconalA positive here is expected, not a false positive.
    2 sources, 2011 to 2019
    • Participants given secobarbital, itself a barbiturate, excreted the drug in urine.
    • The Quidel urine screening panel also detects it in analytical testing.

    What each source found

  • AmobarbitalA positive here is expected, not a false positive.
    1 source, 1994

    Secobarbital-directed reagents were less sensitive to amobarbital, a genuine barbiturate used in the UK.

    What each source found

Tested With No False Positive, or Not Proven (7)

Suspected, but Not Proven3

A report, a list or a study names it, but no study we found showed it makes the screen read positive.

  • TolmetinTolectinSuspected, but the studies did not show it.
    1 source, 1995
    • The older EMIT evaluation documented optical interference across assays.
    • It did not establish that tolmetin made a urine barbiturate screen read positive.

    What each source found

  • MephenytoinSuspected in a case report, but not shown to cause it.
    1 source, 2000

    The authors of a mephenytoin overdose report raise possible urine barbiturate positivity.

    What each source found

  • PhenytoinDilantinSuspected in a case report, but not shown to cause it.
    1 source, 1988

    A 1988 letter names phenytoin and a hydroxylated metabolite in a false-positive urine barbiturate result.

    What each source found

Tested: No False Positive Found4

It was tested and did not make the screen read positive. Other brands of the test can differ.

  • AcetaminophenParacetamol, TylenolIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Acetaminophen at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • DextromethorphanDelsym, DXMIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Dextromethorphan at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • DiphenhydramineBenadryl, Unisom SleepGelsIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Diphenhydramine at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

  • MeprobamateEquanil, MiltownIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors observed no interference from Meprobamate at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Acetaminophen Test?

Acetaminophen (urine screen)

This is a urine toxicology screen. The result does not give the blood acetaminophen concentration used to assess a suspected overdose.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

Has Caused a False Positive4

Studies or case reports found it can make the screen read positive for a drug that was not there. How often that happens at a usual dose is not known.

  • CarbidopaLodosynOnly in lab experiments so far, not in people taking it.
    1 source, 2021
    • When added separately to urine, carbidopa produced a false-positive acetaminophen screen at less than 40 micrograms/mL.
    • Patients usually received levodopa and carbidopa together.

    What each source found

  • EntacaponeComtanOnly in lab experiments so far, not in people taking it.
    1 source, 2021
    • Entacapone produced a positive urine acetaminophen result in a spiking experiment at 400 micrograms/mL.
    • The patient-record association could be explained by treatment with levodopa or carbidopa.

    What each source found

  • LevodopaL-dopaOnly in lab experiments so far, not in people taking it.
    1 source, 2021
    • When added separately to urine, levodopa produced a false-positive acetaminophen screen at less than 40 micrograms/mL.
    • Patients usually received levodopa and carbidopa together.

    What each source found

  • MethyldopaAldometOnly in lab experiments so far, not in people taking it.
    1 source, 2021
    • Both methyldopa and its alpha-methyldopamine metabolite produced interference in the urine acetaminophen assay.
    • A second metabolite, 3-O-methyldopa, did not.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Acetylfentanyl Test?

Acetylfentanyl-specific biochip

This is the acetylfentanyl channel of a specialized urine opioid biochip. Other fentanyl tests use different antibodies.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

Tested With No False Positive, or Not Proven (3)

Suspected, but Not Proven3

A report, a list or a study names it, but no study we found showed it makes the screen read positive.

  • MorphineMS Contin, RoxanolSuspected in a case report, but not shown to cause it.
    1 source, 2022
    • One unconfirmed result accompanied tramadol, pholcodine and morphine.
    • Another unconfirmed result accompanied tramadol.

    What each source found

  • PholcodinepholcodinSuspected in a case report, but not shown to cause it.
    1 source, 2022
    • One unconfirmed result accompanied tramadol, pholcodine and morphine.
    • Another unconfirmed result accompanied tramadol.

    What each source found

  • TramadolConZip, UltramSuspected in a case report, but not shown to cause it.
    1 source, 2022
    • One unconfirmed result accompanied tramadol, pholcodine and morphine.
    • Another unconfirmed result accompanied tramadol.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Alcohol (Ethanol) Test?

Urine ethanol

This test measures alcohol itself. Fermentation in a stored urine sample is a different problem from an EtG immunoassay cross-reaction.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

Tested With No False Positive, or Not Proven (2)

A Problem With the Urine Sample2

Something already in the urine, or what happened to the sample after it was collected, affected the result.

  • Bacteriuria with E. coliEscherichia coliSomething in the urine sample, not a medicine, changed the result.
    1 source, 2009
    • Two infected urines produced ethanol and EtG after glucose supplementation and a week at room temperature.
    • Ethyl sulfate did not form in these specimens.

    What each source found

  • EmpagliflozinJardianceSomething in the urine sample, not a medicine, changed the result.
    1 source, 2024
    • A patient taking empagliflozin had glucose in his urine.
    • The fresh specimen contained no detectable ethanol.
    • Ethanol appeared when the sample was held at room temperature, consistent with fermentation after collection.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Carfentanil Test?

Carfentanil-specific biochip

This is the carfentanil channel of a specialized urine opioid biochip. A near-cutoff result on it is presumptive.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

Tested With No False Positive, or Not Proven (2)

Suspected, but Not Proven2

A report, a list or a study names it, but no study we found showed it makes the screen read positive.

  • TilidineSuspected in a case report, but not shown to cause it.
    1 source, 2022

    One borderline unconfirmed carfentanil result accompanied tramadol, and another accompanied tilidine.

    What each source found

  • TramadolConZip, UltramSuspected in a case report, but not shown to cause it.
    1 source, 2022

    One borderline unconfirmed carfentanil result accompanied tramadol, and another accompanied tilidine.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Carisoprodol (Soma) Test?

Carisoprodol and meprobamate

Some urine tests target the muscle relaxant carisoprodol. Others target its metabolite meprobamate. Check which analyte the lab measured.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 3 kinds of results in this list

Has Caused a False Positive1

Studies or case reports found it can make the screen read positive for a drug that was not there. How often that happens at a usual dose is not known.

  • FelbamateFelbatolOnly in lab experiments so far, not in people taking it.
    2 sources, 2018 to 2019
    • Felbamate made two urine screens positive in manufacturer experiments reviewed by the FDA.
    • With LZI, 400 ng/mL felbamate gave a result equivalent to 100 ng/mL meprobamate.
    • The Immunalysis assay needed 120,000 ng/mL felbamate at its 280 ng/mL meprobamate cutoff.

    What each source found

The Test Is Made to Find It2

It is the drug the test looks for, contains it, or the body turns it into it. A positive here can be real.

  • CarisoprodolSomaA positive here is expected, not a false positive.
    3 sources, 2011 to 2019
    • Carisoprodol is an intended source of a positive result.
    • Both the medicine and its metabolite meprobamate can contribute.
    • A clinical urine study compared carisoprodol immunoassay results with LC-MS/MS.

    What each source found

  • MeprobamateEquanil, MiltownA positive here is expected, not a false positive.
    3 sources, 2011 to 2019
    • Meprobamate is the substance these assays use for calibration.
    • A patient who takes meprobamate itself can therefore have a positive result on a test labeled for the carisoprodol metabolite.

    What each source found

Tested With No False Positive, or Not Proven (1)

Tested: No False Positive Found1

It was tested and did not make the screen read positive. Other brands of the test can differ.

  • MethocarbamolRobaxinIn lab experiments, this test stayed negative.
    2 sources, 2018 to 2019

    Methocarbamol at 200,000 ng/mL failed to reach the LZI meprobamate cutoff of 100 ng/mL, and the same concentration tested negative on the Immunalysis assay with a 280 ng/mL cutoff.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Clonazepam Test?

Clonazepam-specific biochip

A specialized urine biochip targeting clonazepam is different from a general benzodiazepine screen.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 2 kinds of results in this list
Tested With No False Positive, or Not Proven (3)

Suspected, but Not Proven3

A report, a list or a study names it, but no study we found showed it makes the screen read positive.

  • AlprazolamXanaxFound alongside false positives, but not shown to cause them.
    1 source, 2022

    Alprazolam was detected in a subset of unconfirmed clonazepam urine results that also contained diazepam-related material.

    What each source found

  • LorazepamAtivanFound alongside false positives, but not shown to cause them.
    1 source, 2022

    Lorazepam was detected in a subset of unconfirmed clonazepam urine results that also contained diazepam-related material.

    What each source found

  • FlurazepamDalmaneSuspected in a case report, but not shown to cause it.
    1 source, 2022

    Norflurazepam was the only other benzodiazepine detected in one urine that screened positive for clonazepam and failed to confirm.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Diphenhydramine Test?

An experimental antihistamine-specific urine/blood ELISA. This differs from a tricyclic antidepressant or phencyclidine screen.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 2 kinds of results in this list
Tested With No False Positive, or Not Proven (3)

Tested: No False Positive Found3

It was tested and did not make the screen read positive. Other brands of the test can differ.

  • BrompheniramineBrompheniramine maleateIn lab experiments, this test stayed negative.
    1 source, 2012

    The evaluated antihistamine showed less than 1% relative response with this antibody in the authors' comparison.

    What each source found

  • ChlorpheniramineIn lab experiments, this test stayed negative.
    1 source, 2012

    The evaluated antihistamine showed less than 1% relative response with this antibody in the authors' comparison.

    What each source found

  • DoxylamineUnisom SleepTabsIn lab experiments, this test stayed negative.
    1 source, 2012

    The evaluated antihistamine showed less than 1% relative response with this antibody in the authors' comparison.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive EDDP (Methadone) Test?

EDDP (methadone metabolite)

Look here for a report naming EDDP. A parent-methadone assay has its own cross-reaction profile.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 3 kinds of results in this list

Has Caused a False Positive9

Studies or case reports found it can make the screen read positive for a drug that was not there. How often that happens at a usual dose is not known.

  • KratomMitragyna speciosa, mitragynineSeen in people taking it, and a second test proved it false.
    1 source, 2020
    • A conference abstract reported 24 selected samples with kratom alkaloids and no confirmed methadone or EDDP.
    • Further testing suggested an unidentified kratom metabolite could account for the EDDP screen.

    What each source found

  • ChlorpromazineThorazineOnly in lab experiments so far, not in people taking it.
    1 source, 2014

    Added chlorpromazine at 1 micrograms/mL produced a presumptive positive for the methadone metabolite EDDP in the published validation.

    What each source found

  • CitalopramCelexaOnly in lab experiments so far, not in people taking it.
    1 source, 2014

    Added citalopram at 100 micrograms/mL produced a presumptive positive for the methadone metabolite EDDP in the published validation.

    What each source found

  • DoxylamineUnisom SleepTabsOnly in lab experiments so far, not in people taking it.
    1 source, 2014

    Added doxylamine at 100 micrograms/mL produced a presumptive positive for the methadone metabolite EDDP in the published validation.

    What each source found

  • FluoxetineProzacOnly in lab experiments so far, not in people taking it.
    1 source, 2014

    Added fluoxetine at 100 micrograms/mL produced a presumptive positive for the methadone metabolite EDDP in the published validation.

    What each source found

  • PhencyclidinePCPOnly in lab experiments so far, not in people taking it.
    1 source, 2014

    Added phencyclidine at 10 micrograms/mL produced a presumptive positive for the methadone metabolite EDDP in the published validation.

    What each source found

  • QuetiapineSeroquelOnly in lab experiments so far, not in people taking it.
    1 source, 2014

    Added quetiapine at 100 micrograms/mL produced a presumptive positive for the methadone metabolite EDDP in the published validation.

    What each source found

  • SertralineZoloftOnly in lab experiments so far, not in people taking it.
    1 source, 2014

    Added sertraline at 100 micrograms/mL produced a presumptive positive for the methadone metabolite EDDP in the published validation.

    What each source found

  • ThioridazineMellarilOnly in lab experiments so far, not in people taking it.
    1 source, 2014

    Added thioridazine at 1 micrograms/mL produced a presumptive positive for the methadone metabolite EDDP in the published validation.

    What each source found

The Test Is Made to Find It1

It is the drug the test looks for, contains it, or the body turns it into it. A positive here can be real.

  • MethadoneDolophine, MethadoseA positive here is expected, not a false positive.
    2 sources, 2014 to 2017
    • EDDP is a principal urinary metabolite of methadone.
    • Its presence can be expected after taking methadone.
    • The modified assay yielded 0.033% for methadone and 97% for its target metabolite EDDP relative response.

    What each source found

Tested With No False Positive, or Not Proven (1)

Tested: No False Positive Found1

It was tested and did not make the screen read positive. Other brands of the test can differ.

  • TapentadolNucynta, PalexiaIn lab experiments, this test stayed negative.
    1 source, 2012

    Tapentadol and its tested metabolites did not cross-react with the EDDP assay in the study that found parent-methadone assay positives.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive EtG (Alcohol) Test?

EtG (ethyl glucuronide)

EtG is a metabolite used to look for ethanol exposure. A reaction to another alcohol metabolite, genuine ethanol exposure from a product, and changes in a stored sample require different interpretations. Some instruments flag an interference separately from a positive result.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 4 kinds of results in this list

Has Caused a False Positive4

Studies or case reports found it can make the screen read positive for a drug that was not there. How often that happens at a usual dose is not known.

  • Chloral hydrateSeen in people taking it, and again in lab experiments.
    1 source, 2009
    • A patient receiving chloral hydrate had positive EtG screens.
    • LC-MS/MS found neither EtG nor EtS.
    • A volunteer who took chloral hydrate also had a measurable immunoassay response.

    What each source found

  • Propanol-based hand sanitizerIsopropanol, Isopropyl alcoholSeen in people taking it, and again in lab experiments.
    3 sources, 2012 to 2016
    • After repeated use of a sanitizer containing 1- and 2-propanol, urine screened positive for EtG.
    • Mass spectrometry detected propyl glucuronides and found no EtG.
    • Controlled spiking reproduced interference.

    What each source found

  • Solvent mixtures containing non-ethanol alcoholsAliphatic alcohols, ButanolSeen in people taking it, and again in lab experiments.
    3 sources, 2014 to 2026
    • An exposed worker had repeated positive screens with no EtG on high-resolution mass spectrometry.
    • Other alcohol glucuronides were present.
    • In separate experiments, several propyl and butyl glucuronides reacted with the DRI assay.

    What each source found

  • SevofluraneSeen in a case report about a person taking it.
    1 source, 2018

    A report links a sevoflurane metabolite to an EtG signal after exposure to the inhaled anesthetic.

    What each source found

The Test Is Made to Find It2

It is the drug the test looks for, contains it, or the body turns it into it. A positive here can be real.

  • Ethanol-based hand sanitizerEthyl alcohol hand rubA positive here is expected, not a false positive.
    2 sources, 2014 to 2016

    A controlled repeated-exposure study measured EtG in urine after participants used an ethanol-containing hand rub and after vapor exposure alone.

    What each source found

  • Ethanol-containing mouthwashAlcohol-based mouthwash, Mouth rinse with ethanolA positive here is expected, not a false positive.
    2 sources, 2006 to 2016
    • A controlled study found measurable EtG after use of an ethanol-containing mouthwash.
    • Ethanol exposure from a product can produce genuine EtG.

    What each source found

Tested With No False Positive, or Not Proven (3)

A Problem With the Urine Sample1

Something already in the urine, or what happened to the sample after it was collected, affected the result.

  • Bacteriuria with E. coliEscherichia coliSomething in the urine sample, not a medicine, changed the result.
    3 sources, 2009 to 2026
    • In one pregnant patient with recurrent E. coli infection, EtG was repeatedly positive while the other alcohol markers were negative.
    • The authors suspected formation of EtG in the collected urine.
    • Two infected urines produced ethanol and EtG after glucose supplementation and a week at room temperature.
    • Ethyl sulfate did not form in these specimens.

    What each source found

Suspected, but Not Proven2

A report, a list or a study names it, but no study we found showed it makes the screen read positive.

  • MorphineMS Contin, RoxanolSuspected, but lab experiments did not show it.
    1 source, 2017

    The modified assay yielded 0.093% for morphine-6-glucuronide relative response.

    What each source found

  • Sodium oxybateLumryz, Sodium gamma-hydroxybutyrateSuspected, but lab experiments did not show it.
    1 source, 2017

    The modified assay yielded 0.19% for GHB glucuronide relative response.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Etizolam Test?

Etizolam-specific biochip

A targeted urine etizolam biochip may respond in samples that contain other benzodiazepines.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

Tested With No False Positive, or Not Proven (5)

Suspected, but Not Proven5

A report, a list or a study names it, but no study we found showed it makes the screen read positive.

  • AlprazolamXanaxSuspected in a case report, but not shown to cause it.
    1 source, 2022
    • Two unconfirmed urine etizolam results contained other benzodiazepines.
    • One contained alprazolam, hydroxyalprazolam and oxazepam.
    • The other contained lorazepam, nordiazepam, oxazepam and temazepam.

    What each source found

  • DiazepamValiumSuspected in a case report, but not shown to cause it.
    1 source, 2022
    • Two unconfirmed urine etizolam results contained other benzodiazepines.
    • One contained alprazolam, hydroxyalprazolam and oxazepam.
    • The other contained lorazepam, nordiazepam, oxazepam and temazepam.

    What each source found

  • LorazepamAtivanSuspected in a case report, but not shown to cause it.
    1 source, 2022
    • Two unconfirmed urine etizolam results contained other benzodiazepines.
    • One contained alprazolam, hydroxyalprazolam and oxazepam.
    • The other contained lorazepam, nordiazepam, oxazepam and temazepam.

    What each source found

  • OxazepamSeraxSuspected in a case report, but not shown to cause it.
    1 source, 2022
    • Two unconfirmed urine etizolam results contained other benzodiazepines.
    • One contained alprazolam, hydroxyalprazolam and oxazepam.
    • The other contained lorazepam, nordiazepam, oxazepam and temazepam.

    What each source found

  • TemazepamRestorilSuspected in a case report, but not shown to cause it.
    1 source, 2022
    • Two unconfirmed urine etizolam results contained other benzodiazepines.
    • One contained alprazolam, hydroxyalprazolam and oxazepam.
    • The other contained lorazepam, nordiazepam, oxazepam and temazepam.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Flunitrazepam metabolite Test?

Flunitrazepam (7-aminoflunitrazepam)

A specialized urine test for the main flunitrazepam metabolite. Other benzodiazepines can react differently on this test and on a general benzodiazepine screen.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

Has Caused a False Positive1

Studies or case reports found it can make the screen read positive for a drug that was not there. How often that happens at a usual dose is not known.

  • DiazepamValiumSeen in people taking it, and again in lab experiments.
    2 sources, 2002 to 2005
    • Diazepam produced noticeable off-target reactivity in this specialized assay.
    • Of 25 benzodiazepines investigated, diazepam was the only compound beyond flunitrazepam itself with significant cross-reactivity on these specialized tests.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Gabapentin Test?

The available cross-reactivity evidence here concerns a dedicated gabapentin urine immunoassay.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 3 kinds of results in this list

Has Caused a False Positive1

Studies or case reports found it can make the screen read positive for a drug that was not there. How often that happens at a usual dose is not known.

  • LevamisoleErgamisolOnly in lab experiments so far, not in people taking it.
    1 source, 2026

    In a 2026 validation study, urine containing at least 50 micrograms/mL of levamisole gave a false-positive gabapentin screen.

    What each source found

The Test Is Made to Find It1

It is the drug the test looks for, contains it, or the body turns it into it. A positive here can be real.

  • GabapentinNeurontinA positive here is expected, not a false positive.
    1 source, 2026
    • Gabapentin is the target of this specialty urine test.
    • Investigators verified urine results against LC-MS/MS using authentic case specimens in addition to laboratory controls.

    What each source found

Tested With No False Positive, or Not Proven (1)

Suspected, but Not Proven1

A report, a list or a study names it, but no study we found showed it makes the screen read positive.

  • PregabalinLyrica, Lyrica CRSuspected, but lab experiments did not show it.
    2 sources, 2026
    • The manufacturer measured weak reactivity of pregabalin in buffer.
    • An independent forensic study described minimal cross-reactivity from pregabalin.
    • A urine concentration that makes this gabapentin test positive after taking pregabalin was not established in the material reviewed.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive GHB Test?

Gamma-hydroxybutyrate (GHB)

The rapid GHB strip and a quantitative urine measurement answer different questions. Prescription sodium oxybate supplies GHB.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 2 kinds of results in this list

Has Caused a False Positive1

Studies or case reports found it can make the screen read positive for a drug that was not there. How often that happens at a usual dose is not known.

  • Ascorbic acidL-ascorbic acid, Vitamin COnly in lab experiments so far, not in people taking it.
    1 source, 2012
    • The manufacturer reports that extreme urinary ascorbic acid concentrations can turn this strip positive for GHB.
    • It included a separate vitamin C strip to investigate that interference.

    What each source found

The Test Is Made to Find It1

It is the drug the test looks for, contains it, or the body turns it into it. A positive here can be real.

  • Sodium oxybateLumryz, Sodium gamma-hydroxybutyrateA positive here is expected, not a false positive.
    1 source, 2001
    • Sodium oxybate is the sodium salt of GHB.
    • Researchers detected GHB in a volunteer’s urine after separate oral doses of the sodium salt.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Heroin (6-MAM) Test?

Heroin metabolite (6-AM or 6-MAM)

A screen for this heroin metabolite is distinct from a morphine-positive opiates result. Ask which analyte was confirmed.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 3 kinds of results in this list

Has Caused a False Positive2

Studies or case reports found it can make the screen read positive for a drug that was not there. How often that happens at a usual dose is not known.

  • NalorphineOnly in lab experiments so far, not in people taking it.
    1 source, 2009

    The 2009 comparison lists weak reactivity for Nalorphine on the Microgenics CEDIA screen.

    What each source found

  • OxymorphoneOpanaOnly in lab experiments so far, not in people taking it.
    1 source, 2009

    The 2009 comparison lists weak reactivity for Oxymorphone on the Microgenics CEDIA screen.

    What each source found

Depends on the Brand of Test7

Some brands of the screen reacted to it and others did not, or the studies disagree. The lab can tell you which brand it used.

  • Codeinecodeine phosphateIn people and in lab experiments, some brands reacted and others did not.
    5 sources, 1991 to 2017
    • A 2005 CEDIA experiment found a positive heroin-marker screen at 60,000 ng/mL of codeine.
    • Later CEDIA instructions report a negative at 500,000 ng/mL, and recombinant-antibody HEIA remained negative at 1,000,000 ng/mL.

    What each source found

  • MorphineMS Contin, RoxanolIn people and in lab experiments, some brands reacted and others did not.
    11 sources, 1991 to 2017
    • A CEDIA study found that morphine at 10,000 ng/mL triggered the heroin-marker screen.
    • Later CEDIA instructions report a negative at 9,000 ng/mL.
    • A recombinant-antibody test showed much weaker interference, with a response near cutoff around 300,000 ng/mL.
    • The authors characterized the cross-reactivity of morphine and its 3- and 6-glucuronides as minimal on this reagent.
    • In samples already containing 6-MAM by GC-MS, the authors attributed differences in RIA levels to morphine and morphine-6-glucuronide.
    • All 21 unconfirmed positives in one series contained free morphine at 410–2,010 ng/mL.
    • Morphine and both major morphine glucuronides showed minimal reactivity on the two ADVIA 6-AM applications.

    What each source found

  • Poppy seedsPapaver somniferum, poppy seed foodsIn people taking it, some brands reacted and others did not.
    2 sources, 1991 to 2014
    • The older CEDIA heroin-marker test produced false positives in some urine collected after controlled poppy seed ingestion.
    • The Lin-Zhi 6-AM assay produced none.
    • Investigators measured genuine morphine and codeine from the seeds.

    What each source found

  • HydrocodoneHysingla ERIn lab experiments, some brands reacted and others did not.
    3 sources, 2005 to 2017
    • A 2005 study found a positive CEDIA heroin-marker screen with a hydrocodone standard at 60,000 ng/mL.
    • Later CEDIA instructions report a negative at 300,000 ng/mL, and recombinant-antibody HEIA remained negative at 1,000,000 ng/mL.

    What each source found

  • HydromorphoneDilaudidIn lab experiments, some brands reacted and others did not.
    4 sources, 2005 to 2017
    • A 2005 study found a positive CEDIA heroin-marker screen with a hydromorphone standard at 10,000 ng/mL.
    • Later CEDIA instructions report a negative at the same concentration.
    • The recombinant-antibody HEIA study reported a near-cutoff response only at a much higher level.

    What each source found

  • OxycodoneOxyContin, RoxicodoneIn lab experiments, some brands reacted and others did not.
    3 sources, 2005 to 2017
    • A 2005 study found a positive CEDIA heroin-marker screen with a oxycodone standard at 61,000 ng/mL.
    • Later CEDIA instructions report a negative at 400,000 ng/mL, and recombinant-antibody HEIA remained negative at 1,000,000 ng/mL.

    What each source found

  • PentazocineTalwinIn lab experiments, some brands reacted and others did not.
    2 sources, 2005 to 2015
    • A 2005 study found a positive CEDIA heroin-marker screen with a pentazocine standard at 35,000 ng/mL.
    • Wang and colleagues included pentazocine among compounds with no interference on the recombinant-antibody assay.

    What each source found

The Test Is Made to Find It1

It is the drug the test looks for, contains it, or the body turns it into it. A positive here can be real.

  • Heroindiacetylmorphine, diamorphineA positive here is expected, not a false positive.
    1 source, 1991
    • Heroin breaks down to 6-acetylmorphine, also called 6-MAM, 6-AM or 6-monoacetylmorphine.
    • This metabolite was detected after heroin administration but not after morphine or codeine in controlled testing.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Hydrocodone Test?

Hydrocodone / hydromorphone

Check whether the lab used a dedicated hydrocodone/hydromorphone assay. A medicine and its metabolites can contribute to the result.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 3 kinds of results in this list

Depends on the Brand of Test3

Some brands of the screen reacted to it and others did not, or the studies disagree. The lab can tell you which brand it used.

  • Codeinecodeine phosphateIn people and in lab experiments, some brands reacted and others did not.
    2 sources, 2000 to 2016
    • There are two possible reasons for a positive.
    • Codeine itself reacted with the Lin-Zhi test in spiked urine.
    • In a separate controlled dosing study, people taking codeine produced small amounts of actual hydrocodone in urine.

    What each source found

  • MorphineMS Contin, RoxanolIn people and in lab experiments, some brands reacted and others did not.
    2 sources, 2008 to 2016
    • Added morphine reacted on the Lin-Zhi hydrocodone/hydromorphone screen.
    • Separately, people taking high doses of morphine have excreted small amounts of hydromorphone, a target of this combined screen.

    What each source found

  • DihydrocodeineIn lab experiments, some brands reacted and others did not.
    1 source, 2016
    • Dihydrocodeine at 5,000 ng/mL triggered the 100 ng/mL cutoff.
    • It did not trigger the 300 ng/mL cutoff even at 20,000 ng/mL.

    What each source found

The Test Is Made to Find It2

It is the drug the test looks for, contains it, or the body turns it into it. A positive here can be real.

  • HydrocodoneHysingla ERA positive here is expected, not a false positive.
    2 sources, 2016 to 2022

    An assay for hydrocodone and hydromorphone can appropriately detect prescribed hydrocodone and its metabolite.

    What each source found

  • HydromorphoneDilaudidA positive here is expected, not a false positive.
    1 source, 2016
    • This particular reagent is designed to recognize hydrocodone and hydromorphone.
    • A person prescribed hydromorphone can therefore screen positive.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive K2 or Spice Test?

Synthetic cannabinoids (K2 or Spice)

Synthetic cannabinoid assays and routine THC urine tests target different compounds.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 5 kinds of results in this list

Has Caused a False Positive1

Studies or case reports found it can make the screen read positive for a drug that was not there. How often that happens at a usual dose is not known.

  • LamotrigineLamictalSeen in people taking it, and again in lab experiments.
    1 source, 2021
    • Urine from lamotrigine users showed a K2/1 signal despite negative targeted LC-MS/MS.
    • Adding lamotrigine or user urine reproduced the interference.

    What each source found

The Test Is Made to Find It2

It is the drug the test looks for, contains it, or the body turns it into it. A positive here can be real.

  • UR-144A positive here is expected, not a false positive.
    3 sources, 2014 to 2015
    • The assay did not recognize the tested metabolites of UR-144, a synthetic cannabinoid.
    • This dedicated assay recognized hydroxylated UR-144 and XLR-11 metabolites more strongly than the parent drugs.
    • Parent-drug cross-reactivity was below 10%.
    • The NMS antibody showed negligible or absent recognition of the tested UR-144 material, in contrast to a test designed specifically to identify UR-144/XLR-11.

    What each source found

  • XLR-11A positive here is expected, not a false positive.
    2 sources, 2014 to 2015
    • This dedicated assay recognized hydroxylated UR-144 and XLR-11 metabolites more strongly than the parent drugs.
    • Parent-drug cross-reactivity was below 10%.
    • The NMS antibody showed negligible or absent recognition of the tested XLR-11 material, in contrast to a test designed specifically to identify UR-144/XLR-11.

    What each source found

Tested With No False Positive, or Not Proven (57)

Suspected, but Not Proven1

A report, a list or a study names it, but no study we found showed it makes the screen read positive.

  • BuprenorphineBelbuca, ButransSuspected, but lab experiments did not show it.
    2 sources, 2014 to 2015
    • A mixture of buprenorphine and norbuprenorphine, each at 1,000 ng/mL, gave a K2 Spice response of 7.3 ng/mL.
    • That crossed the investigators’ proposed 5 ng/mL cutoff but stayed below the manufacturer’s 10 ng/mL cutoff.
    • On the separate NMS ELISA, challenges including both compounds at 1,000 ng/mL did not produce a positive or appreciably suppress the 5 ng/mL control.

    What each source found

Tested: No False Positive Found56

It was tested and did not make the screen read positive. Other brands of the test can differ.

  • 2C-B4-Bromo-2,5-dimethoxy-β-phenethylamineIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with 2C-B.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • 6-AcetylcodeineacetylcodeineIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with 6-acetylcodeine.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • AcetaminophenParacetamol, TylenolIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with acetaminophen.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • AlprazolamXanaxIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with alprazolam.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • AmphetamineAmfetamineIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with amphetamine and p-hydroxyamphetamine.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • AspirinAcetylsalicylic acid, ASAIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with acetylsalicylic acid.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • BDBIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with BDB.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • BromazepamIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with bromazepam.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • BrompheniramineBrompheniramine maleateIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with brompheniramine.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • CaffeineIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with caffeine.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • CannabidiolCBD, EpidiolexIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with cannabidiol.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • CannabigerolIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with cannabigerol.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • CannabinolCBNIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with cannabinol.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • CathinoneIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with cathinone.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • ChlorpheniramineIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with chlorpheniramine.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • ClomipramineAnafranilIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with clomipramine.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • ClonazepamKlonopinIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with clonazepam and 7-aminoclonazepam.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • ClonidineCatapres, KapvayIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with clonidine.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • CocaethyleneIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with cocaethylene and norcocaethylene.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • Cocaine (medical topical use)Cocaine hydrochloride, Intranasal cocaineIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with cocaine, benzoylecgonine, norcocaine, ecgonine, norbenzoylecgonine, ecgonine ethyl ester, ecgonine methyl ester, anhydroecgonine methyl ester and the tested hydroxylated metabolites.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • Codeinecodeine phosphateIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with codeine and norcodeine.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • DextromethorphanDelsym, DXMIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with dextromethorphan.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • DiazepamValiumIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with diazepam and nordiazepam.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • DiphenhydramineBenadryl, Unisom SleepGelsIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with diphenhydramine.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • DronabinolMarinol, SyndrosIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with THC, 11-hydroxy-THC and THC-COOH.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • EphedrineAkovazIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with ephedrine.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • EthylamphetamineEtilamfetamine, N-ethylamphetamineIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with ethylamphetamine.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • FlunitrazepamRohypnolIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with flunitrazepam and 7-aminoflunitrazepam.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • FluoxetineProzacIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with fluoxetine and norfluoxetine.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • FlurazepamDalmaneIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with flurazepam.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • Heroindiacetylmorphine, diamorphineIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with 6-acetylmorphine.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • HydrocodoneHysingla ERIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with hydrocodone.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • IbuprofenAdvil, MotrinIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with ibuprofen.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • ImipramineTofranilIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with imipramine.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • KetamineKetalar, Racemic ketamineIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with ketamine.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • LorazepamAtivanIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with lorazepam.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • MBDBN-methyl-1- -2-butanamineIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with MBDB.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • MDATenamfetamine, 3,4-MethylenedioxyamphetamineIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with MDA.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • MDEA3,4-MethylenedioxyethylamphetamineIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with MDEA.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • MDMAEcstasy, MollyIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with MDMA and its HMA and HMMA derivatives.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • MethadoneDolophine, MethadoseIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with methadone, EDDP and EMDP.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • MethamphetamineD-methamphetamine, DesoxynIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with methamphetamine and p-hydroxymethamphetamine.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • MorphineMS Contin, RoxanolIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with morphine, normorphine and morphine-3- and morphine-6-glucuronide.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • Nicotine replacement therapyNicotine, Nicotine gumIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with nicotine, cotinine, norcotinine and trans-3′-hydroxycotinine.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • NitrazepamIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with nitrazepam and 7-aminonitrazepam.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • OxazepamSeraxIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with oxazepam.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • OxycodoneOxyContin, RoxicodoneIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with oxycodone and noroxycodone.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • OxymorphoneOpanaIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with oxymorphone and noroxymorphone.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • ParoxetineIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with paroxetine.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • PentazocineTalwinIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with pentazocine.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • PhentermineAdipex-P, LomairaIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with phentermine.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • PMAIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with p-methoxyamphetamine.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • PMMAIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with p-methoxymethamphetamine.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • PropoxypheneDarvon, DextropropoxypheneIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with propoxyphene.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • PseudoephedrineSudafedIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with pseudoephedrine.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

  • TemazepamRestorilIn lab experiments, this test stayed negative.
    1 source, 2015
    • The researchers challenged the assay with temazepam.
    • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Ketamine Test?

A dedicated ketamine test is different from the PCP line on a standard panel.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 3 kinds of results in this list

Depends on the Brand of Test1

Some brands of the screen reacted to it and others did not, or the studies disagree. The lab can tell you which brand it used.

  • QuetiapineSeroquelIn people and in lab experiments, some brands reacted and others did not.
    2 sources, 2017 to 2026
    • Two patients taking quetiapine screened positive for ketamine, and both results failed confirmation.
    • In a separate manufacturer study, urine spiked with quetiapine tested negative on ARK Ketamine II at both cutoffs.

    What each source found

The Test Is Made to Find It2

It is the drug the test looks for, contains it, or the body turns it into it. A positive here can be real.

  • KetamineKetalar, Racemic ketamineA positive here is expected, not a false positive.
    3 sources, 2005 to 2026
    • After children received ketamine for anesthesia, investigators detected ketamine and norketamine in urine.
    • The ARK screening assay also responds to norketamine and dehydronorketamine.
    • Norketamine at 200 ng/mL exhibited 2.1% cross-reactivity in the ketamine assay.
    • Ketamine and its metabolite were identified in 34 tested urine specimens.

    What each source found

  • EsketamineS-ketamine, SpravatoA positive here is expected, not a false positive.
    1 source, 2026
    • Esketamine is the S form of ketamine.
    • In spiked urine, 2,000 and 4,000 ng/mL of S-ketamine reached the respective 50 and 100 ng/mL assay cutoffs.
    • The manufacturer measured 2.5% reactivity for S-ketamine at both cutoffs.

    What each source found

Tested With No False Positive, or Not Proven (15)

Tested: No False Positive Found15

It was tested and did not make the screen read positive. Other brands of the test can differ.

  • AmphetamineAmfetamineIn lab experiments, this test stayed negative.
    1 source, 2009

    The tested Amphetamine challenge produced no response at 10,000 ng/mL.

    What each source found

  • Cocaine (medical topical use)Cocaine hydrochloride, Intranasal cocaineIn lab experiments, this test stayed negative.
    1 source, 2009

    Both cocaine and benzoylecgonine showed no cross-reactivity at 10,000 ng/mL in the Neogen ketamine assay.

    What each source found

  • DextromethorphanDelsym, DXMIn lab experiments, this test stayed negative.
    1 source, 2026

    Urine spiked with dextromethorphan at 100,000 ng/mL remained negative at both ketamine cutoffs in the manufacturer’s testing.

    What each source found

  • DiazepamValiumIn lab experiments, this test stayed negative.
    1 source, 2009

    The tested Diazepam challenge produced no response at 10,000 ng/mL.

    What each source found

  • Heroindiacetylmorphine, diamorphineIn lab experiments, this test stayed negative.
    1 source, 2009

    The tested heroin metabolite, 6-monoacetylmorphine, showed no cross-reactivity at 10,000 ng/mL.

    What each source found

  • LamotrigineLamictalIn lab experiments, this test stayed negative.
    1 source, 2026

    Urine spiked with lamotrigine at 100,000 ng/mL remained negative at both ketamine cutoffs in the manufacturer’s testing.

    What each source found

  • MDATenamfetamine, 3,4-MethylenedioxyamphetamineIn lab experiments, this test stayed negative.
    1 source, 2009

    The tested MDA challenge produced no response at 10,000 ng/mL.

    What each source found

  • MDEA3,4-MethylenedioxyethylamphetamineIn lab experiments, this test stayed negative.
    1 source, 2009

    The tested MDEA challenge produced no response at 10,000 ng/mL.

    What each source found

  • MDMAEcstasy, MollyIn lab experiments, this test stayed negative.
    1 source, 2009

    The tested MDMA challenge produced no response at 10,000 ng/mL.

    What each source found

  • MethadoneDolophine, MethadoseIn lab experiments, this test stayed negative.
    1 source, 2009

    The tested Methadone challenge produced no response at 10,000 ng/mL.

    What each source found

  • MethamphetamineD-methamphetamine, DesoxynIn lab experiments, this test stayed negative.
    1 source, 2009

    Methamphetamine showed no cross-reactivity at 10,000 ng/mL in the Neogen ketamine assay.

    What each source found

  • MorphineMS Contin, RoxanolIn lab experiments, this test stayed negative.
    1 source, 2009

    The tested Morphine challenge produced no response at 10,000 ng/mL.

    What each source found

  • PhencyclidinePCPIn lab experiments, this test stayed negative.
    1 source, 2009

    The tested Phencyclidine challenge produced no response at 10,000 ng/mL.

    What each source found

  • TiletamineIn lab experiments, this test stayed negative.
    1 source, 2009

    The tested Tiletamine challenge produced no response at 10,000 ng/mL.

    What each source found

  • VenlafaxineEffexor, Effexor XRIn lab experiments, this test stayed negative.
    1 source, 2026

    Urine spiked with venlafaxine at 100,000 ng/mL remained negative at both ketamine cutoffs in the manufacturer’s testing.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Kratom Test?

Kratom (mitragynine)

This assay targets a kratom alkaloid. A report naming EDDP instead belongs under the methadone metabolite test.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

Depends on the Brand of Test1

Some brands of the screen reacted to it and others did not, or the studies disagree. The lab can tell you which brand it used.

  • MethadoneDolophine, MethadoseIn people and in lab experiments, some brands reacted and others did not.
    1 source, 2025
    • A conference report found that high concentrations of methadone and EDDP each triggered the kratom screen.
    • Both were present in many investigated patient samples that failed mitragynine confirmation.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive LSD Test?

LSD (lysergic acid diethylamide)

Older urine LSD assays and current manufacturer instructions describe different sets of potential interferents. Match the assay to the report.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 3 kinds of results in this list

Has Caused a False Positive22

Studies or case reports found it can make the screen read positive for a drug that was not there. How often that happens at a usual dose is not known.

  • AmbroxolMucosolvanSeen in people taking it, and again in lab experiments.
    2 sources, 1998 to 2002
    • Twelve intensive care urine samples tested positive on CEDIA for LSD and were negative by confirmatory chromatography.
    • All contained ambroxol and follow-up testing demonstrated cross-reactivity.

    What each source found

  • BupropionAplenzin, WellbutrinSeen in people taking it, and again in lab experiments.
    3 sources, 1997 to 2014
    • Investigators found bupropion in a patient whose LSD and amphetamine CEDIA screens failed confirmation.
    • A separate historical EMIT urine-spiking test implicated bupropion, as identified in Saitman Table VI.

    What each source found

  • SertralineZoloftSeen in people taking it, and again in lab experiments.
    3 sources, 1997 to 2014
    • A 2012 CEDIA investigation followed a patient who had taken extra sertraline and found interference when sertraline was added to urine.
    • A separate historical EMIT spiking experiment also implicated sertraline, as identified in Saitman Table VI.

    What each source found

  • AmitriptylineElavilOnly in lab experiments so far, not in people taking it.
    3 sources, 1997 to 2014
    • Ritter and colleagues reproduced positive EMIT results by adding individual medicines to normal urine.
    • Table VI of the subsequent Saitman review identifies amitriptyline as one of the interferents in that experiment.
    • In the CEDIA series the drug was detected among patients with unconfirmed LSD screens.

    What each source found

  • BenzphetamineDidrex, RegimexOnly in lab experiments so far, not in people taking it.
    2 sources, 1997 to 2014
    • Ritter and colleagues reproduced positive EMIT results by adding individual medicines to normal urine.
    • Table VI of the subsequent Saitman review identifies benzphetamine as one of the interferents in that experiment.

    What each source found

  • BrompheniramineBrompheniramine maleateOnly in lab experiments so far, not in people taking it.
    2 sources, 2002 to 2014
    • Wiegand and colleagues challenged three assays with 144 compounds.
    • Saitman Table VI identifies brompheniramine as producing a positive EMIT II result at 25 micrograms/mL.

    What each source found

  • BuspironeBuSparOnly in lab experiments so far, not in people taking it.
    2 sources, 1997 to 2014
    • Ritter and colleagues reproduced positive EMIT results by adding individual medicines to normal urine.
    • Table VI of the subsequent Saitman review identifies buspirone as one of the interferents in that experiment.

    What each source found

  • CephradineCefradine, VelosefOnly in lab experiments so far, not in people taking it.
    2 sources, 1997 to 2014
    • Ritter and colleagues reproduced positive EMIT results by adding individual medicines to normal urine.
    • Table VI of the subsequent Saitman review identifies cephradine as one of the interferents in that experiment.

    What each source found

  • ChlorpromazineThorazineOnly in lab experiments so far, not in people taking it.
    3 sources, 1997 to 2024
    • Ritter and colleagues reproduced positive EMIT results by adding individual medicines to normal urine.
    • Table VI of the subsequent Saitman review identifies chlorpromazine as one of the interferents in that experiment.
    • The later Siemens instructions also specifically flag chlorpromazine use when interpreting a positive screen.

    What each source found

  • DesipramineNorpraminOnly in lab experiments so far, not in people taking it.
    2 sources, 1997 to 2014
    • Ritter and colleagues reproduced positive EMIT results by adding individual medicines to normal urine.
    • Table VI of the subsequent Saitman review identifies desipramine as one of the interferents in that experiment.

    What each source found

  • DiltiazemCardizemOnly in lab experiments so far, not in people taking it.
    2 sources, 1997 to 2014
    • Ritter and colleagues reproduced positive EMIT results by adding individual medicines to normal urine.
    • Table VI of the subsequent Saitman review identifies diltiazem as one of the interferents in that experiment.

    What each source found

  • DoxepinSilenor, SinequanOnly in lab experiments so far, not in people taking it.
    3 sources, 1997 to 2014
    • Ritter and colleagues reproduced positive EMIT results by adding individual medicines to normal urine.
    • Table VI of the subsequent Saitman review identifies doxepin as one of the interferents in that experiment.
    • In the CEDIA series the drug was detected among patients with unconfirmed LSD screens.

    What each source found

  • HaloperidolHaldolOnly in lab experiments so far, not in people taking it.
    2 sources, 1997 to 2014
    • Ritter and colleagues reproduced positive EMIT results by adding individual medicines to normal urine.
    • Table VI of the subsequent Saitman review identifies haloperidol as one of the interferents in that experiment.

    What each source found

  • ImipramineTofranilOnly in lab experiments so far, not in people taking it.
    3 sources, 1997 to 2014
    • Wiegand and colleagues challenged three assays with 144 compounds.
    • Saitman Table VI identifies imipramine as producing a positive EMIT II result at 50 micrograms/mL.
    • The review also lists imipramine in the earlier Ritter experiment.

    What each source found

  • LabetalolNormodyne, TrandateOnly in lab experiments so far, not in people taking it.
    2 sources, 1997 to 2014
    • Ritter and colleagues reproduced positive EMIT results by adding individual medicines to normal urine.
    • Table VI of the subsequent Saitman review identifies labetalol as one of the interferents in that experiment.

    What each source found

  • MethadoneDolophine, MethadoseOnly in lab experiments so far, not in people taking it.
    1 source, 2024

    The manufacturer measured a response near the LSD cutoff with methadone at 400 µg/mL in its specificity evaluation.

    What each source found

  • MethylphenidateConcerta, MetadateOnly in lab experiments so far, not in people taking it.
    2 sources, 2002 to 2014
    • Wiegand and colleagues challenged three assays with 144 compounds.
    • Saitman Table VI identifies methylphenidate as producing a positive EMIT II result at 50 micrograms/mL.

    What each source found

  • MetoclopramideReglanOnly in lab experiments so far, not in people taking it.
    3 sources, 1997 to 2014
    • Ritter and colleagues reproduced positive EMIT results by adding individual medicines to normal urine.
    • Table VI of the subsequent Saitman review identifies metoclopramide as one of the interferents in that experiment.
    • In the CEDIA series the drug was detected among patients with unconfirmed LSD screens.

    What each source found

  • ProchlorperazineCompazineOnly in lab experiments so far, not in people taking it.
    2 sources, 1997 to 2014
    • Ritter and colleagues reproduced positive EMIT results by adding individual medicines to normal urine.
    • Table VI of the subsequent Saitman review identifies prochlorperazine as one of the interferents in that experiment.

    What each source found

  • RisperidoneRisperdal, Risperdal ConstaOnly in lab experiments so far, not in people taking it.
    2 sources, 1997 to 2014
    • Ritter and colleagues reproduced positive EMIT results by adding individual medicines to normal urine.
    • Table VI of the subsequent Saitman review identifies risperidone as one of the interferents in that experiment.

    What each source found

  • ThioridazineMellarilOnly in lab experiments so far, not in people taking it.
    2 sources, 1997 to 2014
    • Ritter and colleagues reproduced positive EMIT results by adding individual medicines to normal urine.
    • Table VI of the subsequent Saitman review identifies thioridazine as one of the interferents in that experiment.

    What each source found

  • TrazodoneDesyrel, OleptroOnly in lab experiments so far, not in people taking it.
    4 sources, 1997 to 2024
    • Ritter and colleagues reproduced positive EMIT results by adding individual medicines to normal urine.
    • Table VI of the subsequent Saitman review identifies trazodone as one of the interferents in that experiment.
    • Siemens separately measured a response near the LSD cutoff with m-CPP, a trazodone metabolite, at 33 micrograms/mL.

    What each source found

Depends on the Brand of Test9

Some brands of the screen reacted to it and others did not, or the studies disagree. The lab can tell you which brand it used.

  • FentanylDuragesic, SublimazeIn people and in lab experiments, some brands reacted and others did not.
    5 sources, 1997 to 2019
    • A fentanyl-associated hospital case had positive screens but no LSD or major LSD metabolite by LC-MS.
    • Historical investigators reported laboratory interference at high concentrations.
    • In contrast, a CEDIA insert reported a negative response at 40 ng/mL fentanyl.
    • A case report attributed an unconfirmed urine LSD screen to fentanyl given in the emergency department several hours earlier.

    What each source found

  • DextroamphetamineD-amphetamine, DexamphetamineIn lab experiments, some brands reacted and others did not.
    2 sources, 2019 to 2024
    • The manufacturer measured a response near the LSD cutoff with dextroamphetamine at 500 µg/mL in its specificity evaluation.
    • A separate CEDIA insert lists a negative result for amphetamine at 500,000 ng/mL without specifying the isomer.

    What each source found

  • ErgonovineErgometrineIn lab experiments, some brands reacted and others did not.
    5 sources, 1996 to 2024
    • Saitman Table VI reports an older EMIT II response at 4 micrograms/mL ergonovine.
    • Siemens revision 08 reports a near-cutoff response at 1 microgram/mL.
    • CEDIA reported 0.0% cross-reactivity at 10 micrograms/mL; another microplate assay showed very weak reactivity.

    What each source found

  • FluoxetineProzacIn lab experiments, some brands reacted and others did not.
    3 sources, 1997 to 2019
    • Ritter and colleagues reproduced positive EMIT results by adding individual medicines to normal urine.
    • Table VI of the subsequent Saitman review identifies fluoxetine as one of the interferents in that experiment.
    • The CEDIA manufacturer reported a negative response when it tested fluoxetine at 400 micrograms/mL.

    What each source found

  • LysergolIn lab experiments, some brands reacted and others did not.
    3 sources, 2002 to 2019
    • Wiegand and colleagues challenged three assays with 144 compounds.
    • Saitman Table VI identifies lysergol as producing a positive EMIT II result at 25 micrograms/mL.
    • The CEDIA insert reported zero measurable cross-reactivity at 5 micrograms/mL, a lower challenge concentration.

    What each source found

  • MethamphetamineD-methamphetamine, DesoxynIn lab experiments, some brands reacted and others did not.
    2 sources, 2019 to 2024
    • The manufacturer measured a response near the LSD cutoff with methamphetamine at 100 µg/mL in its specificity evaluation.
    • Thermo’s CEDIA LSD test remained negative with methamphetamine at 200,000 ng/mL.
    • The insert does not specify the isomer.

    What each source found

  • MethysergideIn lab experiments, some brands reacted and others did not.
    2 sources, 2019 to 2024
    • The manufacturer measured a response near the LSD cutoff with methysergide at 3 µg/mL in its specificity evaluation.
    • Thermo’s CEDIA insert reports 0.0% cross-reactivity for methysergide maleate at 50,000 ng/mL.

    What each source found

  • PhencyclidinePCPIn lab experiments, some brands reacted and others did not.
    2 sources, 2019 to 2024
    • The manufacturer measured a response near the LSD cutoff with phencyclidine at 30 µg/mL in its specificity evaluation.
    • Thermo’s CEDIA LSD test remained negative with phencyclidine at 500,000 ng/mL.

    What each source found

  • VerapamilCalan, VerelanIn lab experiments, some brands reacted and others did not.
    3 sources, 1997 to 2019
    • Ritter and colleagues reproduced positive EMIT results by adding individual medicines to normal urine.
    • Table VI of the subsequent Saitman review identifies verapamil as one of the interferents in that experiment.
    • The CEDIA manufacturer reported a negative response when it tested verapamil at 500 micrograms/mL.

    What each source found

Tested With No False Positive, or Not Proven (11)

Suspected, but Not Proven11

A report, a list or a study names it, but no study we found showed it makes the screen read positive.

  • AtracuriumTracriumFound alongside false positives, but not shown to cause them.
    1 source, 2002

    The investigators identified atracurium among candidate interferents after profiling patient specimens whose LSD screens did not confirm by chromatography.

    What each source found

  • BupivacaineMarcaineFound alongside false positives, but not shown to cause them.
    1 source, 2002

    The investigators identified bupivacaine among candidate interferents after profiling patient specimens whose LSD screens did not confirm by chromatography.

    What each source found

  • DiphenhydramineBenadryl, Unisom SleepGelsFound alongside false positives, but not shown to cause them.
    1 source, 2002

    The investigators identified diphenhydramine among candidate interferents after profiling patient specimens whose LSD screens did not confirm by chromatography.

    What each source found

  • DoxylamineUnisom SleepTabsFound alongside false positives, but not shown to cause them.
    1 source, 2002

    The investigators identified doxylamine among candidate interferents after profiling patient specimens whose LSD screens did not confirm by chromatography.

    What each source found

  • LidocaineLignocaine, XylocaineFound alongside false positives, but not shown to cause them.
    1 source, 2002

    The investigators identified lidocaine among candidate interferents after profiling patient specimens whose LSD screens did not confirm by chromatography.

    What each source found

  • MepivacaineCarbocaineFound alongside false positives, but not shown to cause them.
    1 source, 2002

    The investigators identified mepivacaine among candidate interferents after profiling patient specimens whose LSD screens did not confirm by chromatography.

    What each source found

  • PipamperoneDipiperonFound alongside false positives, but not shown to cause them.
    1 source, 2002

    The investigators identified pipamperone among candidate interferents after profiling patient specimens whose LSD screens did not confirm by chromatography.

    What each source found

  • PrilocaineCitanestFound alongside false positives, but not shown to cause them.
    1 source, 2002

    The investigators identified prilocaine among candidate interferents after profiling patient specimens whose LSD screens did not confirm by chromatography.

    What each source found

  • PromethazinePhenerganFound alongside false positives, but not shown to cause them.
    1 source, 2002

    The investigators identified promethazine among candidate interferents after profiling patient specimens whose LSD screens did not confirm by chromatography.

    What each source found

  • RanitidineZantacFound alongside false positives, but not shown to cause them.
    2 sources, 2002 to 2019
    • Ranitidine was detected among patient specimens whose CEDIA LSD screens failed confirmation.
    • Separately, the CEDIA manufacturer reported a negative response when it tested ranitidine at 500 micrograms/mL.

    What each source found

  • TramadolConZip, UltramFound alongside false positives, but not shown to cause them.
    1 source, 2002

    The investigators identified tramadol among candidate interferents after profiling patient specimens whose LSD screens did not confirm by chromatography.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Methaqualone Test?

A dedicated methaqualone screen can recognize related compounds. The finding depends on the assay.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 2 kinds of results in this list

Has Caused a False Positive1

Studies or case reports found it can make the screen read positive for a drug that was not there. How often that happens at a usual dose is not known.

  • MecloqualoneOnly in lab experiments so far, not in people taking it.
    1 source, 2021

    Mecloqualone, a related historical sedative, gave a positive urine result at 500 ng/mL in manufacturer testing.

    What each source found

The Test Is Made to Find It1

It is the drug the test looks for, contains it, or the body turns it into it. A positive here can be real.

  • MethaqualoneQuaaludeA positive here is expected, not a false positive.
    1 source, 1996
    • Both urine screens detected exposure after six adults received methaqualone.
    • Conjugated hydroxylated metabolites accounted for much of the signal.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Nicotine (Cotinine) Test?

Nicotine metabolite (cotinine)

Nicotine replacement is one source of real cotinine. Share the product used when discussing what a positive result means.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

The Test Is Made to Find It1

It is the drug the test looks for, contains it, or the body turns it into it. A positive here can be real.

  • Nicotine replacement therapyNicotine, Nicotine gumA positive here is expected, not a false positive.
    3 sources, 1988 to 2002
    • The body makes cotinine from nicotine delivered by a patch or other replacement product.
    • Urine cotinine can therefore be present during smoking cessation.
    • An anti-cotinine ELISA also recognized trans-3′-hydroxycotinine with about 30% relative reactivity.
    • This can increase apparent cotinine after actual nicotine exposure.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Piperazines Test?

Phenylpiperazines and benzylpiperazines

Specialized Randox urine biochip channels can respond to medicines with related chemical structures or a real piperazine metabolite of a prescription medicine.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 2 kinds of results in this list

The Test Is Made to Find It1

It is the drug the test looks for, contains it, or the body turns it into it. A positive here can be real.

  • TrazodoneDesyrel, OleptroA positive here is expected, not a false positive.
    1 source, 2022

    The authors linked 10 positive piperazine results to trazodone and/or its real metabolite mCPP, a phenylpiperazine.

    What each source found

Tested With No False Positive, or Not Proven (6)

Suspected, but Not Proven6

A report, a list or a study names it, but no study we found showed it makes the screen read positive.

  • CetirizineZyrtecFound alongside false positives, but not shown to cause them.
    1 source, 2022

    The authors proposed medicines containing a piperazine structure, including Cetirizine, as explanations across seven unconfirmed results.

    What each source found

  • ClotiapineFound alongside false positives, but not shown to cause them.
    1 source, 2022

    The authors proposed medicines containing a piperazine structure, including Clotiapine, as explanations across seven unconfirmed results.

    What each source found

  • HydroxyzineAtarax, VistarilFound alongside false positives, but not shown to cause them.
    1 source, 2022

    The authors proposed medicines containing a piperazine structure, including Hydroxyzine, as explanations across seven unconfirmed results.

    What each source found

  • MirtazapineFound alongside false positives, but not shown to cause them.
    1 source, 2022

    The authors proposed medicines containing a piperazine structure, including Mirtazapine, as explanations across seven unconfirmed results.

    What each source found

  • OlanzapineFound alongside false positives, but not shown to cause them.
    1 source, 2022

    The authors proposed medicines containing a piperazine structure, including Olanzapine, as explanations across seven unconfirmed results.

    What each source found

  • QuetiapineSeroquelFound alongside false positives, but not shown to cause them.
    1 source, 2022

    The authors proposed medicines containing a piperazine structure, including Quetiapine, as explanations across seven unconfirmed results.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Pregabalin Test?

A dedicated pregabalin test can detect this prescribed medicine in urine. See the individual entries for the assay studied.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 2 kinds of results in this list

The Test Is Made to Find It1

It is the drug the test looks for, contains it, or the body turns it into it. A positive here can be real.

  • PregabalinLyrica, Lyrica CRA positive here is expected, not a false positive.
    2 sources, 2013 to 2019
    • Pregabalin is the target.
    • A volunteer study measured the drug in urine after oral pregabalin on two occasions, and the ARK assay was separately evaluated for urine pregabalin.

    What each source found

Tested With No False Positive, or Not Proven (1)

Tested: No False Positive Found1

It was tested and did not make the screen read positive. Other brands of the test can differ.

  • GabapentinNeurontinIn lab experiments, this test stayed negative.
    1 source, 2019

    The manufacturer found no cross-reaction from gabapentin at 5,000 micrograms/mL on its pregabalin urine assay.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Propoxyphene Test?

The test target is propoxyphene or a related metabolite and depends on the specific assay.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 3 kinds of results in this list

Has Caused a False Positive9

Studies or case reports found it can make the screen read positive for a drug that was not there. How often that happens at a usual dose is not known.

  • RanitidineZantacOnly in lab experiments so far, not in people taking it.
    1 source, 2022

    Adding ranitidine to urine at 800 micrograms/mL made the dedicated propoxyphene strip positive.

    What each source found

  • 6-AcetylcodeineacetylcodeineListed by a test maker or a medical reference.
    2 sources, 2009

    The compiled manufacturer data list 6-Acetylcodeine as weakly reactive at 60 micrograms/mL.

    What each source found

  • BepridilVascorListed by a test maker or a medical reference.
    2 sources, 2009

    The compiled manufacturer data list Bepridil as weakly reactive at 100 micrograms/mL.

    What each source found

  • CetirizineZyrtecListed by a test maker or a medical reference.
    2 sources, 2009

    The compiled manufacturer data list Cetirizine as weakly reactive at 50 micrograms/mL.

    What each source found

  • FexofenadineAllegraListed by a test maker or a medical reference.
    2 sources, 2009

    The compiled manufacturer data list Fexofenadine as weakly reactive at 20 micrograms/mL.

    What each source found

  • HydroxyzineAtarax, VistarilListed by a test maker or a medical reference.
    2 sources, 2009

    The compiled manufacturer data list Hydroxyzine as weakly reactive at 30 micrograms/mL.

    What each source found

  • IndomethacinIndocinListed by a test maker or a medical reference.
    2 sources, 2009

    The compiled manufacturer data list Indomethacin as weakly reactive at 70 micrograms/mL.

    What each source found

  • NortriptylinePamelorListed by a test maker or a medical reference.
    2 sources, 2009

    The compiled manufacturer data list 10-hydroxynortriptyline, a nortriptyline metabolite, as weakly reactive at 100 micrograms/mL.

    What each source found

  • OxybutyninDitropan, OxytrolListed by a test maker or a medical reference.
    2 sources, 2009

    The compiled manufacturer data list Oxybutynin as weakly reactive at 60 micrograms/mL.

    What each source found

Depends on the Brand of Test5

Some brands of the screen reacted to it and others did not, or the studies disagree. The lab can tell you which brand it used.

  • DiphenhydramineBenadryl, Unisom SleepGelsIn lab experiments, some brands reacted and others did not.
    4 sources, 1999 to 2009
    • A laboratory letter reported EMIT II interference.
    • A 2009 compilation listed weak Biosite Triage reactivity at 70 micrograms/mL but no reaction on several other evaluated reagents, including the Syva reagent in its comparison.
    • Diphenhydramine cross-reacted in urine during specificity testing of Triage PPY.

    What each source found

  • ClemastineTavistSome test makers list it and others do not.
    2 sources, 2009
    • The compiled manufacturer data list Clemastine as weakly reactive at 40 micrograms/mL.
    • The same compilation lists no reaction for Roche Cobas c.

    What each source found

  • CyclobenzaprineAmrix, FlexerilSome test makers list it and others do not.
    2 sources, 2009
    • The 2009 manufacturer-data review lists weak reactivity at 99 micrograms/mL on Abbott and 80 on Syva.
    • Biosite Triage did not react under the reported conditions.

    What each source found

  • ImipramineTofranilSome test makers list it and others do not.
    2 sources, 2009
    • The 2009 manufacturer-data review lists weak reactivity at 40 micrograms/mL on Abbott and 30 on Syva.
    • Beckman, Biosite Triage, Microgenics DRI and Roche Cobas c did not react under the reported conditions.

    What each source found

  • MethaqualoneQuaaludeSome test makers list it and others do not.
    2 sources, 2009
    • The compiled manufacturer data list Methaqualone as weakly reactive at 100 micrograms/mL.
    • Abbott Architect, Beckman, Microgenics DRI, Roche and Syva were listed as unreactive.

    What each source found

The Test Is Made to Find It1

It is the drug the test looks for, contains it, or the body turns it into it. A positive here can be real.

  • PropoxypheneDarvon, DextropropoxypheneA positive here is expected, not a false positive.
    1 source, 1993

    This test detected propoxyphene, and measured its genuine major metabolite norpropoxyphene with 29.3–92.6% cross-reactivity depending on concentration.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Synthetic Cathinones Test?

Synthetic cathinones

This specialty urine panel targets selected synthetic cathinones. Check which compounds the laboratory's panel covers.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 2 kinds of results in this list

Has Caused a False Positive1

Studies or case reports found it can make the screen read positive for a drug that was not there. How often that happens at a usual dose is not known.

  • TramadolConZip, UltramSeen in people taking it, and again in lab experiments.
    1 source, 2021
    • An in-source fragment of N,N-bisdesmethyltramadol co-eluted with 4-MePPP and produced an incorrect mass-spectral library match.
    • Reference material confirmed the interference.

    What each source found

Tested With No False Positive, or Not Proven (2)

Tested: No False Positive Found2

It was tested and did not make the screen read positive. Other brands of the test can differ.

  • EphedrineAkovazIn lab experiments, this test stayed negative.
    1 source, 2014
    • In a urine validation study, ephedrine produced results below the detection limit for both antibodies.
    • One targeted mephedrone/methcathinone and the other targeted MDPV/MDPBP.

    What each source found

  • PseudoephedrineSudafedIn lab experiments, this test stayed negative.
    1 source, 2014
    • In a urine validation study, pseudoephedrine produced results below the detection limit for both antibodies.
    • One targeted mephedrone/methcathinone and the other targeted MDPV/MDPBP.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Tapentadol Test?

Check the name and version of the reagent when comparing a result with published research.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

Depends on the Brand of Test1

Some brands of the screen reacted to it and others did not, or the studies disagree. The lab can tell you which brand it used.

  • TramadolConZip, UltramIn people taking it, some brands reacted and others did not.
    1 source, 2025
    • Twenty-eight samples with a false positive on the original test were negative on the reformulated test and lacked tapentadol by LC-MS/MS.
    • The original reagent showed interference from tramadol-containing urine.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Tramadol Test?

A dedicated tramadol test and a general opiates screen look for different targets.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 2 kinds of results in this list
Tested With No False Positive, or Not Proven (4)

Suspected, but Not Proven3

A report, a list or a study names it, but no study we found showed it makes the screen read positive.

  • DesvenlafaxineKhedezla, O-desmethylvenlafaxineFound alongside false positives, but not shown to cause them.
    1 source, 2022

    The authors proposed O-desmethylvenlafaxine, the active metabolite of venlafaxine, as a possible explanation for unconfirmed tramadol screens.

    What each source found

  • VenlafaxineEffexor, Effexor XRFound alongside false positives, but not shown to cause them.
    1 source, 2022

    The authors proposed O-desmethylvenlafaxine, the active metabolite of venlafaxine, as a possible explanation for unconfirmed tramadol screens.

    What each source found

  • FexofenadineAllegraSuspected in a case report, but not shown to cause it.
    1 source, 2023
    • Two patients taking 180 mg/day had unexpected tramadol strip results.
    • The report associated the screens with fexofenadine.

    What each source found

Tested: No False Positive Found1

It was tested and did not make the screen read positive. Other brands of the test can differ.

  • DiphenhydramineBenadryl, Unisom SleepGelsIn lab experiments, this test stayed negative.
    1 source, 2025

    Diphenhydramine added at 100 µg/mL did not change the tramadol result in drug-free urine or urine close to the cutoff.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Tricyclic Antidepressants Test?

Tricyclic antidepressants (TCA)

A TCA screen can react with compounds of similar structure. Verify whether the study tested urine or serum before applying it.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 5 kinds of results in this list

Has Caused a False Positive19

Studies or case reports found it can make the screen read positive for a drug that was not there. How often that happens at a usual dose is not known.

  • CyclobenzaprineAmrix, FlexerilSeen in people taking it, and again in lab experiments.
    4 sources, 1997 to 2013
    • The muscle relaxant reacted with urine TCA screening in emergency department patients and in spiked urine.
    • One comparison found false positives more often with Biosite than with Syva.
    • Cyclobenzaprine alone at 1,000 ng/mL produced a positive result on the NexScreen cup despite a higher manufacturer-listed concentration.

    What each source found

  • ProchlorperazineCompazineSeen in people taking it, and a second test proved it false.
    2 sources, 2009

    The case-level supplementary table identifies prochlorperazine by GC-MS and lists it as the probable explanation for a Biosite Triage urine TCA result.

    What each source found

  • AlimemazinetrimeprazineOnly in lab experiments so far, not in people taking it.
    1 source, 2019

    In manufacturer testing submitted to FDA, adding trimeprazine to urine produced a TCA-positive result at 83.5 micrograms/mL.

    What each source found

  • ChlorprothixeneTruxalOnly in lab experiments so far, not in people taking it.
    2 sources, 2009 to 2019

    In manufacturer testing submitted to FDA, adding chlorprothixene to urine produced a TCA-positive result at 40 micrograms/mL.

    What each source found

  • CorticosteroneOnly in lab experiments so far, not in people taking it.
    1 source, 2009

    The 2009 comparison lists reactivity at 75,000 ng/mL for Corticosterone on the Biosite Triage screen.

    What each source found

  • DeoxycorticosteroneOnly in lab experiments so far, not in people taking it.
    1 source, 2009

    The 2009 comparison lists reactivity at 75,000 ng/mL for Deoxycorticosterone on the Biosite Triage screen.

    What each source found

  • MaprotilineLudiomilOnly in lab experiments so far, not in people taking it.
    2 sources, 2009 to 2019

    In manufacturer testing submitted to FDA, adding maprotiline to urine produced a TCA-positive result at 240 micrograms/mL.

    What each source found

  • PerphenazineTrilafonOnly in lab experiments so far, not in people taking it.
    2 sources, 2009 to 2019

    In manufacturer testing submitted to FDA, adding perphenazine to urine produced a TCA-positive result at 175 micrograms/mL.

    What each source found

  • PhenothiazineOnly in lab experiments so far, not in people taking it.
    1 source, 2009
    • The 2009 comparison lists reactivity at 60,000 ng/mL for Phenothiazine on the Biosite Triage screen.
    • The tested substance was the parent chemical.
    • Individual phenothiazine medicines have their own results.

    What each source found

  • PromazineSparineOnly in lab experiments so far, not in people taking it.
    2 sources, 2009 to 2019

    In manufacturer testing submitted to FDA, adding promazine to urine produced a TCA-positive result at 35 micrograms/mL.

    What each source found

  • RimcazoleOnly in lab experiments so far, not in people taking it.
    1 source, 2009

    The 2009 comparison lists reactivity at 50,000 ng/mL for Rimcazole on the Biosite Triage screen.

    What each source found

  • ClozapineClozarilListed by a test maker or a medical reference.
    2 sources, 2009

    A 2009 compilation of assay specifications lists clozapine as reactive on the Biosite Triage urine test at 100 micrograms/mL.

    What each source found

  • LisurideDoperginListed by a test maker or a medical reference.
    2 sources, 2009

    A 2009 compilation of assay specifications lists lisuride as reactive on the Biosite Triage urine test at 7.5 micrograms/mL.

    What each source found

  • NefazodoneSerzoneListed by a test maker or a medical reference.
    2 sources, 2009

    A 2009 compilation of assay specifications lists nefazodone as reactive on the Biosite Triage urine test at 100 micrograms/mL.

    What each source found

  • PerazineTaxilanListed by a test maker or a medical reference.
    2 sources, 2009

    A 2009 compilation of assay specifications lists perazine as reactive on the Biosite Triage urine test at 10 micrograms/mL.

    What each source found

  • PrednisoneDeltasoneListed by a test maker or a medical reference.
    2 sources, 2009

    A 2009 compilation of assay specifications lists prednisone as reactive on the Biosite Triage urine test at 50 micrograms/mL.

    What each source found

  • ProgesteronePrometriumListed by a test maker or a medical reference.
    2 sources, 2009

    A 2009 compilation of assay specifications lists progesterone as reactive on the Biosite Triage urine test at 75 micrograms/mL.

    What each source found

  • ThiothixeneNavaneListed by a test maker or a medical reference.
    2 sources, 2009

    A 2009 compilation of assay specifications lists thiothixene as reactive on the Biosite Triage urine test at 20 micrograms/mL.

    What each source found

  • ZaleplonSonataListed by a test maker or a medical reference.
    2 sources, 2009

    A 2009 compilation of assay specifications lists zaleplon as reactive on the Biosite Triage urine test at 65 micrograms/mL.

    What each source found

Depends on the Brand of Test5

Some brands of the screen reacted to it and others did not, or the studies disagree. The lab can tell you which brand it used.

  • CarbamazepineCarbatrol, TegretolIn people and in lab experiments, some brands reacted and others did not.
    7 sources, 2007 to 2022
    • The pediatric study found interference in serum, with none on its urine assay.
    • On PROFILE-V MEDTOXScan, carbamazepine and its 10,11-epoxide were each negative at 100,000 ng/mL.
    • On DRI, neither 5,000 ng/mL of carbamazepine nor 30,000 ng/mL of the epoxide changed the urine controls.
    • A historical Biosite Triage table lists no response to the parent drug, but its iminostilbene metabolite reached the equivalent cutoff at 75,000 ng/mL.

    What each source found

  • ChlorpromazineThorazineIn people and in lab experiments, some brands reacted and others did not.
    6 sources, 2009 to 2022
    • Chlorpromazine at 600 ng/mL reached the DRI cutoff.
    • On PROFILE-V MEDTOXScan it remained negative even at 100,000 ng/mL.
    • A historical Biosite Triage table lists a cutoff-equivalent response at 50,000 ng/mL.
    • Investigators also identified chlorpromazine in a hospital specimen and in postmortem specimens with unconfirmed TCA results.

    What each source found

  • DiphenhydramineBenadryl, Unisom SleepGelsIn people and in lab experiments, some brands reacted and others did not.
    5 sources, 2013 to 2026
    • Two adolescent overdose cases produced TCA-positive screens.
    • In a urine spiking experiment, the screen changed from negative at 100 micrograms/mL diphenhydramine to positive at 500.
    • The patients’ urine contained less parent drug, so metabolites may have contributed.
    • The authors reported no cup interference with Diphenhydramine added at 1,000 ng/mL in drug-free urine.

    What each source found

  • QuetiapineSeroquelIn people and in lab experiments, some brands reacted and others did not.
    5 sources, 2000 to 2022
    • Urine from a patient taking prescribed quetiapine and from an overdose patient tested positive with Syva and Microgenics.
    • Both specimens were negative on Biosite Triage, which also remained negative in the laboratory challenge.
    • The authors found Quetiapine among medicines present in specimens with unconfirmed TCA results across the three devices.
    • Quetiapine was among medications identified across the TCA-negative-by-mass-spectrometry cases with positive screening results in a 340-autopsy series.

    What each source found

  • CyproheptadinePeriactinIn lab experiments, some brands reacted and others did not.
    2 sources, 2025
    • Cyproheptadine reacted on the Randox urine TCA assay at about 230 ng/mL.
    • On the Healgen dip card, adding 100 µg/mL of cyproheptadine did not change the TCA result.

    What each source found

The Test Is Made to Find It7

It is the drug the test looks for, contains it, or the body turns it into it. A positive here can be real.

  • ClomipramineAnafranilA positive here is expected, not a false positive.
    3 sources, 1990 to 2007
    • Clomipramine belongs to the target class and produced a reaction in spiked urine on Triage Plus.
    • However, a clinical comparison found that two point-of-care urine assays did not detect every patient with elevated serum concentrations.
    • Both assays detected clomipramine at 1,000 ng/mL.
    • The Syva system missed it at 400 ng/mL.

    What each source found

  • AmitriptylineElavilA positive here is expected, not a false positive.
    1 source, 2007
    • Amitriptyline is itself a tricyclic antidepressant.
    • The two urine assays detected patients across a range of serum concentrations in the comparative study.

    What each source found

  • DesipramineNorpraminA positive here is expected, not a false positive.
    1 source, 2007
    • Desipramine is itself a tricyclic antidepressant.
    • The two urine assays detected patients across a range of serum concentrations in the comparative study.

    What each source found

  • DoxepinSilenor, SinequanA positive here is expected, not a false positive.
    1 source, 2007
    • Doxepin is itself a tricyclic antidepressant.
    • The two urine assays detected patients across a range of serum concentrations in the comparative study.

    What each source found

  • ImipramineTofranilA positive here is expected, not a false positive.
    1 source, 2007
    • Imipramine is itself a tricyclic antidepressant.
    • The two urine assays detected patients across a range of serum concentrations in the comparative study.

    What each source found

  • NortriptylinePamelorA positive here is expected, not a false positive.
    1 source, 2007
    • Nortriptyline is itself a tricyclic antidepressant.
    • The two urine assays detected patients across a range of serum concentrations in the comparative study.

    What each source found

  • ProtriptylineVivactilA positive here is expected, not a false positive.
    1 source, 1997

    Protriptyline, a tricyclic antidepressant, produced a positive result in urine spiked at the study cutoff.

    What each source found

Tested With No False Positive, or Not Proven (9)

Suspected, but Not Proven4

A report, a list or a study names it, but no study we found showed it makes the screen read positive.

  • HydroxyzineAtarax, VistarilSuspected, but the studies did not show it.
    7 sources, 2007 to 2022
    • In hospital records, people with a documented hydroxyzine exposure had about twice the odds of an unconfirmed Abbott urine TCA result.
    • On DRI, adding 5,000 ng/mL of hydroxyzine to urine preserved both the negative and positive control results.
    • Rapid TOX lists hydroxyzine among compounds its urine panel did not detect below 100,000 ng/mL.

    What each source found

  • TopiramateTopamax, Trokendi XRFound alongside false positives, but not shown to cause them.
    2 sources, 2009

    A discordant Triage urine contained a high apparent concentration of topiramate.

    What each source found

  • VenlafaxineEffexor, Effexor XRFound alongside false positives, but not shown to cause them.
    2 sources, 2009

    Several discordant Triage urines contained high apparent concentrations of venlafaxine and desvenlafaxine.

    What each source found

  • LevomepromazineNozinan, methotrimeprazineSuspected in a case report, but not shown to cause it.
    1 source, 2012
    • A patient who reported taking levomepromazine (Tisercin) and a stimulant supplement had a positive TCA screen.
    • The investigators detected phenothiazines by chromatography and suggested that this drug class explained the result.

    What each source found

Tested: No False Positive Found5

It was tested and did not make the screen read positive. Other brands of the test can differ.

  • BenzocaineAnbesol, Anbesol Maximum StrengthIn people and in lab experiments, this test stayed negative.
    6 sources, 2009 to 2023
    • Benzocaine at 100 µg/mL did not cause a false positive on three urine TCA devices tested in the laboratory.
    • Hospital records showed no clear link between benzocaine exposure and an unconfirmed TCA result.

    What each source found

  • OxcarbazepineOxtellar XR, TrileptalIn people taking it, this test stayed negative.
    1 source, 2007

    In a pediatric study, children taking oxcarbazepine showed no significant TCA activity on the urine assay.

    What each source found

  • AcetaminophenParacetamol, TylenolIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors reported no cup interference with Acetaminophen added at 1,000 ng/mL in drug-free urine.

    What each source found

  • DextromethorphanDelsym, DXMIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors reported no cup interference with Dextromethorphan added at 1,000 ng/mL in drug-free urine.

    What each source found

  • MeprobamateEquanil, MiltownIn lab experiments, this test stayed negative.
    1 source, 2013

    The authors reported no cup interference with Meprobamate added at 1,000 ng/mL in drug-free urine.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Xylazine Test?

These studies concern urine. Investigational and commercial xylazine tests have different cutoffs and can respond differently to the same medicine. A 10 ng/mL investigational dipstick detected clonidine in fortified urine and also recognized a genuine xylazine metabolite.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 2 kinds of results in this list

Has Caused a False Positive1

Studies or case reports found it can make the screen read positive for a drug that was not there. How often that happens at a usual dose is not known.

  • ClonidineCatapres, KapvayOnly in lab experiments so far, not in people taking it.
    1 source, 2025
    • Clonidine added to drug-free urine triggered the investigational xylazine dipstick at 300 ng/mL.
    • The authors calculated 3% relative cross-reactivity.

    What each source found

Depends on the Brand of Test1

Some brands of the screen reacted to it and others did not, or the studies disagree. The lab can tell you which brand it used.

  • LidocaineLignocaine, XylocaineIn people and in lab experiments, some brands reacted and others did not.
    3 sources, 2025
    • In the BTNX study, three of 42 qualitative mass-spectrometry-negative urine samples screened positive.
    • The authors identified lidocaine as a likely interferent.
    • A separate research team listed lidocaine among the compounds that did not cross-react with its 10 ng/mL clinical dipstick in drug-free urine.

    What each source found

What these labels mean What to do next

What Can Cause a False Positive Zolpidem (Ambien) Test?

Zolpidem

These tests specifically screen for zolpidem. Other sleep medicines were examined as comparators in the assay validation.

Grouped by what the research found. Each entry also says how it was studied. Tap one for the details.

See the 2 kinds of results in this list

The Test Is Made to Find It1

It is the drug the test looks for, contains it, or the body turns it into it. A positive here can be real.

  • ZolpidemAmbien, Ambien CRA positive here is expected, not a false positive.
    3 sources, 2008 to 2011
    • Targeted urine testing can detect prescribed zolpidem.
    • A study of patients taking their prescriptions compared two zolpidem screens with GC-MS.
    • The zolpidem immunoassay positives in this DUI comparison were confirmed for zolpidem.

    What each source found

Tested With No False Positive, or Not Proven (2)

Tested: No False Positive Found2

It was tested and did not make the screen read positive. Other brands of the test can differ.

  • ZaleplonSonataIn lab experiments, this test stayed negative.
    2 sources, 2008 to 2009
    • The study reported no cross-reaction from zaleplon with the zolpidem antibody.
    • Zaleplon added to urine at 1,000 ng/mL did not trigger this zolpidem screen.

    What each source found

  • ZopicloneImovane, ZimovaneIn lab experiments, this test stayed negative.
    2 sources, 2008 to 2009
    • The study reported no cross-reaction from zopiclone with this zolpidem antibody.
    • Zopiclone added to urine at 1,000 ng/mL did not trigger this zolpidem screen.

    What each source found

What these labels mean What to do next

Ask About a Drug Test

Ask in your own words about a test, a medicine or a result.

Try one

AI answers from this guide’s research records only, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist. How we use AI

What to Do After an Unexpected Positive

A medicine on this page can explain a screen, but only the lab can say what is really in your sample.

  • Ask What Was Found

    Ask which drug screened positive, which test the lab used, and whether it confirmed the result on the original sample.

  • Share Everything You Take

    Give the person reviewing the result your prescriptions, over-the-counter medicines and supplements, by their exact names.

  • Ask for a Confirmation Test

    A lab can often check for the specific drug and its breakdown products using GC-MS or LC-MS/MS. With a home kit, follow its instructions for sending the sample to a lab.

  • Keep Taking Your Medicine

    Keep taking it as prescribed while you discuss the result with the person who ordered the test. Ask them to review it with the lab before any change to your treatment.

  • If It Was a Workplace Test

    In a federally required workplace test, the lab confirms a positive screen and a Medical Review Officer, a doctor, asks you about your prescriptions before anything is reported to your employer. Many other workplace programs work the same way: have your prescription details ready for that call.

How a Urine Drug Test Works

First: The Screen

A fast test, in a cup, a strip or a lab machine. Some medicines, or what the body turns them into, react with it too. That is a false positive.

Then: The Confirmation

A second test on the sample, such as GC-MS or LC-MS/MS. It identifies the specific drug or its breakdown product.

  • The brand of screen matters. Each brand reacts to its own set of medicines, so a study of one brand does not settle another. That is why many entries here say “Depends on the test.”
  • A lab finding is not a rate. Many entries come from labs adding a medicine to urine, often in large amounts. They show a screen can react, not how often it happens at usual doses.
  • A positive can be real. Some medicines contain the tested drug or turn into it, like a prescribed stimulant on an amphetamine screen. A confirmed result means the drug or its breakdown product was found; it cannot say how much was taken or why.

What the Labels Mean

  • Has Caused a False Positive Studies or case reports found it can make the screen read positive for a drug that was not there. How often that happens at a usual dose is not known.
  • Depends on the Brand of Test Some brands of the screen reacted to it and others did not, or the studies disagree. The lab can tell you which brand it used.
  • The Test Is Made to Find It It is the drug the test looks for, contains it, or the body turns it into it. A positive here can be real.
  • A Problem With the Urine Sample Something already in the urine, or what happened to the sample after it was collected, affected the result.
  • Suspected, but Not Proven A report, a list or a study names it, but no study we found showed it makes the screen read positive.
  • Tested: No False Positive Found It was tested and did not make the screen read positive. Other brands of the test can differ.

How It Was Studied, Strongest Evidence First

This says how the question was studied, not what was found. Each entry’s result is on its own line.

Studied in patients and in the lab
Patients’ samples or records were studied, and the medicine was also tested in a lab.
Studied in people
A study of people’s urine samples or records.
Case report
Reported in one person, or a few.
Lab testing
A lab added the medicine to urine and the screen reacted, or did not.
Reference or test insert
Listed by a test maker or a clinical reference.

Every Medicine in This Guide, A to Z

528 medicines, foods and other things, each with the urine tests it has a record for. Tap a test to read the record.

See all 528, A to Z

0-9

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

X

Z

Drug Test False Positive Questions

What can cause a false positive drug test?

A quick urine drug screen can react to some medicines, or to what the body turns them into, and read positive for a drug you did not take. Which medicines do it depends on the test and its brand. Medicines reported to do it include:

  • Fentanyl screens: trazodone, risperidone and paliperidone.
  • Amphetamines screens: bupropion, labetalol and trazodone.
  • Opiates screens: levofloxacin, ofloxacin and doxylamine.
  • Benzodiazepines screens: efavirenz, oxaprozin and fluoxetine.
  • THC (Marijuana) screens: ibuprofen, naproxen and raltegravir.
  • A lab can check a positive screen with a more specific test, such as GC-MS or LC-MS/MS, which identifies the drug itself.

Can a medicine show up on a drug test?

Yes, in two ways. A medicine can show up as itself, or it can make a quick screen read positive for a drug you did not take.

  • As itself, when the test looks for that kind of drug: codeine on an opiate screen, alprazolam (Xanax) on a benzodiazepine screen and lisdexamfetamine (Vyvanse) on an amphetamine screen.
  • As something else, when a quick screen reacts to it: reported examples include trazodone on some fentanyl screens and bupropion on some amphetamine screens.
  • Look up your medicine at the top of this page to see which urine tests it has been studied on.

What can cause a false positive for fentanyl?

Medicines reported to make some fentanyl screens read positive include trazodone, risperidone, paliperidone and ciprofloxacin.

  • Some depend on which brand of test the lab used, such as labetalol, loperamide and alfentanil.
  • The test can also catch related drugs, such as butyrylfentanyl, 3 methylthienylfentanyl and acetylfentanyl.
  • A positive can be real after fentanyl, which contain or turn into what the test looks for.
  • Use this section when the report specifically says fentanyl. Laboratories use different fentanyl assays, and their responses to other medicines can differ.

What can cause a false positive for amphetamines?

Medicines reported to make some amphetamine screens read positive include bupropion, labetalol, trazodone and bisoprolol.

  • Some depend on which brand of test the lab used, such as amineptine, aripiprazole and atomoxetine.
  • The test can also catch related drugs, such as 4-Fluoroamphetamine, MDA and MDMA.
  • A positive can be real after amphetaminil, clobenzorex and dimethylamphetamine, which contain or turn into what the test looks for.
  • Check whether the report names an amphetamine class screen, methamphetamine, or MDMA. The targets and cross-reactions differ.

What can cause a false positive for opiates?

Medicines reported to make some opiate screens read positive include levofloxacin, ofloxacin, doxylamine and gatifloxacin.

  • Some depend on which brand of test the lab used, such as ciprofloxacin, dextromethorphan and diphenhydramine.
  • The test can also catch related drugs, such as hydrocodone, hydromorphone and pholcodine.
  • A positive can be real after codeine, heroin and morphine, which contain or turn into what the test looks for.
  • “Opiates” on a report usually refers to a morphine-directed assay. Fentanyl, methadone, buprenorphine and oxycodone often have their own test lines.

What can cause a false positive for benzodiazepines?

Medicines reported to make some benzodiazepine screens read positive include efavirenz, oxaprozin, fluoxetine and pirfenidone.

  • Some depend on which brand of test the lab used, such as nefopam, sertraline and fenoprofen.
  • The test can also catch related drugs, such as bentazepam, flualprazolam and rilmazafone.
  • A positive can be real after alprazolam, clonazepam and clonazolam, which contain or turn into what the test looks for.
  • The test may react to several members of the class or to other medicines. Some common benzodiazepines are also missed by certain assays.

What can cause a false positive for THC (marijuana)?

Medicines reported to make some THC screens read positive include ibuprofen, naproxen, raltegravir and rotigotine.

  • Some depend on which brand of test the lab used, such as cannabidiol, efavirenz and niflumic acid.
  • The test can also catch related drugs, such as Delta-10 THC, Delta-8 THC and hexahydrocannabinol.
  • A positive can be real after dronabinol and CBD products containing delta-9 THC, which contain or turn into what the test looks for.
  • A routine urine cannabis test usually looks for a THC metabolite. The source of a confirmed metabolite and whether a person is impaired are separate questions.

Can poppy seeds make you fail a drug test?

Controlled ingestion of raw seeds containing measured morphine and codeine produced genuine urine morphine and codeine. Which samples were positive varied with the cutoff.

  • Food is the source of real opiate molecules here. Seed content and preparation differ. A definitive heroin-metabolite result requires a separate explanation.

Can CBD make you fail a drug test for THC?

Pure CBD did not convert to THC in a controlled study that included prescription cannabidiol. In a separate spiking study, six cannabinoid kits did not react to CBD itself, although some reacted to its 6-hydroxy or 7-hydroxy metabolites. The modified assay yielded 0.08% relative response to Cannabidiol.

  • A single administration study and spiked urine do not establish what every CBD dose or kit will do. Products containing THC present a separate explanation. The study spiked a negative calibrator for a modified, low-cutoff urine screening program. Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.

What does a positive screen tell me?

A rapid urine screen gives a preliminary result. Some medicines or their breakdown products react with the test. The brand of the test and the compound it looks for can change the answer.

What should I ask if a result surprises me?

Ask which substance screened positive, which test the lab used, and whether it confirmed the result on the original sample. Give the reviewer your prescriptions, over-the-counter medicines and supplements. A lab can often check for the specific drug and its metabolites using LC-MS/MS or GC-MS. With a home kit, follow the instructions for sending the sample to the lab.

Should I change my medicine?

Keep taking your medicine as prescribed while you discuss the result with the person who ordered the test. Ask them to review the result with the lab before making a decision about your treatment.

What if the result was already confirmed?

The medicine list here mainly explains preliminary screens. If a specific drug or metabolite was confirmed, ask the lab what it identified. A prescription or another genuine exposure can sometimes explain the finding. A urine result alone cannot establish a dose, impairment, or why someone took a substance. Rare method-specific problems have been described even with mass spectrometry. The laboratory can review the exact method if a confirmed result remains unexplained.

Does a missing medicine mean my result is accurate?

It means this library has no reviewed match under that name. Check the active ingredients on the package and ask the lab about its particular assay. A study in urine also cannot establish what happens on a saliva, blood or hair test.

Can something other than my medicine explain a false positive?

Yes. For example, a lab traced a buprenorphine screen to carryover from the preceding sample on its instrument. A different case had an unconfirmed cocaine screen with no specific interfering medicine established. A medication list alone cannot settle either situation.

More Answers From Our Pharmacists

Where This Comes From

  • Our pharmacists’ review of the published research on urine drug screens, through November 21, 2026: studies of people’s samples, case reports, and lab experiments, found through PubMed and the references in each paper.
  • The test makers’ own instructions and the FDA’s clearance summaries for the screens, which list the medicines each brand was checked against.
  • Clinical guidance on reading urine drug tests, including the ADLM laboratory guidance and the American College of Medical Toxicology’s statements on opioid and THC results, and the FDA’s guidance on home drug tests.
  • Each entry above names the test it concerns and cites the work behind it. 1236 entries in all, for 43 urine tests. This guide is about urine; a saliva, blood or hair test can behave differently.

Every source in this guide (488)

This guide is for information, not medical or legal advice. It cannot say what any one test will do, or what caused your result. Ask the lab, the person who ordered the test, or your pharmacist. Ask our pharmacists, free.